List of Predicted Activities
No - number of activity
Active compounds - number of active compounds
IAP - Invariant accuracy of prediction
This is Activities List for PASS Online
| No | Activity Type | Active compounds | IAP |
| 1 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase inhibitor | 6 | 0.9555 |
| 2 | (R)-3-amino-2-methylpropionate-pyruvate transaminase inhibitor | 24 | 0.9969 |
| 3 | (R)-6-hydroxynicotine oxidase inhibitor | 3 | 0.9296 |
| 4 | (R)-aminopropanol dehydrogenase inhibitor | 10 | 0.9906 |
| 5 | (R)-limonene 6-monooxygenase inhibitor | 3 | 0.9969 |
| 6 | (R)-Pantolactone dehydrogenase (flavin) inhibitor | 8 | 0.8724 |
| 7 | (R,R)-butanediol dehydrogenase inhibitor | 3 | 0.9947 |
| 8 | (S)-2-hydroxy-acid oxidase inhibitor | 28 | 0.9258 |
| 9 | (S)-2-Methylmalate dehydratase inhibitor | 4 | 0.9965 |
| 10 | (S)-3-amino-2-methylpropionate transaminase inhibitor | 8 | 0.9543 |
| 11 | (S)-3-hydroxyacid ester dehydrogenase inhibitor | 3 | 0.9908 |
| 12 | (S)-6-hydroxynicotine oxidase inhibitor | 4 | 0.9526 |
| 13 | (S)-carnitine 3-dehydrogenase inhibitor | 7 | 0.9877 |
| 14 | (S)-methylmalonyl-CoA hydrolase inhibitor | 8 | 1.0000 |
| 15 | [3-methyl-2-oxobutanoate dehydrogenase (lipoamide)] kinase inhibitor | 34 | 0.9919 |
| 16 | [3-methyl-2-oxobutanoate dehydrogenase (lipoamide)]-phosphatase inhibitor | 12 | 0.9998 |
| 17 | [acetyl-CoA carboxylase] kinase inhibitor | 6 | 0.9955 |
| 18 | [acyl-carrier-protein] S-acetyltransferase inhibitor | 7 | 0.9562 |
| 19 | [acyl-carrier-protein] S-malonyltransferase inhibitor | 10 | 0.9873 |
| 20 | [citrate-(pro-3S)-lyase] thiolesterase inhibitor | 4 | 0.9992 |
| 21 | [glutamate-ammonia-ligase] adenylyltransferase inhibitor | 13 | 0.9971 |
| 22 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase inhibitor | 11 | 0.9555 |
| 23 | [hydroxymethylglutaryl-CoA reductase (NADPH)]-phosphatase inhibitor | 8 | 0.9981 |
| 24 | [Isocitrate dehydrogenase (NADP+)] kinase inhibitor | 9 | 0.9979 |
| 25 | [myelin basic protein]-arginine N-methyltransferase inhibitor | 3 | 0.9841 |
| 26 | [phosphorylase] phosphatase inhibitor | 14 | 0.9449 |
| 27 | [protein-PII] uridylyltransferase inhibitor | 27 | 0.9973 |
| 28 | [Skp1-protein]-hydroxyproline N-acetylglucosaminyltransferase inhibitor | 5 | 0.9974 |
| 29 | 1,2-alpha-L-fucosidase inhibitor | 5 | 0.9483 |
| 30 | 1,3-Beta-glucan synthase inhibitor | 3 | 0.9992 |
| 31 | 1,4-Alpha-glucan branching enzyme inhibitor | 4 | 0.9592 |
| 32 | 1,4-Lactonase inhibitor | 4 | 0.8081 |
| 33 | 1,5-Anhydro-D-fructose reductase inhibitor | 9 | 0.9925 |
| 34 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 1737 | 0.9921 |
| 35 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 253 | 0.9977 |
| 36 | 11-Beta-hydroxysteroid dehydrogenase inhibitor | 1789 | 0.9917 |
| 37 | 11-Cis-retinyl-palmitate hydrolase inhibitor | 4 | 0.9960 |
| 38 | 12-Lipoxygenase inhibitor | 86 | 0.9768 |
| 39 | 15-Hydroxyprostaglandin-D dehydrogenase (NADP+) inhibitor | 8 | 0.9686 |
| 40 | 15-Lipoxygenase inhibitor | 269 | 0.9827 |
| 41 | 17-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 49 | 0.9816 |
| 42 | 17-Beta-hydroxysteroid dehydrogenase 5 inhibitor | 6 | 1.0000 |
| 43 | 1-Acylglycerol-3-phosphate O-acyltransferase inhibitor | 45 | 0.8821 |
| 44 | 1-Alkyl-2-acetylglycerol O-acyltransferase inhibitor | 3 | 0.9979 |
| 45 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 441 | 0.9926 |
| 46 | 1-Alkylglycerophosphocholine O-acetyltransferase inhibitor | 24 | 0.9261 |
| 47 | 1-Aminocyclopropane-1-carboxylate deaminase inhibitor | 11 | 0.9876 |
| 48 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 12 | 0.9982 |
| 49 | 1-Phosphofructokinase inhibitor | 9 | 0.9905 |
| 50 | 1-Pyrroline-5-carboxylate dehydrogenase inhibitor | 24 | 0.9895 |
| 51 | 2-(acetamidomethylene)succinate hydrolase inhibitor | 11 | 0.9991 |
| 52 | 2,2-Dialkylglycine decarboxylase (pyruvate) inhibitor | 7 | 0.9888 |
| 53 | 2,3,4,5-Tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase inhibitor | 5 | 0.9715 |
| 54 | 2,3-Dihydroxyindole 2,3-dioxygenase inhibitor | 4 | 0.9852 |
| 55 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 142 | 0.9882 |
| 56 | 2,4-Diaminopentanoate dehydrogenase inhibitor | 3 | 0.9896 |
| 57 | 2,4-Dichlorophenol 6-monooxygenase inhibitor | 9 | 0.9714 |
| 58 | 2,5-Dihydroxypyridine 5,6-dioxygenase inhibitor | 7 | 0.9896 |
| 59 | 2,6-Dihydroxypyridine 3-monooxygenase inhibitor | 3 | 0.9829 |
| 60 | 27-Hydroxycholesterol 7alpha-monooxygenase inhibitor | 6 | 0.8289 |
| 61 | 2-Acylglycerol O-acyltransferase inhibitor | 18 | 0.9388 |
| 62 | 2-Amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase inhibitor | 4 | 0.9987 |
| 63 | 2-Aminoadipate transaminase inhibitor | 6 | 0.9850 |
| 64 | 2-Aminoethylphosphonate-pyruvate transaminase inhibitor | 9 | 0.9906 |
| 65 | 2-Aminohexano-6-lactam racemase inhibitor | 19 | 0.9847 |
| 66 | 2-Aminohexanoate transaminase inhibitor | 3 | 1.0000 |
| 67 | 2-Dehydro-3-deoxy-L-arabinonate dehydratase inhibitor | 4 | 0.9936 |
| 68 | 2-Dehydro-3-deoxy-phosphogluconate aldolase inhibitor | 6 | 0.9916 |
| 69 | 2-Dehydropantoate 2-reductase inhibitor | 7 | 0.8106 |
| 70 | 2-Dehydropantoate aldolase inhibitor | 3 | 0.9918 |
| 71 | 2-Dehydropantolactone reductase (A-specific) inhibitor | 10 | 0.9909 |
| 72 | 2-Enoate reductase inhibitor | 10 | 0.9618 |
| 73 | 2-Ethylmalate synthase inhibitor | 3 | 0.9996 |
| 74 | 2-Haloacid dehalogenase (configuration-inverting) inhibitor | 6 | 0.9858 |
| 75 | 2-Haloacid dehalogenase inhibitor | 3 | 0.9735 |
| 76 | 2-Hydroxy-3-oxoadipate synthase inhibitor | 3 | 0.9827 |
| 77 | 2-Hydroxy-3-oxopropionate reductase inhibitor | 5 | 0.9904 |
| 78 | 2-Hydroxyacylsphingosine 1-beta-galactosyltransferase inhibitor | 3 | 1.0000 |
| 79 | 2-Hydroxymuconate-semialdehyde hydrolase inhibitor | 7 | 0.9331 |
| 80 | 2-Hydroxyquinoline 8-monooxygenase inhibitor | 6 | 0.8414 |
| 81 | 2-Isopropylmalate synthase inhibitor | 15 | 0.9984 |
| 82 | 2-Methylacyl-CoA dehydrogenase inhibitor | 7 | 0.9850 |
| 83 | 2-Methyl-branched-chain-enoyl-CoA reductase inhibitor | 5 | 0.9799 |
| 84 | 2-Methylcitrate dehydratase inhibitor | 4 | 0.9963 |
| 85 | 2-Methylcitrate synthase inhibitor | 3 | 0.9781 |
| 86 | 2-Methyleneglutarate mutase inhibitor | 9 | 0.9916 |
| 87 | 2-Nitrophenol 2-monooxygenase inhibitor | 3 | 0.9904 |
| 88 | 2-Nitropropane dioxygenase inhibitor | 21 | 0.9676 |
| 89 | 2-Oxoaldehyde dehydrogenase (NAD+) inhibitor | 12 | 0.9910 |
| 90 | 2-Oxoaldehyde dehydrogenase (NADP+) inhibitor | 3 | 0.9851 |
| 91 | 2-Oxoglutarate decarboxylase inhibitor | 8 | 0.9824 |
| 92 | 2-Oxoisovalerate dehydrogenase (acylating) inhibitor | 4 | 0.9923 |
| 93 | 2-Pyrocatechuate decarboxylase inhibitor | 20 | 0.9919 |
| 94 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 97 | 0.9997 |
| 95 | 3'(2'),5'-Bisphosphate nucleotidase inhibitor | 4 | 0.9967 |
| 96 | 3(or 17)alpha-hydroxysteroid dehydrogenase inhibitor | 9 | 0.9927 |
| 97 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 63 | 0.9772 |
| 98 | 3,4-Dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione 4,5-dioxygenase inhibitor | 4 | 0.9857 |
| 99 | 3,4-Dihydroxyphenylacetate 2,3-dioxygenase inhibitor | 12 | 0.9960 |
| 100 | 3-Alpha-hydroxysteroid dehydrogenase (B-specific) inhibitor | 7 | 0.9734 |
| 101 | 3-Aminobutyryl-CoA ammonia-lyase inhibitor | 3 | 0.9936 |
| 102 | 3-Carboxyethylcatechol 2,3-dioxygenase inhibitor | 4 | 0.9889 |
| 103 | 3-Chloro-D-alanine dehydrochlorinase inhibitor | 4 | 0.9878 |
| 104 | 3C-like protease (Human coronavirus) inhibitor | 29 | 0.8891 |
| 105 | 3-Cyanoalanine hydratase inhibitor | 4 | 0.8386 |
| 106 | 3-Dehydroquinate dehydratase inhibitor | 14 | 0.9940 |
| 107 | 3-Dehydroquinate synthase inhibitor | 16 | 0.9948 |
| 108 | 3'-Demethylstaurosporine O-methyltransferase inhibitor | 4 | 0.9694 |
| 109 | 3-Demethylubiquinone-9 3-O-methyltransferase inhibitor | 3 | 0.9861 |
| 110 | 3-Deoxy-7-phosphoheptulonate synthase inhibitor | 48 | 0.9917 |
| 111 | 3-Deoxy-8-phosphooctulonate synthase inhibitor | 8 | 0.9948 |
| 112 | 3-Galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase inhibitor | 3 | 0.9936 |
| 113 | 3-Hydroxy-4-oxoquinoline 2,4-dioxygenase inhibitor | 6 | 0.9808 |
| 114 | 3-Hydroxyacyl-CoA dehydrogenase inhibitor | 6 | 0.9908 |
| 115 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 14 | 0.9456 |
| 116 | 3-Hydroxyanthranilate oxidase inhibitor | 13 | 0.9804 |
| 117 | 3-Hydroxybenzoate 4-monooxygenase inhibitor | 7 | 0.9809 |
| 118 | 3-Hydroxybenzoate 6-monooxygenase inhibitor | 5 | 0.8427 |
| 119 | 3-Hydroxybutyrate dehydrogenase inhibitor | 25 | 0.9900 |
| 120 | 3-Hydroxybutyryl-CoA dehydrogenase inhibitor | 3 | 0.9896 |
| 121 | 3-Hydroxydecanoyl-[acyl-carrier-protein] dehydratase inhibitor | 9 | 0.9895 |
| 122 | 3-Hydroxyisobutyryl-CoA hydrolase inhibitor | 7 | 1.0000 |
| 123 | 3-Hydroxyphenylacetate 6-hydroxylase inhibitor | 4 | 0.9906 |
| 124 | 3-Isopropylmalate dehydratase inhibitor | 8 | 0.9862 |
| 125 | 3-Isopropylmalate dehydrogenase inhibitor | 7 | 0.9956 |
| 126 | 3-Ketovalidoxylamine C-N-lyase inhibitor | 4 | 0.9849 |
| 127 | 3-Mercaptopyruvate sulfurtransferase inhibitor | 9 | 0.9997 |
| 128 | 3-Methyl-2-oxobutanoate dehydrogenase (lipoamide) inhibitor | 15 | 0.9953 |
| 129 | 3-Methyl-2-oxobutanoate hydroxymethyltransferase inhibitor | 8 | 0.9816 |
| 130 | 3-Methylbutanal reductase inhibitor | 9 | 0.8575 |
| 131 | 3'-Nucleotidase inhibitor | 8 | 0.9780 |
| 132 | 3-Oxoacid CoA-transferase inhibitor | 26 | 0.9933 |
| 133 | 3-Oxoacyl-[acyl-carrier-protein] synthase II inhibitor | 9 | 0.9838 |
| 134 | 3-Oxoacyl-[acyl-carrier-protein] synthase III inhibitor | 32 | 0.9806 |
| 135 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 54 | 0.9835 |
| 136 | 3-Oxoadipate enol-lactonase inhibitor | 3 | 0.9928 |
| 137 | 3-Oxosteroid 1-dehydrogenase inhibitor | 6 | 0.9944 |
| 138 | 3-Phosphoshikimate 1-carboxyvinyltransferase inhibitor | 41 | 0.9971 |
| 139 | 3-Phytase inhibitor | 9 | 0.8882 |
| 140 | 4,5-Dihydroxyphthalate decarboxylase inhibitor | 16 | 0.9304 |
| 141 | 4a-Hydroxytetrahydrobiopterin dehydratase inhibitor | 3 | 0.9983 |
| 142 | 4-Alpha-glucanotransferase inhibitor | 8 | 0.9915 |
| 143 | 4-Carboxymethyl-4-methylbutenolide mutase inhibitor | 9 | 0.9946 |
| 144 | 4-Chlorobenzoyl-CoA dehalogenase inhibitor | 7 | 0.9771 |
| 145 | 4-Chlorophenylacetate 3,4-dioxygenase inhibitor | 4 | 0.9876 |
| 146 | 4-Coumarate-CoA ligase inhibitor | 8 | 0.8520 |
| 147 | 4-Hydroxy-2-oxoglutarate aldolase inhibitor | 17 | 0.9946 |
| 148 | 4-Hydroxy-4-methyl-2-oxoglutarate aldolase inhibitor | 11 | 0.9954 |
| 149 | 4-Hydroxybenzoate 1-hydroxylase inhibitor | 3 | 0.9995 |
| 150 | 4-Hydroxybenzoate 3-monooxygenase [NAD(P)H] inhibitor | 6 | 0.9998 |
| 151 | 4-Hydroxybenzoate 3-monooxygenase inhibitor | 28 | 0.9858 |
| 152 | 4-Hydroxybenzoate decarboxylase inhibitor | 7 | 0.9973 |
| 153 | 4-Hydroxybenzoate nonaprenyltransferase inhibitor | 15 | 0.9661 |
| 154 | 4-Hydroxybenzoate-CoA ligase inhibitor | 4 | 0.9980 |
| 155 | 4-Hydroxyglutamate transaminase inhibitor | 4 | 0.9857 |
| 156 | 4-Hydroxymandelate oxidase inhibitor | 10 | 0.9266 |
| 157 | 4-Hydroxyphenylacetate 1-monooxygenase inhibitor | 4 | 0.9998 |
| 158 | 4-Hydroxyphenylacetate 3-monooxygenase inhibitor | 8 | 0.8789 |
| 159 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 22 | 0.9950 |
| 160 | 4-Hydroxyproline epimerase inhibitor | 8 | 0.8755 |
| 161 | 4-Methoxybenzoate monooxygenase (O-demethylating) inhibitor | 19 | 0.8921 |
| 162 | 4-Nitrophenol 2-monooxygenase inhibitor | 6 | 0.8201 |
| 163 | 4-Nitrophenylphosphatase inhibitor | 47 | 0.8961 |
| 164 | 4-Phytase inhibitor | 13 | 0.9856 |
| 165 | 4-Pyridoxolactonase inhibitor | 6 | 0.9941 |
| 166 | 5 Hydroxytryptamine 1 agonist | 1903 | 0.9865 |
| 167 | 5 Hydroxytryptamine 1 antagonist | 4787 | 0.9821 |
| 168 | 5 Hydroxytryptamine 1A agonist | 1131 | 0.9884 |
| 169 | 5 Hydroxytryptamine 1A antagonist | 3853 | 0.9851 |
| 170 | 5 Hydroxytryptamine 1B agonist | 65 | 0.9897 |
| 171 | 5 Hydroxytryptamine 1B antagonist | 1027 | 0.9860 |
| 172 | 5 Hydroxytryptamine 1D agonist | 695 | 0.9955 |
| 173 | 5 Hydroxytryptamine 1D antagonist | 1072 | 0.9853 |
| 174 | 5 Hydroxytryptamine 1E antagonist | 33 | 0.9108 |
| 175 | 5 Hydroxytryptamine 1F agonist | 115 | 0.9993 |
| 176 | 5 Hydroxytryptamine 1F antagonist | 216 | 0.9899 |
| 177 | 5 Hydroxytryptamine 2 agonist | 479 | 0.9912 |
| 178 | 5 Hydroxytryptamine 2 antagonist | 4227 | 0.9738 |
| 179 | 5 Hydroxytryptamine 2A agonist | 59 | 0.9501 |
| 180 | 5 Hydroxytryptamine 2A antagonist | 2961 | 0.9809 |
| 181 | 5 Hydroxytryptamine 2B agonist | 9 | 0.9469 |
| 182 | 5 Hydroxytryptamine 2B antagonist | 861 | 0.9782 |
| 183 | 5 Hydroxytryptamine 2C agonist | 415 | 0.9951 |
| 184 | 5 Hydroxytryptamine 2C antagonist | 1781 | 0.9847 |
| 185 | 5 Hydroxytryptamine 3 agonist | 73 | 0.9691 |
| 186 | 5 Hydroxytryptamine 3 antagonist | 1679 | 0.9888 |
| 187 | 5 Hydroxytryptamine 3A antagonist | 254 | 0.9771 |
| 188 | 5 Hydroxytryptamine 4 agonist | 343 | 0.9945 |
| 189 | 5 Hydroxytryptamine 4 antagonist | 571 | 0.9945 |
| 190 | 5 Hydroxytryptamine 4A antagonist | 7 | 0.9353 |
| 191 | 5 Hydroxytryptamine 4B antagonist | 6 | 0.9994 |
| 192 | 5 Hydroxytryptamine 4C antagonist | 4 | 0.9777 |
| 193 | 5 Hydroxytryptamine 4D antagonist | 4 | 0.9777 |
| 194 | 5 Hydroxytryptamine 4E antagonist | 27 | 0.9951 |
| 195 | 5 Hydroxytryptamine 5 antagonist | 126 | 0.9836 |
| 196 | 5 Hydroxytryptamine 5A antagonist | 124 | 0.9851 |
| 197 | 5 Hydroxytryptamine 6 agonist | 29 | 0.9919 |
| 198 | 5 Hydroxytryptamine 6 antagonist | 764 | 0.9914 |
| 199 | 5 Hydroxytryptamine 7 agonist | 8 | 0.9261 |
| 200 | 5 Hydroxytryptamine 7 antagonist | 560 | 0.9838 |
| 201 | 5 Hydroxytryptamine 7L antagonist | 5 | 0.9513 |
| 202 | 5 Hydroxytryptamine 7S antagonist | 5 | 0.9462 |
| 203 | 5 Hydroxytryptamine agonist | 2906 | 0.9786 |
| 204 | 5 Hydroxytryptamine antagonist | 10856 | 0.9662 |
| 205 | 5 Hydroxytryptamine release inhibitor | 33 | 0.8710 |
| 206 | 5 Hydroxytryptamine release stimulant | 17 | 0.9117 |
| 207 | 5 Hydroxytryptamine uptake inhibitor | 4311 | 0.9852 |
| 208 | 5 Hydroxytryptamine uptake stimulant | 5 | 0.8135 |
| 209 | 5 Lipoxygenase activating protein inhibitor | 144 | 0.9996 |
| 210 | 5-Alpha-reductase 1 inhibitor | 467 | 0.9963 |
| 211 | 5-Alpha-reductase 2 inhibitor | 509 | 0.9934 |
| 212 | 5-Alpha-reductase inhibitor | 1463 | 0.9941 |
| 213 | 5-Aminolevulinate synthase inhibitor | 25 | 0.9788 |
| 214 | 5-Aminovalerate transaminase inhibitor | 7 | 0.9965 |
| 215 | 5-Formyltetrahydrofolate cyclo-ligase inhibitor | 11 | 0.9297 |
| 216 | 5-Guanidino-2-oxopentanoate decarboxylase inhibitor | 8 | 0.9999 |
| 217 | 5-Hydroxypentanoate CoA-transferase inhibitor | 4 | 0.9998 |
| 218 | 5-Lipoxygenase inhibitor | 1998 | 0.9832 |
| 219 | 5-Methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase inhibitor | 4 | 0.9959 |
| 220 | 5'-Nucleotidase inhibitor | 45 | 0.9944 |
| 221 | 5-O-(4-coumaroyl)-D-quinate 3'-monooxygenase inhibitor | 3 | 0.8822 |
| 222 | 5-Oxoprolinase (ATP-hydrolysing) inhibitor | 8 | 0.9958 |
| 223 | 6,7-Dihydropteridine reductase inhibitor | 47 | 0.9746 |
| 224 | 6-Carboxyhexanoate-CoA ligase inhibitor | 3 | 0.9894 |
| 225 | 6-Methylsalicylate decarboxylase inhibitor | 8 | 0.9891 |
| 226 | 6-Phospho-beta-glucosidase inhibitor | 8 | 0.9979 |
| 227 | 6-Phosphofructo-2-kinase inhibitor | 11 | 0.9935 |
| 228 | 6-Pyruvoyltetrahydropterin synthase inhibitor | 4 | 0.9873 |
| 229 | 8-Amino-7-oxononanoate synthase inhibitor | 15 | 0.9759 |
| 230 | 8-oxodGTPase stimulant | 12 | 0.9998 |
| 231 | ABCA1 expression enhancer | 211 | 0.9777 |
| 232 | Abl kinase inhibitor | 604 | 0.9708 |
| 233 | Abortion inducer | 38 | 0.9493 |
| 234 | Acaricide | 42 | 0.9447 |
| 235 | Acetate kinase inhibitor | 11 | 0.9080 |
| 236 | Acetate-CoA ligase inhibitor | 23 | 0.9869 |
| 237 | Acetoacetate decarboxylase inhibitor | 8 | 0.9924 |
| 238 | Acetoacetyl-CoA reductase inhibitor | 10 | 0.9980 |
| 239 | Acetoin dehydrogenase inhibitor | 15 | 0.9858 |
| 240 | Acetolactate decarboxylase inhibitor | 15 | 0.9828 |
| 241 | Acetolactate synthase inhibitor | 20 | 0.9840 |
| 242 | Acetylcholine agonist | 2053 | 0.9739 |
| 243 | Acetylcholine antagonist | 3940 | 0.9725 |
| 244 | Acetylcholine M1 receptor agonist | 1014 | 0.9922 |
| 245 | Acetylcholine M1 receptor antagonist | 1263 | 0.9878 |
| 246 | Acetylcholine M2 receptor agonist | 39 | 0.9710 |
| 247 | Acetylcholine M2 receptor antagonist | 1374 | 0.9887 |
| 248 | Acetylcholine M3 receptor agonist | 16 | 0.9963 |
| 249 | Acetylcholine M3 receptor antagonist | 1397 | 0.9863 |
| 250 | Acetylcholine M4 receptor agonist | 57 | 0.9949 |
| 251 | Acetylcholine M4 receptor antagonist | 706 | 0.9885 |
| 252 | Acetylcholine M5 receptor antagonist | 591 | 0.9895 |
| 253 | Acetylcholine muscarinic agonist | 1216 | 0.9883 |
| 254 | Acetylcholine muscarinic antagonist | 3051 | 0.9786 |
| 255 | Acetylcholine neuromuscular blocking agent | 18 | 0.8275 |
| 256 | Acetylcholine nicotinic agonist | 802 | 0.9784 |
| 257 | Acetylcholine nicotinic antagonist | 947 | 0.9789 |
| 258 | Acetylcholine release stimulant | 146 | 0.9625 |
| 259 | Acetylcholinesterase stimulant | 6 | 0.9999 |
| 260 | Acetyl-CoA C-acyltransferase inhibitor | 10 | 0.9641 |
| 261 | Acetyl-CoA carboxylase 1 inhibitor | 96 | 0.9920 |
| 262 | Acetyl-CoA carboxylase 2 inhibitor | 260 | 1.0000 |
| 263 | Acetyl-CoA carboxylase inhibitor | 279 | 0.9918 |
| 264 | Acetyl-CoA transferase 1 inhibitor | 602 | 0.9897 |
| 265 | Acetyl-CoA transferase 2 inhibitor | 226 | 0.9797 |
| 266 | Acetyl-CoA transferase inhibitor | 1569 | 0.9888 |
| 267 | Acetylenecarboxylate hydratase inhibitor | 3 | 0.9889 |
| 268 | Acetylesterase inhibitor | 6 | 0.8663 |
| 269 | Acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase inhibitor | 6 | 0.8268 |
| 270 | Acetylornithine deacetylase inhibitor | 4 | 0.9849 |
| 271 | Acetylserotonin O-methyltransferase inhibitor | 11 | 0.9115 |
| 272 | Acetylspermidine deacetylase inhibitor | 16 | 0.9512 |
| 273 | Acid phosphatase 1 inhibitor | 5 | 1.0000 |
| 274 | Acid phosphatase inhibitor | 43 | 0.9551 |
| 275 | Acidifying agent gastric | 6 | 0.9981 |
| 276 | Acidifying agent non gastric | 7 | 0.9552 |
| 277 | Acidosis | 130 | 0.8121 |
| 278 | Acidosis, lactic | 9 | 0.8839 |
| 279 | Acidosis, metabolic | 45 | 0.8461 |
| 280 | Acid-sensing ion channel blocker | 6 | 0.8824 |
| 281 | ACK1 kinase inhibitor | 9 | 0.9333 |
| 282 | Acneiform eruption | 3 | 0.9468 |
| 283 | Aconitate decarboxylase inhibitor | 4 | 0.9960 |
| 284 | Aconitate hydratase inhibitor | 22 | 0.9919 |
| 285 | Acrocylindropepsin inhibitor | 3 | 0.8770 |
| 286 | Acrosin inhibitor | 20 | 0.9651 |
| 287 | Actin depolymerization stimulant | 8 | 0.9984 |
| 288 | Actin polymerization inhibitor | 5 | 1.0000 |
| 289 | Activin receptor-like kinase 4 inhibitor | 23 | 0.9998 |
| 290 | Acute neurologic disorders treatment | 1183 | 0.8103 |
| 291 | Acylaminoacyl-peptidase inhibitor | 25 | 0.9633 |
| 292 | Acylcarnitine hydrolase inhibitor | 3 | 0.9187 |
| 293 | Acyl-CoA dehydrogenase (NADP+) inhibitor | 19 | 0.9895 |
| 294 | Acyl-CoA dehydrogenase inhibitor | 15 | 0.9935 |
| 295 | Acyl-CoA hydrolase inhibitor | 44 | 0.9787 |
| 296 | Acyl-CoA oxidase inhibitor | 11 | 0.9143 |
| 297 | Acylglycerone-phosphate reductase inhibitor | 6 | 0.9857 |
| 298 | Acyl-lysine deacylase inhibitor | 3 | 0.9942 |
| 299 | Acyloxyacyl hydrolase inhibitor | 15 | 0.9862 |
| 300 | Acylphosphatase inhibitor | 13 | 0.9791 |
| 301 | ADAM inhibitor | 54 | 0.9970 |
| 302 | ADAM10 endopeptidase inhibitor | 125 | 0.9866 |
| 303 | Adamalysin inhibitor | 8 | 0.9967 |
| 304 | Adenine deaminase inhibitor | 10 | 0.9877 |
| 305 | Adenine nucleotide translocase inhibitor | 23 | 0.9632 |
| 306 | Adenine nucleotide translocator 1 inhibitor | 3 | 1.0000 |
| 307 | Adenine phosphoribosyltransferase inhibitor | 23 | 0.9948 |
| 308 | Adenomatous polyposis treatment | 10 | 0.9408 |
| 309 | Adenosine A1 receptor agonist | 273 | 0.9990 |
| 310 | Adenosine A1 receptor agonist enhancer | 10 | 1.0000 |
| 311 | Adenosine A1 receptor antagonist | 2623 | 0.9888 |
| 312 | Adenosine A2 receptor agonist | 239 | 0.9989 |
| 313 | Adenosine A2 receptor antagonist | 2819 | 0.9896 |
| 314 | Adenosine A2a receptor agonist | 216 | 0.9991 |
| 315 | Adenosine A2a receptor antagonist | 2091 | 0.9897 |
| 316 | Adenosine A2b receptor agonist | 17 | 0.9989 |
| 317 | Adenosine A2b receptor antagonist | 852 | 0.9931 |
| 318 | Adenosine A3 receptor agonist | 88 | 0.9980 |
| 319 | Adenosine A3 receptor antagonist | 1365 | 0.9803 |
| 320 | Adenosine deaminase inhibitor | 165 | 0.9838 |
| 321 | Adenosine kinase inhibitor | 334 | 0.9959 |
| 322 | Adenosine receptor agonist | 614 | 0.9947 |
| 323 | Adenosine receptor antagonist | 4310 | 0.9828 |
| 324 | Adenosine regulator | 3 | 0.9014 |
| 325 | Adenosine uptake inhibitor | 55 | 0.9995 |
| 326 | Adenosylhomocysteine nucleosidase inhibitor | 57 | 0.9999 |
| 327 | Adenosylmethionine cyclotransferase inhibitor | 12 | 0.9996 |
| 328 | Adenosylmethionine-8-amino-7-oxononanoate transaminase inhibitor | 12 | 0.9865 |
| 329 | Adenylate cyclase I inhibitor | 54 | 0.9969 |
| 330 | Adenylate cyclase I stimulant | 43 | 1.0000 |
| 331 | Adenylate cyclase inhibitor | 174 | 0.9497 |
| 332 | Adenylate cyclase stimulant | 89 | 0.9372 |
| 333 | Adenylate cyclase V inhibitor | 36 | 0.9598 |
| 334 | Adenylate kinase inhibitor | 23 | 0.9355 |
| 335 | Adenylosuccinate lyase inhibitor | 29 | 0.9961 |
| 336 | Adenylosuccinate synthase inhibitor | 60 | 0.9916 |
| 337 | Adenylyl-sulfate kinase inhibitor | 20 | 0.9723 |
| 338 | Adenylyl-sulfate reductase inhibitor | 5 | 0.8988 |
| 339 | Adenylylsulphatase inhibitor | 17 | 0.9808 |
| 340 | ADP-ribose diphosphatase inhibitor | 7 | 0.9978 |
| 341 | ADP-ribosylarginine hydrolase inhibitor | 6 | 0.9241 |
| 342 | ADP-thymidine kinase inhibitor | 5 | 0.9523 |
| 343 | Adrenal cortex hypoplasia | 3 | 0.9249 |
| 344 | Adrenaline agonist | 2055 | 0.9787 |
| 345 | Adrenaline antagonist | 6430 | 0.9718 |
| 346 | Adrenaline release stimulant | 8 | 0.9338 |
| 347 | Adrenaline uptake inhibitor | 2366 | 0.9878 |
| 348 | Adrenergic | 4509 | 0.9763 |
| 349 | Adrenergic, ophthalmic | 9 | 0.9917 |
| 350 | Aerobactin synthase inhibitor | 3 | 0.9912 |
| 351 | Agaritine gamma-glutamyltransferase inhibitor | 11 | 0.9903 |
| 352 | Age-related macular degeneration treatment | 51 | 0.8810 |
| 353 | Aggrecanase 1 inhibitor | 48 | 0.9768 |
| 354 | Aggrecanase 2 inhibitor | 117 | 0.9941 |
| 355 | Aggrecanase inhibitor | 310 | 0.9948 |
| 356 | Agmatinase inhibitor | 7 | 0.9243 |
| 357 | Agranulocytosis | 408 | 0.8408 |
| 358 | AgrC-1 protein inhibitor | 4 | 1.0000 |
| 359 | AgrC-2 protein inhibitor | 4 | 1.0000 |
| 360 | AICAR transformylase inhibitor | 39 | 0.9618 |
| 361 | Akathisia | 84 | 0.8463 |
| 362 | Alanine carboxypeptidase inhibitor | 10 | 0.9941 |
| 363 | Alanine dehydrogenase inhibitor | 27 | 0.9892 |
| 364 | Alanine racemase inhibitor | 12 | 0.9843 |
| 365 | Alanine transaminase inhibitor | 18 | 0.9862 |
| 366 | Alanine-tRNA ligase inhibitor | 6 | 0.9698 |
| 367 | Albendazole monooxygenase inhibitor | 3 | 0.9698 |
| 368 | Alcohol dehydrogenase (acceptor) inhibitor | 11 | 0.8721 |
| 369 | Alcohol dehydrogenase (NADP+) inhibitor | 45 | 0.9587 |
| 370 | Alcohol dehydrogenase [NAD(P)+] inhibitor | 16 | 0.9279 |
| 371 | Alcohol dehydrogenase alpha inhibitor | 12 | 1.0000 |
| 372 | Alcohol dehydrogenase beta 1 inhibitor | 7 | 1.0000 |
| 373 | Alcohol dehydrogenase beta inhibitor | 7 | 1.0000 |
| 374 | Alcohol dehydrogenase gamma 2 inhibitor | 6 | 0.9999 |
| 375 | Alcohol dehydrogenase gamma inhibitor | 6 | 0.9999 |
| 376 | Alcohol dehydrogenase I inhibitor | 14 | 1.0000 |
| 377 | Alcohol dehydrogenase inhibitor | 119 | 0.9569 |
| 378 | Alcohol dehydrogenase substrate | 71 | 0.9547 |
| 379 | Alcohol O-acetyltransferase inhibitor | 9 | 0.9079 |
| 380 | Alcohol oxidase inhibitor | 17 | 0.9888 |
| 381 | Aldehyde dehydrogenase (NAD+) inhibitor | 38 | 0.9602 |
| 382 | Aldehyde dehydrogenase (NADP+) inhibitor | 17 | 0.9668 |
| 383 | Aldehyde dehydrogenase (pyrroloquinoline-quinone) inhibitor | 7 | 0.8766 |
| 384 | Aldehyde dehydrogenase [NAD(P)+] inhibitor | 5 | 0.9924 |
| 385 | Aldehyde dehydrogenase 1 substrate | 8 | 0.9989 |
| 386 | Aldehyde dehydrogenase 1A2 inhibitor | 30 | 0.9946 |
| 387 | Aldehyde dehydrogenase 2 substrate | 6 | 0.8550 |
| 388 | Aldehyde dehydrogenase 3 substrate | 5 | 0.9987 |
| 389 | Aldehyde dehydrogenase inhibitor | 114 | 0.9600 |
| 390 | Aldehyde dehydrogenase substrate | 55 | 0.9595 |
| 391 | Aldehyde ferredoxin oxidoreductase inhibitor | 5 | 0.9886 |
| 392 | Aldehyde oxidase inhibitor | 27 | 0.8903 |
| 393 | Aldehyde oxidase substrate | 51 | 0.9422 |
| 394 | Aldose 1-epimerase inhibitor | 31 | 0.9932 |
| 395 | Aldose reductase 2 inhibitor | 88 | 0.9956 |
| 396 | Aldose reductase inhibitor | 803 | 0.9861 |
| 397 | Aldose reductase substrate | 11 | 0.9636 |
| 398 | Aldosterone antagonist | 58 | 0.8716 |
| 399 | ALK inhibitor | 121 | 0.9636 |
| 400 | Alkaline phosphatase inhibitor | 336 | 0.9569 |
| 401 | Alkanal monooxygenase (FMN-linked) inhibitor | 27 | 0.9583 |
| 402 | Alkane 1-monooxygenase inhibitor | 4 | 0.9508 |
| 403 | Alkene monooxygenase inhibitor | 3 | 0.9908 |
| 404 | Alkenylglycerophosphocholine hydrolase inhibitor | 5 | 0.9109 |
| 405 | Alkenylglycerophosphoethanolamine hydrolase inhibitor | 6 | 0.9306 |
| 406 | Alkylacetylglycerophosphatase inhibitor | 4 | 0.8816 |
| 407 | Alkylator | 562 | 0.9471 |
| 408 | Alkylglycerone-phosphate synthase inhibitor | 6 | 0.9804 |
| 409 | Alkylglycerophosphoethanolamine phosphodiesterase inhibitor | 5 | 0.9726 |
| 410 | Allantoate deiminase inhibitor | 3 | 0.9931 |
| 411 | Allantoicase inhibitor | 9 | 0.9897 |
| 412 | Allantoin racemase inhibitor | 4 | 0.9903 |
| 413 | Allantoinase inhibitor | 4 | 0.9927 |
| 414 | Allergic contact dermatitis | 93 | 0.8449 |
| 415 | Allergic dermatitis | 73 | 0.8531 |
| 416 | Allergic rhinitis treatment | 409 | 0.9643 |
| 417 | Allophanate hydrolase inhibitor | 5 | 0.9864 |
| 418 | All-trans-retinyl-palmitate hydrolase inhibitor | 4 | 0.9450 |
| 419 | Allyl-alcohol dehydrogenase inhibitor | 6 | 0.9827 |
| 420 | Alopecia treatment | 6 | 0.8647 |
| 421 | Alpha 1 adrenoreceptor agonist | 78 | 0.9922 |
| 422 | Alpha 1 adrenoreceptor antagonist | 3876 | 0.9781 |
| 423 | Alpha 1a adrenoreceptor agonist | 48 | 0.9997 |
| 424 | Alpha 1a adrenoreceptor antagonist | 3142 | 0.9824 |
| 425 | Alpha 1b adrenoreceptor antagonist | 1331 | 0.9832 |
| 426 | Alpha 1d adrenoreceptor antagonist | 1512 | 0.9854 |
| 427 | Alpha 1L adrenoreceptor agonist | 3 | 0.9933 |
| 428 | Alpha 1L adrenoreceptor antagonist | 11 | 0.9722 |
| 429 | Alpha 2 adrenoreceptor agonist | 337 | 0.9871 |
| 430 | Alpha 2 adrenoreceptor antagonist | 1608 | 0.9802 |
| 431 | Alpha 2a adrenoreceptor antagonist | 629 | 0.9809 |
| 432 | Alpha 2b adrenoreceptor agonist | 45 | 0.9992 |
| 433 | Alpha 2b adrenoreceptor antagonist | 420 | 0.9749 |
| 434 | Alpha 2c adrenoreceptor agonist | 45 | 0.9996 |
| 435 | Alpha 2c adrenoreceptor antagonist | 497 | 0.9778 |
| 436 | Alpha 2d adrenoreceptor agonist | 44 | 0.9984 |
| 437 | Alpha 2d adrenoreceptor antagonist | 94 | 0.9881 |
| 438 | Alpha 3 adrenoreceptor agonist | 5 | 0.9935 |
| 439 | Alpha adrenoreceptor agonist | 496 | 0.9798 |
| 440 | Alpha adrenoreceptor antagonist | 5126 | 0.9709 |
| 441 | Alpha galactosidase inhibitor | 16 | 0.9996 |
| 442 | Alpha glucosidase I inhibitor | 5 | 0.9999 |
| 443 | Alpha glucosidase II inhibitor | 8 | 1.0000 |
| 444 | Alpha glucosidase inhibitor | 115 | 0.9797 |
| 445 | Alpha,alpha-phosphotrehalase inhibitor | 5 | 0.9931 |
| 446 | Alpha,alpha-trehalase inhibitor | 20 | 0.9858 |
| 447 | Alpha,alpha-trehalose phosphorylase (configuration-retaining) inhibitor | 11 | 0.9946 |
| 448 | Alpha,alpha-trehalose phosphorylase inhibitor | 4 | 0.9986 |
| 449 | Alpha,alpha-trehalose-phosphate synthase (UDP-forming) inhibitor | 14 | 0.9690 |
| 450 | Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase inhibitor | 11 | 0.9985 |
| 451 | Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase inhibitor | 3 | 0.9964 |
| 452 | Alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase inhibitor | 4 | 0.9599 |
| 453 | Alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase inhibitor | 5 | 0.9913 |
| 454 | Alpha-amino-acid esterase inhibitor | 4 | 0.9991 |
| 455 | Alpha-amylase inhibitor | 28 | 0.9486 |
| 456 | Alpha-glucuronidase inhibitor | 4 | 0.9788 |
| 457 | Alpha-L-fucosidase inhibitor | 44 | 0.9906 |
| 458 | Alpha-L-rhamnosidase inhibitor | 11 | 0.9937 |
| 459 | Alpha-mannosidase inhibitor | 59 | 0.9852 |
| 460 | Alpha-Methylacyl-CoA racemase inhibitor | 8 | 0.9811 |
| 461 | Alpha-N-acetylgalactosaminidase inhibitor | 3 | 0.9947 |
| 462 | Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase inhibitor | 17 | 0.9957 |
| 463 | Alpha-N-acetylglucosaminidase inhibitor | 4 | 0.9797 |
| 464 | Alpha-N-acetylneuraminate alpha-2,8-sialyltransferase inhibitor | 15 | 0.9973 |
| 465 | Alpha-N-arabinofuranosidase inhibitor | 9 | 0.9832 |
| 466 | Alpha-pinene-oxide decyclase inhibitor | 8 | 0.9879 |
| 467 | Alternansucrase inhibitor | 4 | 0.9976 |
| 468 | Altronate dehydratase inhibitor | 7 | 0.9989 |
| 469 | Alzheimer's disease treatment | 2493 | 0.8918 |
| 470 | Amidase inhibitor | 124 | 0.9737 |
| 471 | Amidophosphoribosyltransferase inhibitor | 25 | 0.9973 |
| 472 | Amiloride-sensitive cation channel 3 blocker | 7 | 1.0000 |
| 473 | Amine dehydrogenase inhibitor | 10 | 0.8736 |
| 474 | Amino acid-polyamine-organocation (APC) transporter antagonist | 82 | 0.9998 |
| 475 | Amino-acid N-acetyltransferase inhibitor | 25 | 0.9932 |
| 476 | Amino-acid racemase inhibitor | 6 | 0.9961 |
| 477 | Aminoacylase inhibitor | 19 | 0.9827 |
| 478 | Aminoacyl-tRNA hydrolase inhibitor | 5 | 0.9944 |
| 479 | Aminoacyl-tRNA synthetase inhibitor | 321 | 0.9748 |
| 480 | Aminobutyraldehyde dehydrogenase inhibitor | 3 | 0.8691 |
| 481 | Aminocarboxymuconate-semialdehyde decarboxylase inhibitor | 6 | 0.9885 |
| 482 | Aminoglycoside N6'-acetyltransferase inhibitor | 15 | 0.9997 |
| 483 | Aminolevulinate transaminase inhibitor | 26 | 0.9909 |
| 484 | Aminomuconate-semialdehyde dehydrogenase inhibitor | 4 | 0.9795 |
| 485 | Aminopeptidase A inhibitor | 55 | 0.9991 |
| 486 | Aminopeptidase B inhibitor | 45 | 0.9395 |
| 487 | Aminopeptidase I inhibitor | 26 | 0.9838 |
| 488 | Aminopeptidase microsomal inhibitor | 209 | 0.9787 |
| 489 | Aminopeptidase N inhibitor | 183 | 0.9820 |
| 490 | Aminopeptidase P inhibitor | 9 | 1.0000 |
| 491 | Aminopeptidase Y inhibitor | 8 | 0.9778 |
| 492 | AMP deaminase 2 inhibitor | 69 | 1.0000 |
| 493 | AMP deaminase 3 inhibitor | 21 | 0.9978 |
| 494 | AMP deaminase inhibitor | 103 | 0.9863 |
| 495 | AMP nucleosidase inhibitor | 15 | 0.9952 |
| 496 | AMPA 1 receptor antagonist | 681 | 0.9954 |
| 497 | AMPA 2 receptor antagonist | 452 | 0.9922 |
| 498 | AMPA 3 receptor antagonist | 437 | 0.9925 |
| 499 | AMPA 4 receptor antagonist | 222 | 0.9888 |
| 500 | AMPA 5 receptor antagonist | 4 | 1.0000 |
| 501 | AMPA receptor agonist | 72 | 0.9939 |
| 502 | AMPA receptor antagonist | 1317 | 0.9905 |
| 503 | Amylin agonist | 10 | 1.0000 |
| 504 | Amylo-alpha-1,6-glucosidase inhibitor | 26 | 0.9930 |
| 505 | Amyloid beta aggregation inhibitor | 39 | 0.9747 |
| 506 | Amyloid beta precursor protein antagonist | 295 | 0.9471 |
| 507 | Amylosucrase inhibitor | 5 | 0.9990 |
| 508 | Amyotrophic lateral sclerosis treatment | 180 | 0.9038 |
| 509 | Anabolic | 158 | 0.9603 |
| 510 | Analeptic | 234 | 0.8912 |
| 511 | Analgesic | 8418 | 0.8650 |
| 512 | Analgesic stimulant | 22 | 0.8677 |
| 513 | Analgesic, non-opioid | 6210 | 0.8827 |
| 514 | Anaphylatoxin receptor antagonist | 5 | 0.8968 |
| 515 | Androgen agonist | 219 | 0.9854 |
| 516 | Androgen antagonist | 1280 | 0.9821 |
| 517 | Andropause treatment | 85 | 0.9732 |
| 518 | Androst-4-ene-3,17-dione monooxygenase inhibitor | 9 | 0.9931 |
| 519 | Anemia | 228 | 0.8481 |
| 520 | Anemia, sideroblastic | 4 | 0.9738 |
| 521 | Anesthetic | 707 | 0.9413 |
| 522 | Anesthetic general | 151 | 0.9117 |
| 523 | Anesthetic inhalation | 20 | 0.9878 |
| 524 | Anesthetic local | 463 | 0.9611 |
| 525 | Angiogenesis inhibitor | 4489 | 0.9084 |
| 526 | Angiogenesis stimulant | 23 | 0.8636 |
| 527 | Angiotensin agonist | 12 | 0.9909 |
| 528 | Angiotensin antagonist | 3433 | 0.9894 |
| 529 | Angiotensin AT1 receptor antagonist | 3018 | 0.9897 |
| 530 | Angiotensin AT1A receptor antagonist | 973 | 0.9977 |
| 531 | Angiotensin AT2 receptor agonist | 7 | 0.9874 |
| 532 | Angiotensin AT2 receptor antagonist | 1039 | 0.9971 |
| 533 | Angiotensin II receptor agonist | 9 | 0.9259 |
| 534 | Angiotensin II receptor antagonist | 3407 | 0.9900 |
| 535 | Angiotensin-converting enzyme inhibitor | 694 | 0.9840 |
| 536 | Anhydrotetracycline monooxygenase inhibitor | 4 | 0.9959 |
| 537 | Anorexiant | 363 | 0.8281 |
| 538 | Anthranilate 3-monooxygenase (deaminating) inhibitor | 11 | 0.9584 |
| 539 | Anthranilate phosphoribosyltransferase inhibitor | 5 | 0.9966 |
| 540 | Anthranilate synthase inhibitor | 23 | 0.9848 |
| 541 | Anthranilate-CoA ligase inhibitor | 4 | 0.9820 |
| 542 | Anthrax lethal factor inhibitor | 61 | 0.9347 |
| 543 | Antiacne | 1202 | 0.9697 |
| 544 | Antiacromegalic | 71 | 0.9763 |
| 545 | Antiadrenergic | 6501 | 0.9702 |
| 546 | Antialcoholic | 121 | 0.9102 |
| 547 | Antiallergic | 6195 | 0.8818 |
| 548 | Antiamyloidogenic | 269 | 0.8962 |
| 549 | Antianemic | 182 | 0.9477 |
| 550 | Antianginal | 850 | 0.8299 |
| 551 | Antianorexic | 63 | 0.9316 |
| 552 | Antiarrhythmic | 2201 | 0.9347 |
| 553 | Antiarthritic | 9453 | 0.8648 |
| 554 | Antiasthmatic | 7609 | 0.8877 |
| 555 | Antibacterial | 6950 | 0.9192 |
| 556 | Antibacterial, ophthalmic | 11 | 0.9146 |
| 557 | Antibiotic | 3481 | 0.9682 |
| 558 | Antibiotic Aminoglycoside-like | 48 | 0.9685 |
| 559 | Antibiotic Anthracycline-like | 7 | 0.9622 |
| 560 | Antibiotic beta Lactam-like | 768 | 0.9951 |
| 561 | Antibiotic Carbacephem-like | 22 | 0.9998 |
| 562 | Antibiotic Carbapenem-like | 153 | 0.9987 |
| 563 | Antibiotic Cephalosporin-like | 348 | 0.9996 |
| 564 | Antibiotic Glycopeptide-like | 32 | 0.9809 |
| 565 | Antibiotic Isocephem-like | 7 | 1.0000 |
| 566 | Antibiotic Macrolide-like | 584 | 0.9982 |
| 567 | Antibiotic Naphthyridine-like | 30 | 0.9997 |
| 568 | Antibiotic Oxacephem-like | 12 | 0.9992 |
| 569 | Antibiotic Oxazolidinone-like | 90 | 0.9900 |
| 570 | Antibiotic Penem-like | 41 | 0.9999 |
| 571 | Antibiotic Penicillin-like | 50 | 0.9998 |
| 572 | Antibiotic Quinolone-like | 305 | 0.9918 |
| 573 | Antibiotic Rifamycin-like | 64 | 1.0000 |
| 574 | Antibiotic Tetracycline-like | 12 | 0.9807 |
| 575 | Antibiotic Tribactam-like | 17 | 1.0000 |
| 576 | Antibiotic Trimethoprim-like | 10 | 0.9998 |
| 577 | Anticarcinogenic | 368 | 0.9080 |
| 578 | Anticataract | 63 | 0.9497 |
| 579 | Anticholelithogenic | 41 | 0.9784 |
| 580 | Anticoagulant | 2397 | 0.9489 |
| 581 | Anticonvulsant | 1466 | 0.8832 |
| 582 | Antidepressant | 8006 | 0.9193 |
| 583 | Antidepressant, Imipramin-like | 87 | 0.9574 |
| 584 | Antidiabetic | 11530 | 0.8929 |
| 585 | Antidiabetic (type 1) | 102 | 0.9315 |
| 586 | Antidiabetic (type 2) | 2835 | 0.9415 |
| 587 | Antidiabetic symptomatic | 713 | 0.8985 |
| 588 | Antidiarrheal | 256 | 0.9030 |
| 589 | Antidiuretic hormone agonist | 151 | 0.9975 |
| 590 | Antidiuretic hormone antagonist | 1247 | 0.9947 |
| 591 | Antidote | 122 | 0.9318 |
| 592 | Antidote, heavy metal | 48 | 0.9819 |
| 593 | Antidote, organophosphates | 4 | 1.0000 |
| 594 | Antidyskinetic | 22 | 0.8011 |
| 595 | Antieczematic | 8 | 0.8230 |
| 596 | Antieczematic atopic | 333 | 0.8924 |
| 597 | Antiemetic | 1023 | 0.9583 |
| 598 | Antiemphysemic | 209 | 0.9475 |
| 599 | Antiepileptic | 2456 | 0.9294 |
| 600 | Antifibrinolytic | 17 | 0.8457 |
| 601 | Antifungal | 2087 | 0.9119 |
| 602 | Antifungal (Pneumocystis) | 9 | 0.9701 |
| 603 | Antifungal enhancer | 20 | 0.9556 |
| 604 | Antiglaucomic | 1378 | 0.9431 |
| 605 | Anti-Helicobacter pylori | 143 | 0.9031 |
| 606 | Antihelmintic | 461 | 0.9298 |
| 607 | Antihelmintic (Fasciola) | 5 | 0.9673 |
| 608 | Antihelmintic (Nematodes) | 56 | 0.8950 |
| 609 | Antihematotoxic | 31 | 0.8984 |
| 610 | Antihemorrhagic | 16 | 0.9462 |
| 611 | Antihistaminic | 2969 | 0.9525 |
| 612 | Antihyperaldosteronism | 81 | 0.9986 |
| 613 | Antihyperammonemic | 3 | 0.9980 |
| 614 | Antihypercholesterolemic | 248 | 0.9262 |
| 615 | Antihyperlipoproteinemic | 83 | 0.9553 |
| 616 | Antihypermotility | 77 | 0.9533 |
| 617 | Antihypertensive | 7874 | 0.9007 |
| 618 | Antihypertriglyceridemic | 137 | 0.9709 |
| 619 | Antihypotensive | 38 | 0.9002 |
| 620 | Antihypoxic | 38 | 0.8663 |
| 621 | Antiinfective | 178 | 0.8682 |
| 622 | Antiinfertility, female | 67 | 0.9257 |
| 623 | Antiinflammatory | 5983 | 0.8384 |
| 624 | Antiinflammatory steroid | 3 | 0.9999 |
| 625 | Antiinflammatory, intestinal | 9 | 0.9114 |
| 626 | Antiinflammatory, ophthalmic | 51 | 0.8549 |
| 627 | Antiischemic | 2210 | 0.8978 |
| 628 | Antiischemic, cerebral | 439 | 0.7724 |
| 629 | Antileprosy | 56 | 0.9390 |
| 630 | Antileukemic | 4964 | 0.9392 |
| 631 | Antimetabolite | 732 | 0.9877 |
| 632 | Antimetastatic | 20 | 0.8854 |
| 633 | Antimigraine | 1980 | 0.9437 |
| 634 | Antimitotic | 1925 | 0.9426 |
| 635 | Antimitotic, Podophyllotoxin-like | 3 | 0.9996 |
| 636 | Antimutagenic | 34 | 0.9587 |
| 637 | Antimycobacterial | 726 | 0.8861 |
| 638 | Antimycoplasmal | 37 | 0.9353 |
| 639 | Antimyopathies | 6 | 0.8705 |
| 640 | Antinaupathic | 17 | 0.9496 |
| 641 | Antineoplastic | 49620 | 0.8600 |
| 642 | Antineoplastic (bladder cancer) | 330 | 0.9195 |
| 643 | Antineoplastic (bone cancer) | 68 | 0.8915 |
| 644 | Antineoplastic (brain cancer) | 512 | 0.8931 |
| 645 | Antineoplastic (breast cancer) | 5569 | 0.9292 |
| 646 | Antineoplastic (carcinoma) | 1904 | 0.9626 |
| 647 | Antineoplastic (cervical cancer) | 2035 | 0.9598 |
| 648 | Antineoplastic (colon cancer) | 5457 | 0.9519 |
| 649 | Antineoplastic (colorectal cancer) | 5654 | 0.9465 |
| 650 | Antineoplastic (endocrine cancer) | 167 | 0.9092 |
| 651 | Antineoplastic (gastric cancer) | 541 | 0.9393 |
| 652 | Antineoplastic (glioblastoma multiforme) | 347 | 0.9156 |
| 653 | Antineoplastic (glioma) | 497 | 0.9348 |
| 654 | Antineoplastic (insulinoma) | 44 | 0.9999 |
| 655 | Antineoplastic (liver cancer) | 363 | 0.9181 |
| 656 | Antineoplastic (lung cancer) | 2975 | 0.9384 |
| 657 | Antineoplastic (lymphocytic leukemia) | 2803 | 0.9570 |
| 658 | Antineoplastic (lymphoma) | 979 | 0.9355 |
| 659 | Antineoplastic (melanoma) | 1397 | 0.9377 |
| 660 | Antineoplastic (multiple myeloma) | 199 | 0.8722 |
| 661 | Antineoplastic (non-Hodgkin's lymphoma) | 73 | 0.8131 |
| 662 | Antineoplastic (non-small cell lung cancer) | 872 | 0.9146 |
| 663 | Antineoplastic (ovarian cancer) | 2006 | 0.9504 |
| 664 | Antineoplastic (pancreatic cancer) | 312 | 0.8817 |
| 665 | Antineoplastic (renal cancer) | 466 | 0.9247 |
| 666 | Antineoplastic (sarcoma) | 320 | 0.9122 |
| 667 | Antineoplastic (small cell lung cancer) | 186 | 0.8764 |
| 668 | Antineoplastic (solid tumors) | 709 | 0.8687 |
| 669 | Antineoplastic (squamous cell carcinoma) | 1226 | 0.9673 |
| 670 | Antineoplastic (thyroid cancer) | 59 | 0.9074 |
| 671 | Antineoplastic (uterine cancer) | 139 | 0.9374 |
| 672 | Antineoplastic alkaloid | 23 | 0.9106 |
| 673 | Antineoplastic antibiotic | 1599 | 0.9783 |
| 674 | Antineoplastic antimetabolite | 166 | 0.9507 |
| 675 | Antineoplastic enhancer | 774 | 0.9081 |
| 676 | Antineoplastic, alkylator | 118 | 0.9671 |
| 677 | Antinephritic | 83 | 0.8514 |
| 678 | Antineurogenic pain | 561 | 0.8844 |
| 679 | Antineurotic | 47 | 0.8063 |
| 680 | Antinociceptive | 41 | 0.8573 |
| 681 | Antiobesity | 7769 | 0.9117 |
| 682 | Antiosteoporotic | 2666 | 0.9266 |
| 683 | Antioxidant | 843 | 0.9388 |
| 684 | Antiparasitic | 605 | 0.9272 |
| 685 | Antiparkinsonian | 2768 | 0.8938 |
| 686 | Antiparkinsonian, rigidity relieving | 37 | 0.9269 |
| 687 | Antiparkinsonian, tremor relieving | 114 | 0.9430 |
| 688 | Antiperistaltic | 10 | 0.9467 |
| 689 | Antiprotozoal | 2191 | 0.9152 |
| 690 | Antiprotozoal (Amoeba) | 88 | 0.8685 |
| 691 | Antiprotozoal (Babesia) | 5 | 0.9739 |
| 692 | Antiprotozoal (Coccidial) | 98 | 0.9027 |
| 693 | Antiprotozoal (Histomonas) | 7 | 0.9963 |
| 694 | Antiprotozoal (Leishmania) | 151 | 0.8793 |
| 695 | Antiprotozoal (Plasmodium) | 1322 | 0.9382 |
| 696 | Antiprotozoal (Toxoplasma) | 21 | 0.9204 |
| 697 | Antiprotozoal (Trichomonas) | 89 | 0.9183 |
| 698 | Antiprotozoal (Trypanosoma) | 225 | 0.8786 |
| 699 | Antiprotozoal activity enhancer | 5 | 1.0000 |
| 700 | Antipruritic | 268 | 0.8756 |
| 701 | Antipruritic, allergic | 146 | 0.8504 |
| 702 | Antipruritic, non-allergic | 68 | 0.9386 |
| 703 | Antipsoriatic | 1771 | 0.8972 |
| 704 | Antipsychotic | 6680 | 0.9291 |
| 705 | Antipyretic | 410 | 0.9186 |
| 706 | Antirickettsial | 18 | 0.9426 |
| 707 | Antischistosomal | 39 | 0.9434 |
| 708 | Antiseborrheic | 10 | 0.9069 |
| 709 | Antisecretoric | 192 | 0.9073 |
| 710 | Antiseptic | 170 | 0.9572 |
| 711 | Antismoking | 189 | 0.9738 |
| 712 | Antispirochetal | 35 | 0.9629 |
| 713 | Antithrombocytopenic | 144 | 0.9803 |
| 714 | Antithrombotic | 557 | 0.8755 |
| 715 | Antithyroid | 40 | 0.9460 |
| 716 | Antitoxic | 145 | 0.9049 |
| 717 | Antitreponemal | 8 | 0.9194 |
| 718 | Antituberculosic | 434 | 0.8837 |
| 719 | Antitussive | 247 | 0.9355 |
| 720 | Antitussive, narcotic | 35 | 0.9677 |
| 721 | Antiulcerative | 893 | 0.8868 |
| 722 | Antiuremic | 39 | 0.9324 |
| 723 | Antiviral | 11347 | 0.9180 |
| 724 | Antiviral (Adenovirus) | 23 | 0.8787 |
| 725 | Antiviral (CMV) | 15 | 0.8695 |
| 726 | Antiviral (Hepatitis B) | 53 | 0.9037 |
| 727 | Antiviral (Hepatitis C) | 1472 | 0.9647 |
| 728 | Antiviral (Hepatitis) | 1753 | 0.9559 |
| 729 | Antiviral (Herpes) | 142 | 0.8940 |
| 730 | Antiviral (Herpesvirus 3, Human) | 7 | 1.0000 |
| 731 | Antiviral (HIV) | 7050 | 0.9475 |
| 732 | Antiviral (Influenza A) | 31 | 0.8733 |
| 733 | Antiviral (Influenza) | 150 | 0.8826 |
| 734 | Antiviral (Parainfluenza) | 5 | 0.9999 |
| 735 | Antiviral (Picornavirus) | 31 | 0.8105 |
| 736 | Antiviral (Poxvirus) | 41 | 0.9041 |
| 737 | Antiviral (Rhinovirus) | 13 | 0.8066 |
| 738 | Antiviral (Trachoma) | 12 | 0.9872 |
| 739 | Anxiolytic | 8121 | 0.9103 |
| 740 | Apical sodium codependent bile acid transporter inhibitor | 16 | 1.0000 |
| 741 | Apnea | 24 | 0.8961 |
| 742 | APOA1 expression enhancer | 17 | 0.8257 |
| 743 | Apolipoprotein A inhibitor | 71 | 1.0000 |
| 744 | Apolipoprotein B inhibitor | 225 | 0.9955 |
| 745 | Apolipoprotein B-100 inhibitor | 50 | 0.9985 |
| 746 | Apoptosis agonist | 1299 | 0.8655 |
| 747 | Apoptosis antagonist | 248 | 0.9008 |
| 748 | Apyrase inhibitor | 17 | 0.8180 |
| 749 | AR expression inhibitor | 31 | 0.8773 |
| 750 | Arabinogalactan endo-1,4-beta-galactosidase inhibitor | 4 | 0.9982 |
| 751 | Arabinose isomerase inhibitor | 7 | 0.9934 |
| 752 | Arabinose-5-phosphate isomerase inhibitor | 4 | 0.9997 |
| 753 | Arachidonate-CoA ligase inhibitor | 7 | 0.9987 |
| 754 | Arachidonic acid antagonist | 93 | 0.9438 |
| 755 | Aralkylamine dehydrogenase inhibitor | 6 | 0.9992 |
| 756 | Aralkylamine N-acetyltransferase inhibitor | 16 | 0.9885 |
| 757 | Arginase inhibitor | 34 | 0.9930 |
| 758 | Arginine 2-monooxygenase inhibitor | 4 | 0.8953 |
| 759 | Arginine decarboxylase inhibitor | 38 | 0.9845 |
| 760 | Arginine deiminase inhibitor | 22 | 0.9473 |
| 761 | Arginine kinase inhibitor | 12 | 0.9951 |
| 762 | Arginine N-succinyltransferase inhibitor | 3 | 0.9997 |
| 763 | Arginine racemase inhibitor | 3 | 0.9994 |
| 764 | Arginine-tRNA ligase inhibitor | 17 | 0.9942 |
| 765 | Argininosuccinate lyase inhibitor | 10 | 0.9937 |
| 766 | Argininosuccinate synthase inhibitor | 21 | 0.9886 |
| 767 | Arginyltransferase inhibitor | 6 | 0.9938 |
| 768 | Aromatase inhibitor | 1202 | 0.9909 |
| 769 | Aromatic-amino-acid transaminase inhibitor | 14 | 0.9887 |
| 770 | Aromatic-hydroxylamine O-acetyltransferase inhibitor | 7 | 0.8507 |
| 771 | Aryl hydrocarbon receptor agonist | 12 | 0.9209 |
| 772 | Aryl hydrocarbon receptor antagonist | 57 | 0.9776 |
| 773 | Aryl sulfotransferase inhibitor | 30 | 0.9516 |
| 774 | Arylacetonitrilase inhibitor | 11 | 0.9642 |
| 775 | Aryl-acylamidase inhibitor | 35 | 0.9218 |
| 776 | Aryl-alcohol dehydrogenase (NADP+) inhibitor | 7 | 0.9854 |
| 777 | Aryl-alcohol dehydrogenase inhibitor | 10 | 0.9854 |
| 778 | Aryl-aldehyde dehydrogenase (NADP+) inhibitor | 6 | 0.9908 |
| 779 | Arylalkyl acylamidase inhibitor | 6 | 0.9881 |
| 780 | Arylamine N-acetyltransferase inhibitor | 33 | 0.9439 |
| 781 | Arylamine N-Acetyltransferase substrate | 103 | 0.9854 |
| 782 | Aryldialkylphosphatase inhibitor | 5 | 0.9838 |
| 783 | Arylesterase inhibitor | 9 | 0.9351 |
| 784 | Arylformamidase inhibitor | 28 | 0.9840 |
| 785 | Arylmalonate decarboxylase inhibitor | 3 | 0.9727 |
| 786 | Arylsulfatase inhibitor | 22 | 0.9741 |
| 787 | Arylsulfate sulfotransferase inhibitor | 7 | 0.9093 |
| 788 | Asparaginase inhibitor | 19 | 0.9648 |
| 789 | Asparagine synthase (glutamine-hydrolysing) inhibitor | 81 | 0.9935 |
| 790 | Asparagine-oxo-acid transaminase inhibitor | 17 | 0.9947 |
| 791 | Asparagine-tRNA ligase inhibitor | 6 | 0.9901 |
| 792 | Asparaginyl endopeptidase inhibitor | 54 | 0.9924 |
| 793 | Aspartate 1-decarboxylase inhibitor | 7 | 0.9958 |
| 794 | Aspartate 4-decarboxylase inhibitor | 19 | 0.9832 |
| 795 | Aspartate ammonia-lyase inhibitor | 26 | 0.9946 |
| 796 | Aspartate carbamoyltransferase inhibitor | 26 | 0.9858 |
| 797 | Aspartate kinase inhibitor | 24 | 0.9516 |
| 798 | Aspartate N-acetyltransferase inhibitor | 3 | 0.9999 |
| 799 | Aspartate racemase inhibitor | 4 | 0.9942 |
| 800 | Aspartate transaminase inhibitor | 21 | 0.9848 |
| 801 | Aspartate-ammonia ligase (ADP-forming) inhibitor | 4 | 0.9937 |
| 802 | Aspartate-ammonia ligase inhibitor | 3 | 0.9764 |
| 803 | Aspartate-phenylpyruvate transaminase inhibitor | 4 | 0.8708 |
| 804 | Aspartate-semialdehyde dehydrogenase inhibitor | 13 | 0.9928 |
| 805 | Aspartate-tRNA ligase inhibitor | 6 | 0.9855 |
| 806 | Aspartoacylase inhibitor | 4 | 0.9852 |
| 807 | Aspartyl aminopeptidase inhibitor | 8 | 0.9886 |
| 808 | Aspartyl protease inhibitor | 3 | 1.0000 |
| 809 | Aspartyltransferase inhibitor | 4 | 0.8491 |
| 810 | Aspergillopepsin I inhibitor | 8 | 0.9302 |
| 811 | Aspergillopepsin II inhibitor | 4 | 0.9479 |
| 812 | Aspergillus nuclease S1 inhibitor | 8 | 0.9495 |
| 813 | Aspulvinone dimethylallyltransferase inhibitor | 3 | 0.8428 |
| 814 | Assemblin inhibitor | 7 | 0.9949 |
| 815 | Astacin inhibitor | 19 | 0.9851 |
| 816 | Asthma | 202 | 0.7902 |
| 817 | Astringent | 11 | 0.9907 |
| 818 | Ataxia | 433 | 0.8297 |
| 819 | Atherosclerosis treatment | 3679 | 0.8892 |
| 820 | ATM kinase inhibitor | 74 | 0.9833 |
| 821 | ATP adenylyltransferase inhibitor | 7 | 0.9853 |
| 822 | ATP citrate lysase inhibitor | 47 | 0.9963 |
| 823 | ATP citrate synthase inhibitor | 20 | 0.9966 |
| 824 | ATP deaminase inhibitor | 5 | 0.9970 |
| 825 | ATP diphosphatase inhibitor | 4 | 0.9954 |
| 826 | ATP phosphoribosyltransferase inhibitor | 16 | 0.9237 |
| 827 | ATPase (Mitochondrial F1F0) inhibitor | 17 | 0.9998 |
| 828 | ATPase (Vacuolar H+) inhibitor | 73 | 0.9929 |
| 829 | ATPase inhibitor | 150 | 0.9327 |
| 830 | ATPase stimulant | 18 | 0.8749 |
| 831 | ATP-binding cassette A1 stimulant | 3 | 0.9529 |
| 832 | ATP-dependent RNA helicase inhibitor | 10 | 1.0000 |
| 833 | Atrolysin A inhibitor | 11 | 0.9515 |
| 834 | Atrolysin C inhibitor | 10 | 0.9811 |
| 835 | Attention deficit/hyperactivity disorder treatment | 666 | 0.9741 |
| 836 | Aureolysin inhibitor | 4 | 0.9838 |
| 837 | Aurora kinase inhibitor | 999 | 0.9818 |
| 838 | Aurora-A kinase inhibitor | 600 | 0.9823 |
| 839 | Aurora-B kinase inhibitor | 504 | 0.9851 |
| 840 | Aurora-C kinase inhibitor | 46 | 0.9655 |
| 841 | Autoimmune disorders treatment | 3972 | 0.8791 |
| 842 | Autophagy inducer | 3 | 0.9338 |
| 843 | Autotaxin inhibitor | 50 | 0.9734 |
| 844 | AXL receptor tyrosine kinase inhibitor | 40 | 0.9419 |
| 845 | Azobenzene reductase inhibitor | 5 | 0.9855 |
| 846 | Bacillus subtilis ribonuclease inhibitor | 6 | 0.9963 |
| 847 | Bacterial efflux pump inhibitor | 16 | 0.9125 |
| 848 | Bacterial leucyl aminopeptidase inhibitor | 29 | 0.9931 |
| 849 | Baculoviral IAP repeat-containing protein 4 inhibitor | 118 | 0.9914 |
| 850 | Baculoviral IAP repeat-containing protein inhibitor | 162 | 0.9915 |
| 851 | Bcl2 antagonist | 134 | 0.9300 |
| 852 | Bcl-xL inhibitor | 120 | 0.9815 |
| 853 | Bcr-Abl kinase inhibitor | 91 | 0.9502 |
| 854 | Behavioral disturbance | 1535 | 0.8342 |
| 855 | Benzaldehyde dehydrogenase (NAD+) inhibitor | 8 | 0.9941 |
| 856 | Benzaldehyde dehydrogenase (NADP+) inhibitor | 3 | 0.9776 |
| 857 | Benzoate 4-monooxygenase inhibitor | 19 | 0.9384 |
| 858 | Benzoate-CoA ligase inhibitor | 6 | 0.8950 |
| 859 | Benzodiazepine antagonist | 455 | 0.9885 |
| 860 | Benzodiazepine inverse agonist | 59 | 0.9912 |
| 861 | Benzodiazepine receptor peripheral-type antagonist | 425 | 0.9967 |
| 862 | Benzoin aldolase inhibitor | 3 | 0.9997 |
| 863 | Benzoylformate decarboxylase inhibitor | 9 | 0.8942 |
| 864 | Beta 1 adrenoreceptor agonist | 49 | 0.9764 |
| 865 | Beta 1 adrenoreceptor antagonist | 677 | 0.9888 |
| 866 | Beta 2 adrenoreceptor agonist | 683 | 0.9948 |
| 867 | Beta 2 adrenoreceptor antagonist | 670 | 0.9897 |
| 868 | Beta 3 adrenoreceptor agonist | 772 | 0.9969 |
| 869 | Beta 3 adrenoreceptor antagonist | 156 | 0.9876 |
| 870 | Beta adrenoreceptor agonist | 1554 | 0.9884 |
| 871 | Beta adrenoreceptor antagonist | 1418 | 0.9818 |
| 872 | Beta amyloid protein antagonist | 122 | 0.9730 |
| 873 | Beta galactosidase inhibitor | 81 | 0.9935 |
| 874 | Beta glucosidase inhibitor | 22 | 0.9982 |
| 875 | Beta glucuronidase inhibitor | 15 | 0.8693 |
| 876 | Beta lactamase II inhibitor | 18 | 1.0000 |
| 877 | Beta lactamase Imi-1 inhibitor | 5 | 0.9992 |
| 878 | Beta lactamase inhibitor | 437 | 0.9626 |
| 879 | Beta lactamase TEM-1 inhibitor | 42 | 0.9994 |
| 880 | Beta tubulin antagonist | 478 | 0.9907 |
| 881 | Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase inhibitor | 13 | 0.9933 |
| 882 | Beta-adrenergic receptor kinase inhibitor | 22 | 0.8262 |
| 883 | Beta-alanine-pyruvate transaminase inhibitor | 3 | 0.9893 |
| 884 | Beta-amylase inhibitor | 9 | 0.9940 |
| 885 | Beta-carotene 15,15'-monooxygenase inhibitor | 17 | 0.9417 |
| 886 | Beta-cyclopiazonate dehydrogenase inhibitor | 7 | 0.9829 |
| 887 | Beta-D-fucosidase inhibitor | 20 | 0.9895 |
| 888 | Beta-fructofuranosidase inhibitor | 43 | 0.9914 |
| 889 | Beta-galactoside alpha-2,3-sialyltransferase inhibitor | 10 | 0.9985 |
| 890 | Beta-glucosidase inhibitor | 59 | 0.9887 |
| 891 | Betaine-aldehyde dehydrogenase inhibitor | 18 | 0.9926 |
| 892 | Betaine-homocysteine S-methyltransferase inhibitor | 9 | 0.9982 |
| 893 | Beta-Lysine 5,6-aminomutase inhibitor | 4 | 0.9975 |
| 894 | Beta-mannosidase inhibitor | 10 | 0.9863 |
| 895 | Beta-N-acetylgalactosaminidase inhibitor | 3 | 0.9845 |
| 896 | Beta-N-acetylhexosaminidase inhibitor | 43 | 0.9803 |
| 897 | Beta-Phosphoglucomutase inhibitor | 5 | 0.9990 |
| 898 | Beta-ureidopropionase inhibitor | 16 | 0.9702 |
| 899 | Bile-salt sulfotransferase inhibitor | 4 | 0.9867 |
| 900 | Biliary tract disorders treatment | 94 | 0.8916 |
| 901 | Bilirubin oxidase inhibitor | 9 | 0.9172 |
| 902 | Biliverdin reductase inhibitor | 11 | 0.9936 |
| 903 | Biotin carboxylase inhibitor | 4 | 0.9862 |
| 904 | Biotin-[methylmalonyl-CoA-carboxytransferase] ligase inhibitor | 4 | 0.9996 |
| 905 | Biotin-[propionyl-CoA-carboxylase (ATP-hydrolysing)] ligase inhibitor | 3 | 0.9783 |
| 906 | Biotin-CoA ligase inhibitor | 3 | 0.9894 |
| 907 | Biotinidase inhibitor | 8 | 0.8388 |
| 908 | Biphenyl-2,3-diol 1,2-dioxygenase inhibitor | 15 | 0.9906 |
| 909 | Bipolar disorder treatment | 192 | 0.9633 |
| 910 | Bis(5'-adenosyl)-triphosphatase inhibitor | 4 | 0.9908 |
| 911 | Bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) inhibitor | 12 | 0.9960 |
| 912 | Bis(5'-nucleosyl)-tetraphosphatase (symmetrical) inhibitor | 11 | 0.9964 |
| 913 | Bisphosphoglycerate mutase inhibitor | 4 | 0.9843 |
| 914 | Bisphosphoglycerate phosphatase inhibitor | 5 | 0.9697 |
| 915 | Bisphosphonate | 55 | 0.9996 |
| 916 | Blasticidin-S deaminase inhibitor | 4 | 0.9776 |
| 917 | Bombesin 1 receptor antagonist | 10 | 0.9934 |
| 918 | Bombesin 2 receptor antagonist | 19 | 0.9812 |
| 919 | Bombesin 3 receptor agonist | 24 | 0.9948 |
| 920 | Bombesin agonist | 25 | 0.9960 |
| 921 | Bombesin antagonist | 148 | 0.9888 |
| 922 | Bone diseases treatment | 3281 | 0.9229 |
| 923 | Bone formation stimulant | 476 | 0.9203 |
| 924 | Bone morphogenic protein 1 inhibitor | 146 | 0.9997 |
| 925 | Bone morphogenic protein inhibitor | 148 | 0.9989 |
| 926 | Bontoxilysin inhibitor | 6 | 0.9511 |
| 927 | Bothrolysin inhibitor | 3 | 0.9824 |
| 928 | Botulin neurotoxin A light chain inhibitor | 11 | 0.8695 |
| 929 | Botulinum neurotoxin type B inhibitor | 8 | 1.0000 |
| 930 | Brachyurin inhibitor | 8 | 0.9774 |
| 931 | Bradycardic | 275 | 0.8012 |
| 932 | Bradykinin agonist | 15 | 0.9991 |
| 933 | Bradykinin antagonist | 1208 | 0.9957 |
| 934 | Bradykinin B1 receptor agonist | 6 | 1.0000 |
| 935 | Bradykinin B1 receptor antagonist | 568 | 0.9972 |
| 936 | Bradykinin B2 receptor agonist | 9 | 0.9997 |
| 937 | Bradykinin B2 receptor antagonist | 545 | 0.9990 |
| 938 | BRAF expression inhibitor | 4 | 0.9900 |
| 939 | Branched-chain-amino-acid transaminase inhibitor | 21 | 0.9943 |
| 940 | Breast cancer-resistant protein inhibitor | 39 | 0.9778 |
| 941 | Bronchoconstrictor | 198 | 0.8132 |
| 942 | Bronchodilator | 1813 | 0.9585 |
| 943 | Bruton tyrosine kinase inhibitor | 70 | 0.9609 |
| 944 | Bulimia treatment | 103 | 0.9973 |
| 945 | Bullous pemphigoid | 8 | 0.9616 |
| 946 | Butyrate-CoA ligase inhibitor | 10 | 0.9885 |
| 947 | Butyrylcholinesterase inhibitor | 952 | 0.9890 |
| 948 | Butyrylcholinesterase stimulant | 3 | 0.9992 |
| 949 | Butyryl-CoA dehydrogenase inhibitor | 9 | 0.9963 |
| 950 | Ca(v)2.2 blocker | 344 | 0.9835 |
| 951 | Ca2+/calmodulin-dependent kinase I inhibitor | 18 | 0.9146 |
| 952 | Ca2+/calmodulin-dependent kinase II inhibitor | 86 | 0.9606 |
| 953 | Ca2+/calmodulin-dependent protein kinase inhibitor | 96 | 0.9198 |
| 954 | Ca2+-transporting ATPase inhibitor | 12 | 0.8608 |
| 955 | Cachexia treatment | 140 | 0.9415 |
| 956 | Cadherin antagonist | 3 | 0.9996 |
| 957 | Calcineurin inhibitor | 13 | 0.9996 |
| 958 | Calcitonin gene-related peptide 1 receptor antagonist | 256 | 0.9968 |
| 959 | Calcitonin gene-related peptide antagonist | 649 | 0.9962 |
| 960 | Calcitonin stimulant | 17 | 0.9664 |
| 961 | Calcium antagonist | 72 | 0.9576 |
| 962 | Calcium channel (voltage-sensitive) activator | 6 | 0.8068 |
| 963 | Calcium channel (voltage-sensitive) blocker | 2248 | 0.9617 |
| 964 | Calcium channel activator | 49 | 0.9153 |
| 965 | Calcium channel blocker | 4357 | 0.9548 |
| 966 | Calcium channel L-type blocker | 1379 | 0.9857 |
| 967 | Calcium channel N-type blocker | 623 | 0.9510 |
| 968 | Calcium channel T-type blocker | 344 | 0.9834 |
| 969 | Calcium regulator | 259 | 0.8387 |
| 970 | Calcium release-activated channel blocker | 51 | 0.9967 |
| 971 | Calcium-sensing receptor agonist | 5 | 0.9847 |
| 972 | Calcium-sensing receptor antagonist | 87 | 0.9924 |
| 973 | Calpain inhibitor | 863 | 0.9326 |
| 974 | Camphor 1,2-monooxygenase inhibitor | 4 | 0.9845 |
| 975 | Cancer associated disorders treatment | 49 | 0.8612 |
| 976 | Cancer procoagulant inhibitor | 11 | 0.9750 |
| 977 | Candidapepsin 2 inhibitor | 10 | 0.9999 |
| 978 | Candidapepsin inhibitor | 17 | 0.9723 |
| 979 | Cannabinoid receptor antagonist | 1962 | 0.9902 |
| 980 | Capillary fragility treatment | 18 | 0.9700 |
| 981 | Carbamoyl-phosphate synthase (ammonia) inhibitor | 15 | 0.9903 |
| 982 | Carbamoyl-serine ammonia-lyase inhibitor | 3 | 0.9990 |
| 983 | Carbonic anhydrase I inhibitor | 812 | 0.9989 |
| 984 | Carbonic anhydrase I stimulant | 56 | 0.9995 |
| 985 | Carbonic anhydrase II inhibitor | 1211 | 0.9981 |
| 986 | Carbonic anhydrase II stimulant | 59 | 0.9929 |
| 987 | Carbonic anhydrase inhibitor | 1344 | 0.9976 |
| 988 | Carbonic anhydrase IV inhibitor | 810 | 0.9989 |
| 989 | Carbonic anhydrase IV stimulant | 50 | 0.9999 |
| 990 | Carbonic anhydrase IX inhibitor | 156 | 0.9990 |
| 991 | Carbonic anhydrase stimulant | 74 | 0.9912 |
| 992 | Carbonic anhydrase V inhibitor | 75 | 0.9905 |
| 993 | Carbonic anhydrase VII inhibitor | 22 | 0.9985 |
| 994 | Carbonic anhydrase XII inhibitor | 34 | 0.9993 |
| 995 | Carbonic anhydrase XIV inhibitor | 18 | 0.9792 |
| 996 | Carbonic anhydrase XV inhibitor | 3 | 1.0000 |
| 997 | Carbon-monoxide dehydrogenase inhibitor | 3 | 0.9756 |
| 998 | Carboxy-cis,cis-muconate cyclase inhibitor | 19 | 0.9979 |
| 999 | Carboxycyclohexadienyl dehydratase inhibitor | 5 | 0.9999 |
| 1000 | Carboxylate reductase inhibitor | 6 | 0.9976 |
| 1001 | Carboxylesterase inhibitor | 43 | 0.9798 |
| 1002 | Carboxymethylenebutenolidase inhibitor | 3 | 0.9944 |
| 1003 | Carboxypeptidase B inhibitor | 39 | 0.9958 |
| 1004 | Carboxypeptidase D inhibitor | 9 | 0.9528 |
| 1005 | Carboxypeptidase E inhibitor | 21 | 0.9448 |
| 1006 | Carboxypeptidase M inhibitor | 6 | 0.9960 |
| 1007 | Carboxypeptidase Taq inhibitor | 3 | 0.9263 |
| 1008 | Carboxypeptidase U inhibitor | 17 | 0.9934 |
| 1009 | Carcinogenic | 1813 | 0.9329 |
| 1010 | Carcinogenic, group 1 | 23 | 0.8685 |
| 1011 | Carcinogenic, group 2A | 36 | 0.9549 |
| 1012 | Carcinogenic, group 2B | 194 | 0.9602 |
| 1013 | Carcinogenic, group 3 | 387 | 0.9479 |
| 1014 | Carcinogenic, mouse | 456 | 0.9210 |
| 1015 | Carcinogenic, mouse, female | 384 | 0.9152 |
| 1016 | Carcinogenic, mouse, male | 365 | 0.9298 |
| 1017 | Carcinogenic, rat | 603 | 0.9314 |
| 1018 | Carcinogenic, rat, female | 445 | 0.9249 |
| 1019 | Carcinogenic, rat, male | 511 | 0.9305 |
| 1020 | Cardiac myosin stimulant | 4 | 1.0000 |
| 1021 | Cardiodepressant | 160 | 0.9148 |
| 1022 | Cardioprotectant | 187 | 0.8845 |
| 1023 | Cardiotonic | 3225 | 0.8896 |
| 1024 | Cardiovascular analeptic | 18 | 0.9339 |
| 1025 | Carminative | 4 | 0.9778 |
| 1026 | Carnitinamidase inhibitor | 7 | 0.9571 |
| 1027 | Carnitine 3-dehydrogenase inhibitor | 11 | 0.9846 |
| 1028 | Carnitine dehydratase inhibitor | 4 | 0.9921 |
| 1029 | Carnitine O-octanoyltransferase inhibitor | 7 | 0.9833 |
| 1030 | Carnitine palmitoyltransferase inhibitor | 23 | 0.9830 |
| 1031 | Carnosine synthase inhibitor | 14 | 0.9575 |
| 1032 | Caspase 2 inhibitor | 13 | 0.9468 |
| 1033 | Caspase 3 inhibitor | 629 | 0.9655 |
| 1034 | Caspase 3 stimulant | 83 | 0.8102 |
| 1035 | Caspase 6 inhibitor | 126 | 0.9992 |
| 1036 | Caspase 7 inhibitor | 303 | 0.9996 |
| 1037 | Caspase 8 inhibitor | 242 | 0.9935 |
| 1038 | Caspase 8 stimulant | 31 | 0.8330 |
| 1039 | Caspase 9 inhibitor | 37 | 0.9686 |
| 1040 | Catalase inhibitor | 27 | 0.9607 |
| 1041 | Catalase stimulant | 53 | 0.9270 |
| 1042 | Cataract | 115 | 0.8204 |
| 1043 | Catechol 1,2-dioxygenase inhibitor | 20 | 0.9909 |
| 1044 | Catechol 2,3-dioxygenase inhibitor | 32 | 0.9946 |
| 1045 | Catechol O methyltransferase inhibitor | 58 | 0.9816 |
| 1046 | Catechol oxidase inhibitor | 15 | 0.9748 |
| 1047 | Catenin beta inhibitor | 35 | 0.8642 |
| 1048 | Cathepsin B inhibitor | 665 | 0.9863 |
| 1049 | Cathepsin D inhibitor | 605 | 0.9802 |
| 1050 | Cathepsin E inhibitor | 38 | 0.9662 |
| 1051 | Cathepsin F inhibitor | 29 | 0.9761 |
| 1052 | Cathepsin G inhibitor | 97 | 0.9593 |
| 1053 | Cathepsin H inhibitor | 43 | 0.9396 |
| 1054 | Cathepsin K inhibitor | 661 | 0.9987 |
| 1055 | Cathepsin L inhibitor | 671 | 0.9858 |
| 1056 | Cathepsin S inhibitor | 649 | 0.9952 |
| 1057 | Cathepsin T inhibitor | 7 | 0.9472 |
| 1058 | Cathepsin V inhibitor | 31 | 0.9982 |
| 1059 | CC chemokine 1 receptor antagonist | 298 | 0.9948 |
| 1060 | CC chemokine 10 receptor antagonist | 10 | 1.0000 |
| 1061 | CC chemokine 2 receptor antagonist | 413 | 0.9857 |
| 1062 | CC chemokine 3 receptor antagonist | 339 | 0.9934 |
| 1063 | CC chemokine 4 receptor antagonist | 55 | 0.9521 |
| 1064 | CC chemokine 5 receptor agonist | 14 | 0.9998 |
| 1065 | CC chemokine 5 receptor antagonist | 461 | 0.9881 |
| 1066 | CC chemokine 9 receptor antagonist | 23 | 0.9762 |
| 1067 | CC chemokine receptor 2B antagonist | 3 | 0.9590 |
| 1068 | CC chemokine receptor agonist | 15 | 0.9840 |
| 1069 | CC chemokine receptor antagonist | 1506 | 0.9806 |
| 1070 | CD45 antagonist | 96 | 0.9789 |
| 1071 | CD80 antagonist | 81 | 1.0000 |
| 1072 | CDC25 phosphatase inhibitor | 32 | 0.9937 |
| 1073 | CDC25A inhibitor | 90 | 0.9740 |
| 1074 | CDC25B inhibitor | 147 | 0.9820 |
| 1075 | CDC25C inhibitor | 32 | 0.9670 |
| 1076 | CDC7 inhibitor | 94 | 0.9956 |
| 1077 | CDK/Cyclin complex inhibitor | 1090 | 0.9791 |
| 1078 | CDK1/cyclin B inhibitor | 307 | 0.9910 |
| 1079 | CDK2/cyclin A inhibitor | 379 | 0.9640 |
| 1080 | CDK2/cyclin A3 inhibitor | 30 | 1.0000 |
| 1081 | CDK2/cyclin E inhibitor | 439 | 0.9923 |
| 1082 | CDK4/cyclin D inhibitor | 425 | 0.9955 |
| 1083 | CDK4/cyclin D1 inhibitor | 249 | 0.9878 |
| 1084 | CDK4/cyclin D3 inhibitor | 7 | 1.0000 |
| 1085 | CDK5/p25 inhibitor | 48 | 0.9855 |
| 1086 | CDK9/cyclin T1 inhibitor | 7 | 0.8531 |
| 1087 | CDP-4-dehydro-6-deoxyglucose reductase inhibitor | 4 | 0.9856 |
| 1088 | CDP-diacylglycerol diphosphatase inhibitor | 6 | 0.9993 |
| 1089 | CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase inhibitor | 3 | 0.9776 |
| 1090 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase inhibitor | 15 | 0.9225 |
| 1091 | CDP-diacylglycerol-serine O-phosphatidyltransferase inhibitor | 6 | 0.9077 |
| 1092 | CDP-glycerol diphosphatase inhibitor | 6 | 0.9999 |
| 1093 | CDP-glycerol glycerophosphotransferase inhibitor | 4 | 0.8338 |
| 1094 | Celiac disease treatment | 47 | 0.9780 |
| 1095 | Cell adhesion inhibitor | 681 | 0.9582 |
| 1096 | Cell adhesion molecule inhibitor | 135 | 0.8599 |
| 1097 | Cell wall biosynthesis inhibitor | 20 | 0.8851 |
| 1098 | Cell wall synthesis inhibitor | 443 | 0.9599 |
| 1099 | Cellobiose phosphorylase inhibitor | 10 | 0.9929 |
| 1100 | Cellulase inhibitor | 12 | 0.9732 |
| 1101 | Cellulose 1,4-beta-cellobiosidase inhibitor | 11 | 0.8941 |
| 1102 | Cellulose synthase (UDP-forming) inhibitor | 13 | 0.8970 |
| 1103 | Centromere associated protein inhibitor | 7 | 0.9048 |
| 1104 | Ceramidase inhibitor | 12 | 0.9982 |
| 1105 | Ceramide glucosyltransferase inhibitor | 18 | 0.9537 |
| 1106 | Cerebroside-sulfatase inhibitor | 9 | 0.9807 |
| 1107 | Cerebrovascular disordes treatment | 478 | 0.9238 |
| 1108 | Cerevisin inhibitor | 8 | 0.9884 |
| 1109 | CF transmembrane conductance regulator agonist | 8 | 0.8484 |
| 1110 | CF transmembrane conductance regulator antagonist | 35 | 0.9731 |
| 1111 | Chalcone isomerase inhibitor | 26 | 0.9952 |
| 1112 | Channel-conductance-controlling ATPase inhibitor | 5 | 0.9639 |
| 1113 | Chaperonin ATPase inhibitor | 6 | 0.9652 |
| 1114 | Check point kinase 1 inhibitor | 488 | 0.9899 |
| 1115 | Check point kinase 2 inhibitor | 121 | 0.9856 |
| 1116 | Check point kinase inhibitor | 567 | 0.9893 |
| 1117 | Chelator | 117 | 0.9721 |
| 1118 | Chelator, Iron | 37 | 0.9963 |
| 1119 | Chemokine receptor agonist | 15 | 0.9840 |
| 1120 | Chemokine receptor antagonist | 2247 | 0.9784 |
| 1121 | Chemopreventive | 345 | 0.9419 |
| 1122 | Chemoprotective | 194 | 0.9141 |
| 1123 | Chemosensitizer | 203 | 0.8432 |
| 1124 | Chenodeoxycholoyltaurine hydrolase inhibitor | 3 | 0.9634 |
| 1125 | Chitin deacetylase inhibitor | 3 | 0.9994 |
| 1126 | Chitin synthase inhibitor | 31 | 0.9440 |
| 1127 | Chitinase inhibitor | 29 | 0.8941 |
| 1128 | Chitobiosyldiphosphodolichol beta-mannosyltransferase inhibitor | 5 | 0.9834 |
| 1129 | Chitosanase inhibitor | 8 | 0.9455 |
| 1130 | Chloramphenicol O-acetyltransferase inhibitor | 5 | 0.9954 |
| 1131 | Chlordecone reductase inhibitor | 4 | 0.9112 |
| 1132 | Chloride channel activator | 41 | 0.8813 |
| 1133 | Chloride channel blocker | 10 | 0.9503 |
| 1134 | Chloride peroxidase inhibitor | 3 | 0.8850 |
| 1135 | Chloride/bicarbonate exchanger inhibitor | 24 | 0.9915 |
| 1136 | Cholate-CoA ligase inhibitor | 9 | 0.9879 |
| 1137 | Cholecystokinin A agonist | 104 | 0.9993 |
| 1138 | Cholecystokinin A antagonist | 1477 | 0.9947 |
| 1139 | Cholecystokinin agonist | 109 | 0.9991 |
| 1140 | Cholecystokinin antagonist | 2074 | 0.9931 |
| 1141 | Cholecystokinin B antagonist | 1501 | 0.9946 |
| 1142 | Choleretic | 116 | 0.9383 |
| 1143 | Cholestanetriol 26-monooxygenase inhibitor | 9 | 0.9124 |
| 1144 | Cholestasis | 206 | 0.8288 |
| 1145 | Cholestenol delta-isomerase inhibitor | 8 | 0.9997 |
| 1146 | Cholestenone 5alpha-reductase inhibitor | 12 | 0.9174 |
| 1147 | Cholesterol absorption inhibitor | 192 | 0.9765 |
| 1148 | Cholesterol antagonist | 119 | 0.8763 |
| 1149 | Cholesterol ester transfer protein antagonist | 572 | 0.9931 |
| 1150 | Cholesterol esterase inhibitor | 183 | 0.9953 |
| 1151 | Cholesterol monooxygenase (side-chain-cleaving) inhibitor | 7 | 1.0000 |
| 1152 | Cholesterol oxidase inhibitor | 15 | 0.9837 |
| 1153 | Cholesterol synthesis inhibitor | 81 | 0.9672 |
| 1154 | Choline acetyltransferase stimulant | 5 | 0.9341 |
| 1155 | Choline dehydrogenase inhibitor | 5 | 0.9941 |
| 1156 | Choline kinase inhibitor | 12 | 0.9267 |
| 1157 | Choline sulfotransferase inhibitor | 20 | 0.9886 |
| 1158 | Choline-phosphate cytidylyltransferase inhibitor | 15 | 0.8990 |
| 1159 | Cholinergic | 3980 | 0.9615 |
| 1160 | Cholinergic antagonist | 4093 | 0.9704 |
| 1161 | Choline-sulfatase inhibitor | 8 | 0.9743 |
| 1162 | Choloylglycine hydrolase inhibitor | 3 | 0.9849 |
| 1163 | Chondroitin 6-sulfotransferase inhibitor | 4 | 0.9883 |
| 1164 | Chorea | 45 | 0.8993 |
| 1165 | Choreoathetosis | 29 | 0.8850 |
| 1166 | Chorismate mutase inhibitor | 22 | 0.9978 |
| 1167 | Chronic obstructive pulmonary disease treatment | 2161 | 0.9326 |
| 1168 | Chymase inhibitor | 177 | 0.9895 |
| 1169 | Chymosin inhibitor | 3 | 0.8770 |
| 1170 | Chymotrypsin inhibitor | 249 | 0.9718 |
| 1171 | Cis-1,2-dihydro-1,2-dihydroxynaphthalene dehydrogenase inhibitor | 3 | 0.9693 |
| 1172 | Citrate (Si)-synthase inhibitor | 26 | 0.9918 |
| 1173 | Clavaminate synthase inhibitor | 3 | 0.9747 |
| 1174 | Cleft palate | 9 | 0.8488 |
| 1175 | Clostripain inhibitor | 22 | 0.9424 |
| 1176 | Cl--transporting ATPase inhibitor | 5 | 0.8936 |
| 1177 | CMP-KDO synthase inhibitor | 3 | 0.9992 |
| 1178 | CMP-N-acetylneuraminate monooxygenase inhibitor | 13 | 0.9702 |
| 1179 | CMP-N-acylneuraminate phosphodiesterase inhibitor | 23 | 0.9859 |
| 1180 | CNS active muscle relaxant | 140 | 0.9665 |
| 1181 | Coactivator-associated arginine methyltransferase 1 inhibitor | 5 | 0.8750 |
| 1182 | Coagulant | 22 | 0.9765 |
| 1183 | Cocain dependency treatment | 201 | 0.9616 |
| 1184 | Coccolysin inhibitor | 11 | 0.9052 |
| 1185 | Coenzyme-B sulfoethylthiotransferase inhibitor | 3 | 0.8743 |
| 1186 | Cognition disorders treatment | 6742 | 0.8971 |
| 1187 | Collagenase 3 inhibitor | 1699 | 0.9900 |
| 1188 | Collagenase inhibitor | 753 | 0.9881 |
| 1189 | Colony stimulating factor agonist | 36 | 0.9498 |
| 1190 | Colony stimulating factor antagonist | 278 | 0.9712 |
| 1191 | Colorectum cell-derived growth factor antagonist | 5 | 1.0000 |
| 1192 | Coma | 311 | 0.8260 |
| 1193 | CO-methylating acetyl-CoA synthase inhibitor | 3 | 1.0000 |
| 1194 | Complement C5a chemotactic receptor antagonist | 103 | 0.9886 |
| 1195 | Complement C5a convertase stimulant | 3 | 1.0000 |
| 1196 | Complement factor 1 inhibitor | 34 | 0.9503 |
| 1197 | Complement factor 1r inhibitor | 31 | 0.9991 |
| 1198 | Complement factor D inhibitor | 3 | 0.8511 |
| 1199 | Complement inhibitor | 51 | 0.8929 |
| 1200 | Complement stimulant | 3 | 1.0000 |
| 1201 | Conjunctivitis | 341 | 0.7731 |
| 1202 | Consciousness alteration | 571 | 0.8078 |
| 1203 | Constipation treatment | 92 | 0.9469 |
| 1204 | Contraceptive | 791 | 0.9535 |
| 1205 | Contraceptive female | 119 | 0.9307 |
| 1206 | Contraceptive male | 177 | 0.9681 |
| 1207 | Coproporphyrinogen oxidase inhibitor | 28 | 0.9844 |
| 1208 | Corneal wound healing stimulator | 11 | 0.9883 |
| 1209 | Corticosteroid antagonist | 3 | 0.9245 |
| 1210 | Corticosteroid side-chain-isomerase inhibitor | 5 | 0.9693 |
| 1211 | Corticosteroid-like | 52 | 0.9986 |
| 1212 | Corticotropin releasing factor 1 receptor antagonist | 733 | 0.9997 |
| 1213 | Corticotropin releasing factor antagonist | 33 | 0.9850 |
| 1214 | Corticotropin-like | 3 | 0.9908 |
| 1215 | Cortisol sulfotransferase inhibitor | 14 | 0.9980 |
| 1216 | Cortisone alpha-reductase inhibitor | 4 | 0.9999 |
| 1217 | Cortisone beta-reductase inhibitor | 7 | 0.9993 |
| 1218 | CPB protease inhibitor | 3 | 0.9994 |
| 1219 | CpG-Oligodeoxynucleotides inhibitor | 27 | 1.0000 |
| 1220 | Creatinase inhibitor | 8 | 0.9916 |
| 1221 | Creatine kinase inhibitor | 30 | 0.9738 |
| 1222 | Creatininase inhibitor | 6 | 0.9013 |
| 1223 | Creatinine deaminase inhibitor | 3 | 0.9911 |
| 1224 | Crotonoyl-[acyl-carrier-protein] hydratase inhibitor | 3 | 0.9842 |
| 1225 | Cruzipain inhibitor | 168 | 0.9779 |
| 1226 | c-Src kinase inhibitor | 1446 | 0.9824 |
| 1227 | CTGF expression inhibitor | 11 | 0.9480 |
| 1228 | CTP synthase inhibitor | 14 | 0.9864 |
| 1229 | Cushing's syndrome treatment | 76 | 0.9699 |
| 1230 | Cutinase inhibitor | 6 | 0.9687 |
| 1231 | CXC chemokine 1 receptor antagonist | 113 | 0.9933 |
| 1232 | CXC chemokine 2 receptor antagonist | 124 | 0.9839 |
| 1233 | CXC chemokine 3 receptor antagonist | 155 | 0.9926 |
| 1234 | CXC chemokine 4 receptor antagonist | 145 | 0.9940 |
| 1235 | CXC chemokine 5 receptor antagonist | 328 | 0.9999 |
| 1236 | CXC chemokine L1/GRO-alpha antagonist | 17 | 1.0000 |
| 1237 | CXC chemokine receptor antagonist | 869 | 0.9888 |
| 1238 | Cyanate hydratase inhibitor | 13 | 0.9862 |
| 1239 | Cyanoalanine nitrilase inhibitor | 5 | 0.8426 |
| 1240 | Cyanosis | 162 | 0.8357 |
| 1241 | Cyclamate sulfohydrolase inhibitor | 4 | 0.9906 |
| 1242 | Cyclic AMP agonist | 15 | 0.8708 |
| 1243 | Cyclic AMP modulator | 40 | 0.8940 |
| 1244 | Cyclic AMP phosphodiesterase inhibitor | 188 | 0.8747 |
| 1245 | Cyclic GMP phosphodiesterase inhibitor | 19 | 0.8800 |
| 1246 | Cyclin-dependent kinase 1 inhibitor | 1143 | 0.9856 |
| 1247 | Cyclin-dependent kinase 2 inhibitor | 2002 | 0.9832 |
| 1248 | Cyclin-dependent kinase 4 inhibitor | 958 | 0.9903 |
| 1249 | Cyclin-dependent kinase 5 inhibitor | 700 | 0.9902 |
| 1250 | Cyclin-dependent kinase 6 inhibitor | 53 | 0.9663 |
| 1251 | Cyclin-dependent kinase 7 inhibitor | 53 | 0.9652 |
| 1252 | Cyclin-dependent kinase 9 inhibitor | 63 | 0.9825 |
| 1253 | Cyclin-dependent kinase inhibitor | 3665 | 0.9779 |
| 1254 | Cycloartenol synthase inhibitor | 19 | 0.9654 |
| 1255 | Cyclohexadienyl dehydrogenase inhibitor | 12 | 0.9993 |
| 1256 | Cyclohexanone monooxygenase inhibitor | 11 | 0.8499 |
| 1257 | Cyclohexyl-isocyanide hydratase inhibitor | 3 | 0.9812 |
| 1258 | Cyclomaltodextrin glucanotransferase inhibitor | 17 | 0.9995 |
| 1259 | Cyclomaltodextrinase inhibitor | 6 | 0.8355 |
| 1260 | Cyclooxygenase 1 inhibitor | 1376 | 0.9737 |
| 1261 | Cyclooxygenase 1 substrate | 3 | 0.9957 |
| 1262 | Cyclooxygenase 2 inhibitor | 3370 | 0.9772 |
| 1263 | Cyclooxygenase 3 inhibitor | 18 | 0.9972 |
| 1264 | Cyclooxygenase inhibitor | 4216 | 0.9660 |
| 1265 | Cyclooxygenase substrate | 15 | 0.9085 |
| 1266 | Cyclopentanone monooxygenase inhibitor | 5 | 0.9791 |
| 1267 | Cyclopropane-fatty-acyl-phospholipid synthase inhibitor | 10 | 0.9503 |
| 1268 | CYP11B substrate | 7 | 1.0000 |
| 1269 | CYP11B1 inhibitor | 313 | 0.9915 |
| 1270 | CYP11B1 substrate | 3 | 1.0000 |
| 1271 | CYP11B2 inhibitor | 315 | 0.9980 |
| 1272 | CYP11B2 substrate | 6 | 1.0000 |
| 1273 | CYP17 inhibitor | 7 | 0.9396 |
| 1274 | CYP17 substrate | 10 | 0.9857 |
| 1275 | CYP17A substrate | 4 | 0.9999 |
| 1276 | CYP19 inducer | 3 | 1.0000 |
| 1277 | CYP19 inhibitor | 43 | 0.9640 |
| 1278 | CYP19 substrate | 23 | 0.9742 |
| 1279 | CYP19A1 expression inhibitor | 24 | 0.8452 |
| 1280 | CYP19A1 substrate | 12 | 1.0000 |
| 1281 | CYP1A inducer | 45 | 0.9169 |
| 1282 | CYP1A inhibitor | 435 | 0.8861 |
| 1283 | CYP1A substrate | 620 | 0.8871 |
| 1284 | CYP1A1 inducer | 30 | 0.9603 |
| 1285 | CYP1A1 inhibitor | 83 | 0.9216 |
| 1286 | CYP1A1 substrate | 328 | 0.9196 |
| 1287 | CYP1A2 inducer | 24 | 0.8894 |
| 1288 | CYP1A2 inhibitor | 412 | 0.8901 |
| 1289 | CYP1A2 substrate | 477 | 0.8823 |
| 1290 | CYP1A3 substrate | 5 | 0.9954 |
| 1291 | CYP1B substrate | 83 | 0.9315 |
| 1292 | CYP1B1 inducer | 9 | 0.9991 |
| 1293 | CYP1B1 inhibitor | 62 | 0.9750 |
| 1294 | CYP1B1 substrate | 81 | 0.9427 |
| 1295 | CYP24 inhibitor | 11 | 0.9121 |
| 1296 | CYP24 substrate | 14 | 0.9763 |
| 1297 | CYP26 inhibitor | 19 | 0.9931 |
| 1298 | CYP26 substrate | 5 | 0.9492 |
| 1299 | CYP26A substrate | 4 | 0.9356 |
| 1300 | CYP27 substrate | 14 | 0.9835 |
| 1301 | CYP27A substrate | 12 | 0.9798 |
| 1302 | CYP27A1 inhibitor | 9 | 0.9995 |
| 1303 | CYP27A1 substrate | 8 | 0.9999 |
| 1304 | CYP2A substrate | 228 | 0.8866 |
| 1305 | CYP2A1 substrate | 16 | 0.8611 |
| 1306 | CYP2A10 substrate | 4 | 0.9785 |
| 1307 | CYP2A11 substrate | 3 | 0.9754 |
| 1308 | CYP2A13 substrate | 3 | 0.9996 |
| 1309 | CYP2A2 substrate | 8 | 0.9586 |
| 1310 | CYP2A3 substrate | 14 | 0.9598 |
| 1311 | CYP2A4 substrate | 3 | 0.9069 |
| 1312 | CYP2A5 inhibitor | 34 | 0.9959 |
| 1313 | CYP2A5 substrate | 8 | 0.9369 |
| 1314 | CYP2A6 inhibitor | 78 | 0.9611 |
| 1315 | CYP2A6 substrate | 200 | 0.8818 |
| 1316 | CYP2A8 substrate | 3 | 0.9558 |
| 1317 | CYP2B substrate | 442 | 0.9121 |
| 1318 | CYP2B1 substrate | 179 | 0.9487 |
| 1319 | CYP2B10 substrate | 3 | 0.8610 |
| 1320 | CYP2B11 substrate | 10 | 0.9274 |
| 1321 | CYP2B18 substrate | 4 | 0.8620 |
| 1322 | CYP2B2 substrate | 77 | 0.9118 |
| 1323 | CYP2B4 substrate | 37 | 0.9841 |
| 1324 | CYP2B5 substrate | 3 | 0.9534 |
| 1325 | CYP2B6 substrate | 213 | 0.8888 |
| 1326 | CYP2C substrate | 564 | 0.8703 |
| 1327 | CYP2C10 substrate | 18 | 0.9300 |
| 1328 | CYP2C11 substrate | 86 | 0.9131 |
| 1329 | CYP2C12 substrate | 10 | 0.8496 |
| 1330 | CYP2C18 inhibitor | 13 | 0.9830 |
| 1331 | CYP2C18 substrate | 35 | 0.9206 |
| 1332 | CYP2C19 inducer | 8 | 0.8330 |
| 1333 | CYP2C19 inhibitor | 361 | 0.8825 |
| 1334 | CYP2C19 substrate | 275 | 0.8897 |
| 1335 | CYP2C2 substrate | 5 | 0.9583 |
| 1336 | CYP2C29 substrate | 5 | 0.8303 |
| 1337 | CYP2C3 substrate | 6 | 0.8603 |
| 1338 | CYP2C6 substrate | 53 | 0.9087 |
| 1339 | CYP2C8 inducer | 9 | 0.9708 |
| 1340 | CYP2C8 inhibitor | 55 | 0.8136 |
| 1341 | CYP2C8 substrate | 170 | 0.8477 |
| 1342 | CYP2C9 inducer | 27 | 0.8199 |
| 1343 | CYP2C9 inhibitor | 748 | 0.9007 |
| 1344 | CYP2C9 substrate | 342 | 0.8723 |
| 1345 | CYP2D substrate | 461 | 0.8888 |
| 1346 | CYP2D1 substrate | 37 | 0.9439 |
| 1347 | CYP2D15 substrate | 5 | 0.8161 |
| 1348 | CYP2D16 substrate | 3 | 0.9175 |
| 1349 | CYP2D2 inhibitor | 7 | 0.9295 |
| 1350 | CYP2D6 inhibitor | 994 | 0.9359 |
| 1351 | CYP2D6 substrate | 438 | 0.8882 |
| 1352 | CYP2E substrate | 370 | 0.9073 |
| 1353 | CYP2E1 inducer | 12 | 0.8612 |
| 1354 | CYP2E1 inhibitor | 61 | 0.9526 |
| 1355 | CYP2E1 substrate | 364 | 0.9077 |
| 1356 | CYP2F1 substrate | 8 | 0.9452 |
| 1357 | CYP2G1 substrate | 11 | 0.9626 |
| 1358 | CYP2H substrate | 3 | 0.8461 |
| 1359 | CYP2J substrate | 5 | 0.8653 |
| 1360 | CYP2J2 substrate | 4 | 0.8625 |
| 1361 | CYP3A inducer | 74 | 0.8729 |
| 1362 | CYP3A substrate | 993 | 0.8528 |
| 1363 | CYP3A1 substrate | 48 | 0.8599 |
| 1364 | CYP3A11 substrate | 4 | 0.9992 |
| 1365 | CYP3A2 substrate | 59 | 0.8184 |
| 1366 | CYP3A3 substrate | 36 | 0.8504 |
| 1367 | CYP3A4 inducer | 70 | 0.8669 |
| 1368 | CYP3A4 inhibitor | 1396 | 0.9110 |
| 1369 | CYP3A4 substrate | 840 | 0.8479 |
| 1370 | CYP3A5 inducer | 4 | 0.9753 |
| 1371 | CYP3A5 substrate | 125 | 0.8508 |
| 1372 | CYP3A7 substrate | 41 | 0.8857 |
| 1373 | CYP3C substrate | 7 | 0.9867 |
| 1374 | CYP4A substrate | 39 | 0.8738 |
| 1375 | CYP4A1 substrate | 8 | 0.9914 |
| 1376 | CYP4A11 substrate | 17 | 0.8699 |
| 1377 | CYP4A2 substrate | 4 | 0.9750 |
| 1378 | CYP4B substrate | 16 | 0.9451 |
| 1379 | CYP4B1 substrate | 15 | 0.9446 |
| 1380 | CYP4F substrate | 21 | 0.9817 |
| 1381 | CYP4F12 substrate | 7 | 0.9652 |
| 1382 | CYP4F2 inhibitor | 34 | 0.9951 |
| 1383 | CYP4F2 substrate | 9 | 0.9490 |
| 1384 | CYP4F3 substrate | 10 | 0.9999 |
| 1385 | CYP4F8 substrate | 4 | 0.9997 |
| 1386 | CYP51 inhibitor | 14 | 0.9979 |
| 1387 | CYP7 inhibitor | 7 | 0.8234 |
| 1388 | CYP7 substrate | 8 | 0.9999 |
| 1389 | CYP7A1 substrate | 5 | 1.0000 |
| 1390 | CYP7B substrate | 4 | 0.9997 |
| 1391 | CYP7B1 substrate | 4 | 0.9997 |
| 1392 | Cystathionine beta-lyase inhibitor | 21 | 0.9876 |
| 1393 | Cystathionine beta-synthase inhibitor | 12 | 0.9897 |
| 1394 | Cystathionine gamma-lyase inhibitor | 26 | 0.9899 |
| 1395 | Cysteamine dioxygenase inhibitor | 9 | 0.9802 |
| 1396 | Cysteine desulfurase inhibitor | 5 | 0.9910 |
| 1397 | Cysteine dioxygenase inhibitor | 16 | 0.9980 |
| 1398 | Cysteine protease B inhibitor | 12 | 0.9998 |
| 1399 | Cysteine synthase inhibitor | 20 | 0.9345 |
| 1400 | Cysteine transaminase inhibitor | 3 | 0.9971 |
| 1401 | Cysteine-S-conjugate beta-lyase inhibitor | 3 | 0.9938 |
| 1402 | Cysteine-tRNA ligase inhibitor | 19 | 0.9907 |
| 1403 | Cystic fibrosis treatment | 231 | 0.8626 |
| 1404 | Cystinyl aminopeptidase inhibitor | 35 | 0.9435 |
| 1405 | Cytidine deaminase inhibitor | 511 | 0.9648 |
| 1406 | Cytidylate kinase inhibitor | 19 | 0.9965 |
| 1407 | Cytochrome P450 inhibitor | 3256 | 0.9077 |
| 1408 | Cytochrome P450 stimulant | 17 | 0.8168 |
| 1409 | Cytochrome-b5 reductase inhibitor | 21 | 0.8724 |
| 1410 | Cytochrome-b5 reductase substrate | 3 | 0.8905 |
| 1411 | Cytochrome-c3 hydrogenase inhibitor | 6 | 0.9941 |
| 1412 | Cytokine modulator | 140 | 0.9512 |
| 1413 | Cytokine production inhibitor | 757 | 0.9582 |
| 1414 | Cytokine production stimulant | 260 | 0.9853 |
| 1415 | Cytokine release inhibitor | 7 | 0.9888 |
| 1416 | Cytoprotectant | 37 | 0.8419 |
| 1417 | Cytosine deaminase inhibitor | 27 | 0.9769 |
| 1418 | Cytosol alanyl aminopeptidase inhibitor | 43 | 0.9435 |
| 1419 | Cytosole dipeptidase inhibitor | 5 | 0.9905 |
| 1420 | Cytosolic phospholipase A2 inhibitor | 151 | 0.9927 |
| 1421 | Cytostatic | 320 | 0.9112 |
| 1422 | Cytotoxic | 721 | 0.9308 |
| 1423 | D(-)-tartrate dehydratase inhibitor | 5 | 0.9995 |
| 1424 | D-2-hydroxy-acid dehydrogenase inhibitor | 6 | 0.9920 |
| 1425 | Dactylysin inhibitor | 22 | 0.9223 |
| 1426 | D-Ala-D-Ala ligase inhibitor | 6 | 0.9581 |
| 1427 | D-alanine 2-hydroxymethyltransferase inhibitor | 3 | 0.9850 |
| 1428 | D-alanine transaminase inhibitor | 18 | 0.9914 |
| 1429 | D-Alanine-alanyl-poly(glycerolphosphate) ligase inhibitor | 5 | 0.9998 |
| 1430 | D-Alanine-poly(phosphoribitol) ligase inhibitor | 5 | 0.9990 |
| 1431 | D-amino-acid dehydrogenase inhibitor | 5 | 0.9656 |
| 1432 | D-Amino-acid oxidase inhibitor | 36 | 0.9990 |
| 1433 | D-arabinonolactone oxidase inhibitor | 5 | 0.9915 |
| 1434 | D-aspartate oxidase inhibitor | 18 | 0.9987 |
| 1435 | D-benzoylarginine-4-nitroanilide amidase inhibitor | 5 | 0.9953 |
| 1436 | dCMP deaminase inhibitor | 19 | 0.9970 |
| 1437 | dCTP deaminase inhibitor | 10 | 0.9972 |
| 1438 | dCTP diphosphatase inhibitor | 3 | 1.0000 |
| 1439 | D-cysteine desulfhydrase inhibitor | 5 | 0.9911 |
| 1440 | Deacetoxycephalosporin-C synthase inhibitor | 10 | 0.9908 |
| 1441 | Decylcitrate synthase inhibitor | 4 | 0.9777 |
| 1442 | Dehydro-L-gulonate decarboxylase inhibitor | 3 | 0.9469 |
| 1443 | Delayed rectifier potassium channel activator | 162 | 0.9916 |
| 1444 | Delayed rectifier potassium channel blocker | 56 | 0.9951 |
| 1445 | Delirium | 103 | 0.8240 |
| 1446 | DELTA14-sterol reductase inhibitor | 13 | 0.8945 |
| 1447 | DELTA24-sterol reductase inhibitor | 7 | 0.8779 |
| 1448 | Dementia treatment | 13 | 0.8507 |
| 1449 | Demethylmacrocin O-methyltransferase inhibitor | 10 | 0.9998 |
| 1450 | Demethylsterigmatocystin 6-O-methyltransferase inhibitor | 3 | 0.9891 |
| 1451 | Demyelination | 9 | 0.9305 |
| 1452 | Deoxyadenosine kinase inhibitor | 13 | 0.9212 |
| 1453 | Deoxycytidine deaminase inhibitor | 5 | 0.9911 |
| 1454 | Deoxycytidine kinase inhibitor | 43 | 0.9747 |
| 1455 | Deoxycytidylate 5-hydroxymethyltransferase inhibitor | 7 | 0.9788 |
| 1456 | Deoxyguanosine kinase inhibitor | 37 | 0.9961 |
| 1457 | Deoxyhypusine monooxygenase inhibitor | 16 | 0.9983 |
| 1458 | Deoxyhypusine synthase inhibitor | 27 | 0.9864 |
| 1459 | Deoxynucleoside kinase inhibitor | 24 | 0.9998 |
| 1460 | Deoxyribonuclease (pyrimidine dimer) inhibitor | 3 | 0.9985 |
| 1461 | Deoxyribonuclease I inhibitor | 10 | 0.9498 |
| 1462 | Deoxyribonuclease X inhibitor | 3 | 0.9929 |
| 1463 | Deoxyribose-phosphate aldolase inhibitor | 4 | 0.9909 |
| 1464 | Dependence | 70 | 0.8414 |
| 1465 | Dependence treatment | 1217 | 0.9398 |
| 1466 | Depression | 125 | 0.8172 |
| 1467 | Dermatitis | 875 | 0.8179 |
| 1468 | Dermatologic | 3457 | 0.8876 |
| 1469 | Dethiobiotin synthase inhibitor | 7 | 0.9871 |
| 1470 | Dextranase inhibitor | 9 | 0.9477 |
| 1471 | Dextransucrase inhibitor | 18 | 0.9939 |
| 1472 | D-glutamate oxidase inhibitor | 9 | 0.9906 |
| 1473 | Diabetes insipidus treatment | 30 | 0.9982 |
| 1474 | Diabetic nephropathy treatment | 66 | 0.9004 |
| 1475 | Diabetic neuropathy treatment | 57 | 0.8156 |
| 1476 | Diabetic retinopathy treatment | 267 | 0.9318 |
| 1477 | Diacylglycerol cholinephosphotransferase inhibitor | 28 | 0.9789 |
| 1478 | Diacylglycerol kinase inhibitor | 23 | 0.9394 |
| 1479 | Diacylglycerol O-acyltransferase 1 inhibitor | 93 | 0.9977 |
| 1480 | Diacylglycerol O-acyltransferase inhibitor | 141 | 0.9848 |
| 1481 | Diamine N-acetyltransferase inhibitor | 12 | 0.9461 |
| 1482 | Diamine oxidase inhibitor | 32 | 0.9901 |
| 1483 | Diaminopimelate decarboxylase inhibitor | 13 | 0.9995 |
| 1484 | Diaminopimelate dehydrogenase inhibitor | 7 | 0.9926 |
| 1485 | Diaminopimelate epimerase inhibitor | 8 | 0.9987 |
| 1486 | Diaminopropionate ammonia-lyase inhibitor | 11 | 0.9919 |
| 1487 | Diarrhea | 316 | 0.8166 |
| 1488 | Dichloromethane dehalogenase inhibitor | 9 | 0.9996 |
| 1489 | Dichloromuconate cycloisomerase inhibitor | 4 | 0.9961 |
| 1490 | Diguanidinobutanase inhibitor | 6 | 0.9940 |
| 1491 | Dihydrodipicolinate reductase inhibitor | 8 | 0.8953 |
| 1492 | Dihydrodipicolinate synthase inhibitor | 16 | 0.9944 |
| 1493 | Dihydrofolate reductase (Mycobacterium avium) inhibitor | 11 | 0.9997 |
| 1494 | Dihydrofolate reductase (Pneumocystis carinii) inhibitor | 8 | 0.9999 |
| 1495 | Dihydrofolate reductase (Toxoplasma gondii) inhibitor | 11 | 0.9993 |
| 1496 | Dihydrofolate reductase inhibitor | 1812 | 0.9927 |
| 1497 | Dihydrofolate synthase inhibitor | 13 | 0.9324 |
| 1498 | Dihydrolipoamide S-acetyltransferase inhibitor | 4 | 0.9938 |
| 1499 | Dihydroneopterin aldolase inhibitor | 35 | 0.9997 |
| 1500 | Dihydroorotase inhibitor | 16 | 0.9693 |
| 1501 | Dihydroorotate dehydrogenase inhibitor | 196 | 0.9868 |
| 1502 | Dihydroorotate oxidase inhibitor | 84 | 0.9869 |
| 1503 | Dihydropteroate synthase inhibitor | 31 | 0.9864 |
| 1504 | Dihydropyrimidinase inhibitor | 15 | 0.9900 |
| 1505 | Dihydropyrimidine dehydrogenase inhibitor | 8 | 0.9852 |
| 1506 | Dihydrouracil dehydrogenase (NAD+) inhibitor | 5 | 0.9140 |
| 1507 | Dihydrouracil oxidase inhibitor | 8 | 0.9899 |
| 1508 | Dihydroxyacetanilide dehydrogenase inhibitor | 5 | 0.9997 |
| 1509 | Dihydroxyacetanilide epoxidase inhibitor | 5 | 0.9997 |
| 1510 | Dihydroxy-acid dehydratase inhibitor | 14 | 0.9469 |
| 1511 | Diiodophenylpyruvate reductase inhibitor | 3 | 0.9961 |
| 1512 | Diiodotyrosine transaminase inhibitor | 6 | 0.9991 |
| 1513 | Diisopropyl-fluorophosphatase inhibitor | 5 | 0.9906 |
| 1514 | Dimethylallyltranstransferase inhibitor | 19 | 0.9687 |
| 1515 | Dimethylargininase inhibitor | 3 | 0.9295 |
| 1516 | Dimethylhistidine N-methyltransferase inhibitor | 5 | 0.9923 |
| 1517 | Dimethylmaleate hydratase inhibitor | 3 | 0.9809 |
| 1518 | Dipeptidase E inhibitor | 4 | 0.9349 |
| 1519 | Dipeptidyl peptidase I inhibitor | 68 | 0.9794 |
| 1520 | Dipeptidyl peptidase II inhibitor | 350 | 0.9888 |
| 1521 | Dipeptidyl peptidase inhibitor | 1605 | 0.9880 |
| 1522 | Dipeptidyl peptidase IV inhibitor | 1195 | 0.9902 |
| 1523 | Dipeptidyl peptidase IX inhibitor | 149 | 0.9994 |
| 1524 | Dipeptidyl peptidase VIII inhibitor | 207 | 0.9970 |
| 1525 | Diphenylpicrylhydrazyl (DPPH) scavenger | 3 | 1.0000 |
| 1526 | Diphosphate-fructose-6-phosphate 1-phosphotransferase inhibitor | 17 | 0.9973 |
| 1527 | Diphosphate-serine phosphotransferase inhibitor | 8 | 0.9994 |
| 1528 | Diphosphomevalonate decarboxylase inhibitor | 13 | 0.9332 |
| 1529 | Di-trans,poly-cis-decaprenylcistransferase inhibitor | 4 | 0.9777 |
| 1530 | Diuretic | 736 | 0.9203 |
| 1531 | Diuretic inhibitor | 93 | 0.8720 |
| 1532 | Dizziness | 719 | 0.8120 |
| 1533 | D-lactaldehyde dehydrogenase inhibitor | 11 | 0.8602 |
| 1534 | D-lactate dehydrogenase (cytochrome) inhibitor | 7 | 0.9910 |
| 1535 | D-lactate dehydrogenase inhibitor | 7 | 0.8755 |
| 1536 | D-lactate-2-sulfatase inhibitor | 4 | 0.9990 |
| 1537 | D-Lysine 5,6-aminomutase inhibitor | 22 | 0.9944 |
| 1538 | D-malate dehydrogenase (decarboxylating) inhibitor | 10 | 0.9907 |
| 1539 | DNA damaging | 466 | 0.9633 |
| 1540 | DNA directed DNA polymerase inhibitor | 302 | 0.9560 |
| 1541 | DNA directed RNA polymerase inhibitor | 543 | 0.9374 |
| 1542 | DNA directed RNA polymerase stimulant | 9 | 0.9980 |
| 1543 | DNA gyrase inhibitor | 239 | 0.9897 |
| 1544 | DNA helicase inhibitor | 41 | 0.9789 |
| 1545 | DNA intercalator | 582 | 0.9803 |
| 1546 | DNA ligase (ATP) inhibitor | 21 | 0.8942 |
| 1547 | DNA methylase inhibitor | 41 | 0.9730 |
| 1548 | DNA methyltransferase I inhibitor | 10 | 0.9530 |
| 1549 | DNA nucleotidylexotransferase inhibitor | 21 | 0.9535 |
| 1550 | DNA polymerase I inhibitor | 25 | 0.8537 |
| 1551 | DNA polymerase III inhibitor | 83 | 0.9964 |
| 1552 | DNA repair enzyme inhibitor | 165 | 0.9717 |
| 1553 | DNA synthesis inhibitor | 292 | 0.8955 |
| 1554 | DNA topoisomerase IV inhibitor | 110 | 0.9925 |
| 1555 | DNA-(apurinic or apyrimidinic site) lyase inhibitor | 12 | 0.9259 |
| 1556 | DNA-3-methyladenine glycosylase I inhibitor | 5 | 0.9607 |
| 1557 | DNA-3-methyladenine glycosylase II inhibitor | 3 | 0.9951 |
| 1558 | DNA-dependent protein kinase inhibitor | 309 | 0.9946 |
| 1559 | D-Octopine dehydrogenase inhibitor | 20 | 0.9772 |
| 1560 | Dolichol kinase inhibitor | 8 | 0.9652 |
| 1561 | Dolichyldiphosphatase inhibitor | 3 | 0.9999 |
| 1562 | Dolichyl-diphosphooligosaccharide-protein glycotransferase inhibitor | 3 | 0.9217 |
| 1563 | Dolichyl-phosphatase inhibitor | 6 | 0.9869 |
| 1564 | Dolichyl-phosphate beta-D-mannosyltransferase (T. brucei) inhibitor | 3 | 1.0000 |
| 1565 | Dolichyl-phosphate beta-D-mannosyltransferase inhibitor | 19 | 0.9312 |
| 1566 | Dolichyl-phosphate beta-glucosyltransferase inhibitor | 5 | 0.9145 |
| 1567 | DOPA decarboxylase inhibitor | 10 | 0.9850 |
| 1568 | Dopachrome isomerase inhibitor | 7 | 0.9975 |
| 1569 | Dopamine D1A antagonist | 25 | 0.9994 |
| 1570 | Dopamine D2 agonist inducer | 3 | 1.0000 |
| 1571 | Dopamine D2A antagonist | 82 | 0.9858 |
| 1572 | Dopamine D2B antagonist | 31 | 0.9996 |
| 1573 | Dopamine D2L antagonist | 481 | 0.9887 |
| 1574 | Dopamine D2S antagonist | 122 | 0.9622 |
| 1575 | Dopamine D5 antagonist | 281 | 0.9932 |
| 1576 | Dopamine precursors | 25 | 0.9995 |
| 1577 | Dopamine release inhibitor | 3 | 1.0000 |
| 1578 | Dopamine release stimulant | 7 | 0.9530 |
| 1579 | Dopamine transporter inhibitor | 1221 | 0.9906 |
| 1580 | D-Ornithine 4,5-aminomutase inhibitor | 5 | 0.9915 |
| 1581 | D-proline reductase (dithiol) inhibitor | 5 | 0.9943 |
| 1582 | Drowsiness | 926 | 0.8185 |
| 1583 | Dry eye syndrome treatment | 46 | 0.9197 |
| 1584 | D-Serine ammonia-lyase inhibitor | 4 | 0.9992 |
| 1585 | D-stereospecific aminopeptidase inhibitor | 7 | 0.9957 |
| 1586 | dTDP-glucose 4,6-dehydratase inhibitor | 6 | 0.9998 |
| 1587 | D-threo-aldose 1-dehydrogenase inhibitor | 7 | 0.9369 |
| 1588 | dTMP kinase (Mycobacterium tuberculosis) inhibitor | 11 | 0.9998 |
| 1589 | dTMP kinase inhibitor | 29 | 0.9997 |
| 1590 | Dual specificity phosphatase 1 inhibitor | 11 | 0.9179 |
| 1591 | Dual specificity phosphatase inhibitor | 183 | 0.9508 |
| 1592 | Dual specificity protein phosphatase VHR inhibitor | 9 | 0.9990 |
| 1593 | dUTP diphosphatase inhibitor | 14 | 0.9950 |
| 1594 | D-xylulose reductase inhibitor | 4 | 0.9858 |
| 1595 | Dynamin GTPase inhibitor | 15 | 0.9968 |
| 1596 | Dynein ATPase inhibitor | 3 | 0.9787 |
| 1597 | Dyrk kinase inhibitor | 93 | 0.9804 |
| 1598 | Dysarthria | 100 | 0.8333 |
| 1599 | Dyskinesia | 817 | 0.8407 |
| 1600 | Dysmenorrhea treatment | 166 | 0.9737 |
| 1601 | Dyspepsia treatment | 74 | 0.9340 |
| 1602 | Dysphoria | 38 | 0.8889 |
| 1603 | Dyspnea | 318 | 0.8619 |
| 1604 | Dystonia | 96 | 0.8105 |
| 1605 | Ecdysone 20-monooxygenase inhibitor | 15 | 0.8663 |
| 1606 | Edema | 141 | 0.8132 |
| 1607 | Eicosanoid agonist | 6 | 0.9979 |
| 1608 | EIF4E expression inhibitor | 8 | 0.8337 |
| 1609 | Elastase 1 inhibitor | 58 | 0.9877 |
| 1610 | Elastase 2 inhibitor | 99 | 0.9985 |
| 1611 | Elastase inhibitor | 834 | 0.9877 |
| 1612 | Electrolyte absorption antagonist | 54 | 0.9547 |
| 1613 | Electron transport complex I inhibitor | 26 | 0.9849 |
| 1614 | Electron-transferring-flavoprotein dehydrogenase inhibitor | 3 | 0.8814 |
| 1615 | Embryotoxic | 1743 | 0.9065 |
| 1616 | Emetic | 788 | 0.8204 |
| 1617 | Endo-1,3(4)-beta-glucanase inhibitor | 3 | 0.9913 |
| 1618 | Endo-1,4-beta-xylanase inhibitor | 19 | 0.9823 |
| 1619 | Endo-beta-N-acetylglucosaminidase inhibitor | 7 | 0.9998 |
| 1620 | Endocannabinoid uptake inhibitor | 29 | 0.9920 |
| 1621 | Endocrine disruptor | 223 | 0.8517 |
| 1622 | Endoglycosylceramidase inhibitor | 4 | 0.9864 |
| 1623 | Endometrios treatment | 257 | 0.9763 |
| 1624 | Endonuclease (influenza) inhibitor | 11 | 0.9927 |
| 1625 | Endopeptidase inhibitor | 87 | 0.9301 |
| 1626 | Endopeptidase La inhibitor | 39 | 0.9192 |
| 1627 | Endopeptidase So inhibitor | 7 | 0.8983 |
| 1628 | Endothelial growth factor antagonist | 9 | 0.9448 |
| 1629 | Endothelial nitric-oxide synthase inhibitor | 270 | 0.9974 |
| 1630 | Endothelin A receptor antagonist | 1756 | 0.9967 |
| 1631 | Endothelin B receptor antagonist | 1423 | 0.9959 |
| 1632 | Endothelin receptor agonist | 13 | 0.9997 |
| 1633 | Endothelin receptor antagonist | 2756 | 0.9951 |
| 1634 | Endothelin-converting enzyme inhibitor | 112 | 0.9522 |
| 1635 | Endothiapepsin inhibitor | 5 | 0.9973 |
| 1636 | Enoyl-[acyl-carrier-protein] reductase (NADH) inhibitor | 120 | 0.9896 |
| 1637 | Enoyl-CoA hydratase inhibitor | 9 | 0.9954 |
| 1638 | Enteropeptidase inhibitor | 6 | 0.8343 |
| 1639 | Envelysin inhibitor | 18 | 0.9508 |
| 1640 | EphB4 antagonist | 280 | 0.9882 |
| 1641 | Ephrin antagonist | 369 | 0.9623 |
| 1642 | Epidermal growth factor antagonist | 893 | 0.9907 |
| 1643 | Epidermal growth factor receptor kinase inhibitor | 2326 | 0.9627 |
| 1644 | Epithelial sodium channel blocker | 50 | 0.9921 |
| 1645 | Epoxide hydrolase 2 inhibitor | 281 | 0.9984 |
| 1646 | Epoxide hydrolase inhibitor | 609 | 0.9923 |
| 1647 | Epoxide hydrolase substrate | 147 | 0.9787 |
| 1648 | Equilibrative nucleoside transport protein 1 inhibitor | 97 | 0.9955 |
| 1649 | Equilibrative nucleoside transport protein inhibitor | 127 | 0.9955 |
| 1650 | ErbB antagonist | 841 | 0.9833 |
| 1651 | ErbB-1 antagonist | 12 | 0.9850 |
| 1652 | ErbB-2 antagonist | 796 | 0.9836 |
| 1653 | ErbB-4 antagonist | 42 | 0.9771 |
| 1654 | Erectile dysfunction treatment | 310 | 0.9453 |
| 1655 | Erythro-3-hydroxyaspartate ammonia-lyase inhibitor | 4 | 0.9996 |
| 1656 | Erythropoiesis stimulant | 6 | 0.8483 |
| 1657 | Erythropoietin receptor agonist | 10 | 0.9999 |
| 1658 | Estradiol 17 beta dehydrogenase 2 inhibitor | 81 | 0.9773 |
| 1659 | Estradiol 17 beta dehydrogenase 3 inhibitor | 129 | 0.9954 |
| 1660 | Estradiol 17 beta dehydrogenase inhibitor | 310 | 0.9865 |
| 1661 | Estradiol 17 beta dehydrogenase stimulant | 19 | 0.9987 |
| 1662 | Estradiol 17alpha-dehydrogenase inhibitor | 3 | 0.9903 |
| 1663 | Estrogen agonist | 734 | 0.9797 |
| 1664 | Estrogen alpha receptor agonist | 44 | 0.9943 |
| 1665 | Estrogen antagonist | 2227 | 0.9654 |
| 1666 | Estrogen beta receptor agonist | 185 | 0.9963 |
| 1667 | Estrogen receptor beta antagonist | 1524 | 0.9724 |
| 1668 | Estrogen-related receptor alpha antagonist | 43 | 0.9905 |
| 1669 | Estrone sulfatase inhibitor | 240 | 0.9970 |
| 1670 | Estrone sulfotransferase inhibitor | 39 | 0.9673 |
| 1671 | Estrone sulfotransferase stimulant | 17 | 0.9987 |
| 1672 | Ethanolamine ammonia-lyase inhibitor | 10 | 0.9994 |
| 1673 | Ethanolamine kinase inhibitor | 15 | 0.9886 |
| 1674 | Ethanolamine oxidase inhibitor | 6 | 0.8978 |
| 1675 | Ethanolamine-phosphate cytidylyltransferase inhibitor | 7 | 0.9305 |
| 1676 | Ethanolaminephosphotransferase inhibitor | 28 | 0.9608 |
| 1677 | Ether-a-go-go potassium channel 1 blocker | 21 | 1.0000 |
| 1678 | Ether-a-go-go potassium channel blocker | 21 | 1.0000 |
| 1679 | Eukaryotic elongation factor 2 kinase inhibitor | 3 | 1.0000 |
| 1680 | Euphoria | 43 | 0.8404 |
| 1681 | Excitability | 300 | 0.8206 |
| 1682 | Excitatory amino acid transporter 1 inhibitor | 33 | 0.9989 |
| 1683 | Excitatory amino acid transporter 2 inhibitor | 44 | 0.9994 |
| 1684 | Excitatory amino acid transporter EAAC1 inhibitor | 6 | 0.9912 |
| 1685 | Exoribonuclease II inhibitor | 5 | 0.9379 |
| 1686 | Expectorant | 132 | 0.9329 |
| 1687 | Extrapyramidal disorders treatment | 120 | 0.9591 |
| 1688 | Extrapyramidal effect | 12 | 0.8657 |
| 1689 | Eye irritation, high | 528 | 0.9372 |
| 1690 | Eye irritation, inactive | 91 | 0.8967 |
| 1691 | Eye irritation, moderate | 229 | 0.9674 |
| 1692 | Eye irritation, weak | 348 | 0.9684 |
| 1693 | Factor IXa inhibitor | 9 | 0.9999 |
| 1694 | Factor VII inhibitor | 134 | 0.9956 |
| 1695 | Factor VIIa inhibitor | 214 | 0.9852 |
| 1696 | Factor Xa inhibitor | 1741 | 0.9929 |
| 1697 | Factor XIa inhibitor | 6 | 0.9427 |
| 1698 | Factor XIIIa inhibitor | 52 | 0.9830 |
| 1699 | Factor XIIIa stimulant | 3 | 0.9976 |
| 1700 | FAD diphosphatase inhibitor | 17 | 0.9930 |
| 1701 | Falcipain 2 inhibitor | 112 | 0.9758 |
| 1702 | Falcipain 3 inhibitor | 14 | 0.8963 |
| 1703 | Falcipain inhibitor | 112 | 0.9758 |
| 1704 | Farnesoid X receptor agonist | 96 | 0.9947 |
| 1705 | Farnesoid X receptor antagonist | 22 | 0.8842 |
| 1706 | Farnesyltransferase inhibitor | 2518 | 0.9877 |
| 1707 | Farnesyltranstransferase inhibitor | 5 | 0.9816 |
| 1708 | Fas antagonist | 5 | 1.0000 |
| 1709 | Fasciculation | 28 | 0.8701 |
| 1710 | Fatty acid elongase inhibitor | 18 | 0.9800 |
| 1711 | Fatty acid oxidation inhibitor | 45 | 0.9943 |
| 1712 | Fatty acid synthase inhibitor | 46 | 0.9891 |
| 1713 | Fatty liver | 42 | 0.8053 |
| 1714 | Fatty-acyl-CoA synthase inhibitor | 5 | 0.9353 |
| 1715 | Fatty-acyl-ethyl-ester synthase inhibitor | 3 | 0.9977 |
| 1716 | Female sexual dysfunction treatment | 127 | 0.9712 |
| 1717 | Ferredoxin hydrogenase inhibitor | 8 | 0.9573 |
| 1718 | Ferredoxin-NAD+ reductase inhibitor | 3 | 0.9674 |
| 1719 | Ferredoxin-NADP+ reductase inhibitor | 6 | 0.9780 |
| 1720 | Ferredoxin-nitrite reductase inhibitor | 12 | 0.9559 |
| 1721 | Ferrochelatase inhibitor | 5 | 0.9896 |
| 1722 | Feruloyl esterase inhibitor | 6 | 0.9208 |
| 1723 | Fibrillation, atrial | 16 | 0.8309 |
| 1724 | Fibrinogen receptor antagonist | 29 | 0.8844 |
| 1725 | Fibrinolytic | 38 | 0.8303 |
| 1726 | Fibroblast activation protein alpha inhibitor | 36 | 0.9995 |
| 1727 | Fibroblast growth factor 1 agonist | 3 | 0.9585 |
| 1728 | Fibroblast growth factor 1 antagonist | 579 | 0.9787 |
| 1729 | Fibroblast growth factor 2 antagonist | 143 | 0.9572 |
| 1730 | Fibroblast growth factor 3 antagonist | 177 | 0.9676 |
| 1731 | Fibroblast growth factor agonist | 4 | 0.9270 |
| 1732 | Fibroblast growth factor antagonist | 785 | 0.9756 |
| 1733 | Fibrolase inhibitor | 4 | 0.8907 |
| 1734 | Fibromyalgia syndrome treatment | 53 | 0.9362 |
| 1735 | Fibrosis treatment | 95 | 0.9545 |
| 1736 | Fibrosis, interstitial | 8 | 0.8614 |
| 1737 | Flavin-containing monooxygenase inhibitor | 9 | 0.9471 |
| 1738 | Flavin-containing monooxygenase substrate | 65 | 0.8973 |
| 1739 | FMN adenylyltransferase inhibitor | 7 | 0.9999 |
| 1740 | FMN reductase inhibitor | 22 | 0.9507 |
| 1741 | FMO1 substrate | 17 | 0.9050 |
| 1742 | FMO3 substrate | 38 | 0.8916 |
| 1743 | Focal adhesion kinase 1 inhibitor | 38 | 0.9501 |
| 1744 | Focal adhesion kinase 2 inhibitor | 140 | 0.9157 |
| 1745 | Focal adhesion kinase inhibitor | 202 | 0.9195 |
| 1746 | Folate antagonist | 21 | 0.8698 |
| 1747 | Folate transporter 1 inhibitor | 5 | 0.9997 |
| 1748 | Follicle-stimulating hormone agonist | 11 | 0.9469 |
| 1749 | Follicle-stimulating hormone antagonist | 54 | 0.9997 |
| 1750 | Folylpolyglutamate synthase inhibitor | 19 | 0.9998 |
| 1751 | Formaldehyde dehydrogenase (glutathione) inhibitor | 17 | 0.9769 |
| 1752 | Formaldehyde dehydrogenase inhibitor | 14 | 0.9871 |
| 1753 | Formaldehyde transketolase inhibitor | 6 | 0.9203 |
| 1754 | Formate C-acetyltransferase inhibitor | 5 | 0.9978 |
| 1755 | Formate dehydrogenase inhibitor | 21 | 0.9778 |
| 1756 | Formate-dihydrofolate ligase inhibitor | 14 | 0.8918 |
| 1757 | Formimidoylglutamase inhibitor | 3 | 0.9989 |
| 1758 | Formimidoyltetrahydrofolate cyclodeaminase inhibitor | 8 | 0.9914 |
| 1759 | Formyl peptide receptor antagonist | 58 | 0.9997 |
| 1760 | Formyltetrahydrofolate dehydrogenase inhibitor | 6 | 0.9917 |
| 1761 | Fragilysin inhibitor | 6 | 0.8580 |
| 1762 | Free fatty acid receptor 1 agonist | 28 | 0.9997 |
| 1763 | Free radical scavenger | 249 | 0.9392 |
| 1764 | Fructan beta-fructosidase inhibitor | 4 | 0.9647 |
| 1765 | Fructokinase inhibitor | 13 | 0.9969 |
| 1766 | Fructose 5-dehydrogenase (NADP+) inhibitor | 3 | 0.9899 |
| 1767 | Fructose 5-dehydrogenase inhibitor | 4 | 0.8004 |
| 1768 | Fructose-1,6-bisphosphatase inhibitor | 211 | 0.9989 |
| 1769 | Fructose-2,6-bisphosphate 2-phosphatase inhibitor | 12 | 0.9637 |
| 1770 | Fructose-2,6-bisphosphate 6-phosphatase inhibitor | 4 | 0.9967 |
| 1771 | Fructuronate reductase inhibitor | 3 | 0.9946 |
| 1772 | FtsZ polymerization inhibitor | 5 | 0.9998 |
| 1773 | Fucokinase inhibitor | 9 | 0.9965 |
| 1774 | Fucosterol-epoxide lyase inhibitor | 9 | 0.9326 |
| 1775 | Fumarate hydratase inhibitor | 24 | 0.9958 |
| 1776 | Fumarate reductase (NADH) inhibitor | 7 | 0.8936 |
| 1777 | Fumarylacetoacetase inhibitor | 14 | 0.9945 |
| 1778 | Furin inhibitor | 23 | 0.9824 |
| 1779 | Fusarinine-C ornithinesterase inhibitor | 3 | 0.8407 |
| 1780 | G protein-coupled receptor agonist | 73 | 0.9935 |
| 1781 | GABA A inverse agonist | 8 | 0.8922 |
| 1782 | GABA A receptor agonist | 231 | 0.9451 |
| 1783 | GABA A receptor antagonist | 2765 | 0.9873 |
| 1784 | GABA aminotransferase inhibitor | 14 | 0.8532 |
| 1785 | GABA B receptor agonist | 10 | 0.9188 |
| 1786 | GABA B receptor antagonist | 63 | 0.9940 |
| 1787 | GABA C receptor agonist | 3 | 0.9867 |
| 1788 | GABA C receptor antagonist | 24 | 0.9716 |
| 1789 | GABA inverse agonist | 8 | 0.8922 |
| 1790 | GABA receptor agonist | 386 | 0.9337 |
| 1791 | GABA receptor antagonist | 2835 | 0.9870 |
| 1792 | GABA transporter 1 inhibitor | 150 | 0.9956 |
| 1793 | GABA transporter 2 inhibitor | 11 | 0.9893 |
| 1794 | GABA transporter 3 inhibitor | 8 | 0.9900 |
| 1795 | GABA transporter inhibitor | 157 | 0.9938 |
| 1796 | GABA uptake inhibitor | 68 | 0.9934 |
| 1797 | Galactokinase inhibitor | 6 | 0.9818 |
| 1798 | Galactolipase inhibitor | 12 | 0.8999 |
| 1799 | Galactorrhea | 12 | 0.8594 |
| 1800 | Galactose 1-dehydrogenase (NADP+) inhibitor | 3 | 0.9893 |
| 1801 | Galactose oxidase inhibitor | 13 | 0.9774 |
| 1802 | Galactoside 2-alpha-L-fucosyltransferase inhibitor | 12 | 0.9856 |
| 1803 | Galactoside O-acetyltransferase inhibitor | 4 | 0.9761 |
| 1804 | Galactosylceramidase inhibitor | 8 | 0.9847 |
| 1805 | Galactosylceramide sulfotransferase inhibitor | 10 | 0.9750 |
| 1806 | Galactosylgalactosylglucosylceramidase inhibitor | 5 | 0.9956 |
| 1807 | Galacturan 1,4-alpha-galacturonidase inhibitor | 4 | 0.9915 |
| 1808 | Galectin 3 antagonist | 4 | 0.9989 |
| 1809 | Gallate decarboxylase inhibitor | 5 | 0.9813 |
| 1810 | Gametolysin inhibitor | 15 | 0.9271 |
| 1811 | Gamma-butyrobetaine dioxygenase inhibitor | 18 | 0.9188 |
| 1812 | Gamma-D-Glutamyl-meso-diaminopimelate peptidase inhibitor | 3 | 0.9820 |
| 1813 | Gamma-glutamyl hydrolase inhibitor | 42 | 0.9932 |
| 1814 | Gamma-glutamyltransferase inhibitor | 28 | 0.9128 |
| 1815 | Gamma-guanidinobutyraldehyde dehydrogenase inhibitor | 5 | 0.8899 |
| 1816 | Ganglioside galactosyltransferase inhibitor | 9 | 0.9696 |
| 1817 | Gastric antisecretory | 489 | 0.9209 |
| 1818 | Gastric emptying disorders treatment | 99 | 0.9614 |
| 1819 | Gastric emptying impairment | 3 | 0.9992 |
| 1820 | Gastricsin inhibitor | 25 | 0.9800 |
| 1821 | Gastrin inhibitor | 81 | 0.8352 |
| 1822 | Gastrin-releasing peptide antagonist | 50 | 0.9652 |
| 1823 | Gastritis treatment | 14 | 0.9225 |
| 1824 | Gastroesophageal reflux disease treatment | 220 | 0.9645 |
| 1825 | Gastrointestinal disorders treatment | 294 | 0.9427 |
| 1826 | Gastrointestinal disturbance | 176 | 0.8472 |
| 1827 | Gastrointestinal hemorrhage | 13 | 0.8250 |
| 1828 | Gastrointestinal motility stimulant | 79 | 0.9267 |
| 1829 | Gaucher disease treatment | 12 | 0.9744 |
| 1830 | GDP-L-fucose synthase inhibitor | 3 | 0.9991 |
| 1831 | GDP-mannose 4,6-dehydratase inhibitor | 8 | 0.9997 |
| 1832 | GDP-mannose 6-dehydrogenase inhibitor | 6 | 0.8995 |
| 1833 | Gelatinase inhibitor | 18 | 0.9729 |
| 1834 | General pump inhibitor | 40 | 0.8093 |
| 1835 | Genotoxic | 146 | 0.9488 |
| 1836 | Gentamicin 2''-nucleotidyltransferase inhibitor | 4 | 0.9968 |
| 1837 | Gentamicin 3'-N-acetyltransferase inhibitor | 12 | 0.9980 |
| 1838 | Gentisate 1,2-dioxygenase inhibitor | 6 | 0.9880 |
| 1839 | Geranylgeranyl-diphosphate geranylgeranyltransferase inhibitor | 9 | 0.9614 |
| 1840 | Geranylgeranyltransferase I inhibitor | 668 | 0.9951 |
| 1841 | Geranylgeranyltransferase inhibitor | 735 | 0.9944 |
| 1842 | Geranyltranstransferase (Leishmania) inhibitor | 27 | 0.9999 |
| 1843 | Geranyltranstransferase inhibitor | 105 | 0.9948 |
| 1844 | Gestagen antagonist | 7 | 0.9596 |
| 1845 | Gestagen-like | 56 | 0.9992 |
| 1846 | GHS receptor agonist | 25 | 0.9895 |
| 1847 | GHS receptor antagonist | 134 | 0.9969 |
| 1848 | Giant cell myocarditis | 3 | 0.9967 |
| 1849 | Gingipain K inhibitor | 6 | 0.9404 |
| 1850 | Gingipain R inhibitor | 7 | 0.9869 |
| 1851 | Glaucoma | 86 | 0.8410 |
| 1852 | Globoside alpha-N-acetylgalactosaminyltransferase inhibitor | 13 | 0.9641 |
| 1853 | Glucagon receptor antagonist | 362 | 0.9936 |
| 1854 | Glucagon-like peptide 1 agonist | 9 | 0.9362 |
| 1855 | Glucagon-like peptide 1 receptor antagonist | 30 | 0.9986 |
| 1856 | Glucan 1,3-alpha-glucosidase inhibitor | 19 | 0.9932 |
| 1857 | Glucan 1,3-beta-glucosidase inhibitor | 9 | 0.9913 |
| 1858 | Glucan 1,4-alpha-glucosidase inhibitor | 20 | 0.9964 |
| 1859 | Glucan 1,4-alpha-maltotetraohydrolase inhibitor | 3 | 0.9778 |
| 1860 | Glucan 1,4-alpha-maltotriohydrolase inhibitor | 3 | 0.9617 |
| 1861 | Glucan 1,4-beta-glucosidase inhibitor | 9 | 0.9804 |
| 1862 | Glucan 1,6-alpha-glucosidase inhibitor | 6 | 0.9888 |
| 1863 | Glucan endo-1,3-alpha-glucosidase inhibitor | 3 | 0.9958 |
| 1864 | Glucan endo-1,3-beta-D-glucosidase inhibitor | 11 | 0.8889 |
| 1865 | Glucan endo-1,6-beta-glucosidase inhibitor | 7 | 0.9140 |
| 1866 | Glucarate dehydratase inhibitor | 5 | 0.9909 |
| 1867 | Glucocorticoid agonist | 307 | 0.9936 |
| 1868 | Glucocorticoid antagonist | 900 | 0.9944 |
| 1869 | Gluconate 2-dehydrogenase (acceptor) inhibitor | 4 | 0.8010 |
| 1870 | Gluconate 5-dehydrogenase inhibitor | 3 | 0.9570 |
| 1871 | Gluconate dehydratase inhibitor | 4 | 0.9948 |
| 1872 | Gluconokinase inhibitor | 3 | 0.9731 |
| 1873 | Gluconolactonase inhibitor | 3 | 0.9788 |
| 1874 | Glucosamine 6-phosphate N-acetyltransferase inhibitor | 6 | 0.9958 |
| 1875 | Glucosamine N-acetyltransferase inhibitor | 6 | 0.9971 |
| 1876 | Glucosamine-1-phosphate N-acetyltransferase inhibitor | 4 | 0.9940 |
| 1877 | Glucosamine-6-phosphate deaminase inhibitor | 12 | 0.9826 |
| 1878 | Glucose 1-dehydrogenase inhibitor | 8 | 0.9855 |
| 1879 | Glucose oxidase inhibitor | 7 | 0.8550 |
| 1880 | Glucose-1,6-bisphosphate synthase inhibitor | 11 | 0.9975 |
| 1881 | Glucose-1-phosphatase inhibitor | 3 | 0.9917 |
| 1882 | Glucose-1-phosphate adenylyltransferase inhibitor | 15 | 0.9958 |
| 1883 | Glucose-1-phosphate cytidylyltransferase inhibitor | 12 | 0.9999 |
| 1884 | Glucose-6-phosphate isomerase inhibitor | 22 | 0.9986 |
| 1885 | Glucose-6-phosphate translocase inhibitor | 25 | 0.9975 |
| 1886 | Glucose-dependent insulinotropic receptor agonist | 62 | 0.9986 |
| 1887 | Glucosyl transferase inhibitor | 36 | 0.9478 |
| 1888 | Glucosylceramidase inhibitor | 48 | 0.9962 |
| 1889 | Glucuronate isomerase inhibitor | 5 | 0.9805 |
| 1890 | Glucuronolactone reductase inhibitor | 3 | 0.9890 |
| 1891 | Glutamate (mGluR group I) agonist | 30 | 0.9679 |
| 1892 | Glutamate (mGluR group I) antagonist | 565 | 0.9793 |
| 1893 | Glutamate (mGluR group II) agonist | 36 | 0.9899 |
| 1894 | Glutamate (mGluR group II) antagonist | 273 | 0.9994 |
| 1895 | Glutamate (mGluR group III) agonist | 13 | 0.9993 |
| 1896 | Glutamate (mGluR group III) antagonist | 77 | 0.9798 |
| 1897 | Glutamate (mGluR) agonist | 83 | 0.9876 |
| 1898 | Glutamate (mGluR) antagonist | 858 | 0.9866 |
| 1899 | Glutamate (mGluR1) agonist | 10 | 0.9983 |
| 1900 | Glutamate (mGluR1) antagonist | 255 | 0.9774 |
| 1901 | Glutamate (mGluR1a) agonist | 4 | 0.9999 |
| 1902 | Glutamate (mGluR2) agonist | 30 | 0.9981 |
| 1903 | Glutamate (mGluR2) antagonist | 197 | 0.9989 |
| 1904 | Glutamate (mGluR3) agonist | 11 | 0.9953 |
| 1905 | Glutamate (mGluR3) antagonist | 154 | 0.9991 |
| 1906 | Glutamate (mGluR4) agonist | 5 | 0.9927 |
| 1907 | Glutamate (mGluR4) antagonist | 29 | 0.9977 |
| 1908 | Glutamate (mGluR5) agonist | 17 | 0.9460 |
| 1909 | Glutamate (mGluR5) antagonist | 410 | 0.9830 |
| 1910 | Glutamate (mGluR5a) agonist | 4 | 0.9999 |
| 1911 | Glutamate (mGluR6) agonist | 8 | 0.9991 |
| 1912 | Glutamate (mGluR6) antagonist | 25 | 0.9707 |
| 1913 | Glutamate (mGluR8) agonist | 3 | 0.9977 |
| 1914 | Glutamate (mGluR8) antagonist | 42 | 0.9817 |
| 1915 | Glutamate 5-kinase inhibitor | 9 | 0.8882 |
| 1916 | Glutamate carboxypeptidase inhibitor | 21 | 0.9901 |
| 1917 | Glutamate decarboxylase inhibitor | 43 | 0.9734 |
| 1918 | Glutamate dehydrogenase (NADP+) inhibitor | 18 | 0.9917 |
| 1919 | Glutamate dehydrogenase [NAD(P)+] inhibitor | 45 | 0.9882 |
| 1920 | Glutamate dehydrogenase inhibitor | 34 | 0.9595 |
| 1921 | Glutamate formimidoyltransferase inhibitor | 11 | 0.9969 |
| 1922 | Glutamate N-acetyltransferase inhibitor | 4 | 0.9913 |
| 1923 | Glutamate racemase inhibitor | 72 | 0.9968 |
| 1924 | Glutamate receptor agonist | 370 | 0.9800 |
| 1925 | Glutamate receptor antagonist | 6051 | 0.9730 |
| 1926 | Glutamate release inhibitor | 58 | 0.9520 |
| 1927 | Glutamate synthase (ferredoxin) inhibitor | 21 | 0.9554 |
| 1928 | Glutamate synthase (NADPH) inhibitor | 54 | 0.9772 |
| 1929 | Glutamate uptake inhibitor | 9 | 0.9990 |
| 1930 | Glutamate-1-semialdehyde 2,1-aminomutase inhibitor | 9 | 0.9571 |
| 1931 | Glutamate-5-semialdehyde dehydrogenase inhibitor | 4 | 0.8871 |
| 1932 | Glutamate-cysteine ligase inhibitor | 36 | 0.9917 |
| 1933 | Glutamate-tRNA ligase inhibitor | 6 | 0.8257 |
| 1934 | Glutamin-(asparagin-)ase inhibitor | 13 | 0.9659 |
| 1935 | Glutaminase inhibitor | 20 | 0.9500 |
| 1936 | Glutamine synthetase inhibitor | 38 | 0.9652 |
| 1937 | Glutamine-fructose-6-phosphate transaminase inhibitor | 4 | 0.9942 |
| 1938 | Glutamine-phenylpyruvate transaminase inhibitor | 3 | 0.9666 |
| 1939 | Glutamine-pyruvate transaminase inhibitor | 7 | 0.9931 |
| 1940 | Glutamine-tRNA ligase inhibitor | 9 | 0.9891 |
| 1941 | Glutaminyl-peptide cyclotransferase inhibitor | 12 | 0.8868 |
| 1942 | Glutaminyl-tRNA synthase (glutamine-hydrolysing) inhibitor | 4 | 0.9947 |
| 1943 | Glutamyl endopeptidase II inhibitor | 3 | 0.8403 |
| 1944 | Glutarate-semialdehyde dehydrogenase inhibitor | 3 | 0.9824 |
| 1945 | Glutaryl-CoA dehydrogenase inhibitor | 5 | 0.9875 |
| 1946 | Glutathione dehydrogenase (ascorbate) inhibitor | 7 | 0.9572 |
| 1947 | Glutathione peroxidase inhibitor | 10 | 0.9461 |
| 1948 | Glutathione reductase (NADPH) stimulant | 11 | 0.9752 |
| 1949 | Glutathione reductase inhibitor | 46 | 0.9495 |
| 1950 | Glutathione reductase stimulant | 11 | 0.9752 |
| 1951 | Glutathione S-transferase inhibitor | 53 | 0.9728 |
| 1952 | Glutathione S-transferase substrate | 218 | 0.9635 |
| 1953 | Glutathione synthase inhibitor | 15 | 0.9827 |
| 1954 | Glutathione thiolesterase inhibitor | 3 | 0.9455 |
| 1955 | Glutathione-disulfide reductase inhibitor | 46 | 0.9852 |
| 1956 | Glutathionylspermidine synthase inhibitor | 17 | 0.9997 |
| 1957 | Glyceraldehyde-3-phosphate dehydrogenase (NADP+) inhibitor | 12 | 0.9616 |
| 1958 | Glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) inhibitor | 16 | 0.9858 |
| 1959 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 23 | 0.9845 |
| 1960 | Glycerate kinase inhibitor | 12 | 0.9991 |
| 1961 | Glycerol 2-dehydrogenase (NADP+) inhibitor | 4 | 0.9763 |
| 1962 | Glycerol dehydratase inhibitor | 6 | 0.9951 |
| 1963 | Glycerol dehydrogenase (NADP+) inhibitor | 5 | 0.9770 |
| 1964 | Glycerol dehydrogenase inhibitor | 34 | 0.9854 |
| 1965 | Glycerol kinase inhibitor | 18 | 0.9934 |
| 1966 | Glycerol-1,2-cyclic-phosphate 2-phosphodiesterase inhibitor | 7 | 0.9991 |
| 1967 | Glycerol-1-phosphatase inhibitor | 3 | 0.9922 |
| 1968 | Glycerol-3-phosphate dehydrogenase (NAD+) inhibitor | 21 | 0.9806 |
| 1969 | Glycerol-3-phosphate dehydrogenase [NAD(P)+] inhibitor | 6 | 0.9989 |
| 1970 | Glycerol-3-phosphate dehydrogenase inhibitor | 28 | 0.9068 |
| 1971 | Glycerol-3-phosphate O-acyltransferase inhibitor | 23 | 0.9482 |
| 1972 | Glycerol-3-phosphate oxidase inhibitor | 6 | 0.8267 |
| 1973 | Glycerone-phosphate O-acyltransferase inhibitor | 10 | 0.9846 |
| 1974 | Glycerophosphocholine cholinephosphodiesterase inhibitor | 6 | 0.9942 |
| 1975 | Glycerophosphocholine phosphodiesterase inhibitor | 8 | 0.9962 |
| 1976 | Glyceryl-ether monooxygenase inhibitor | 11 | 0.8711 |
| 1977 | Glycine amidinotransferase inhibitor | 5 | 0.9552 |
| 1978 | Glycine C-acetyltransferase inhibitor | 12 | 0.9078 |
| 1979 | Glycine dehydrogenase (decarboxylating) inhibitor | 3 | 0.9860 |
| 1980 | Glycine hydroxymethyltransferase inhibitor | 30 | 0.9649 |
| 1981 | Glycine N-acyltransferase inhibitor | 6 | 0.9912 |
| 1982 | Glycine N-benzoyltransferase inhibitor | 6 | 0.9901 |
| 1983 | Glycine N-choloyltransferase inhibitor | 10 | 0.9943 |
| 1984 | Glycine N-methyltransferase inhibitor | 9 | 0.9940 |
| 1985 | Glycine receptor agonist | 13 | 0.9401 |
| 1986 | Glycine receptor antagonist | 77 | 0.9671 |
| 1987 | Glycine transaminase inhibitor | 7 | 0.9937 |
| 1988 | Glycine transporter 1 inhibitor | 466 | 0.9968 |
| 1989 | Glycine transporter 2 inhibitor | 74 | 0.9842 |
| 1990 | Glycine transporter inhibitor | 550 | 0.9922 |
| 1991 | Glycine-tRNA ligase inhibitor | 10 | 0.9072 |
| 1992 | Glycogen (starch) synthase inhibitor | 26 | 0.9452 |
| 1993 | Glycogen synthase kinase-3 alpha inhibitor | 345 | 0.9894 |
| 1994 | Glycogen synthase kinase-3 beta inhibitor | 882 | 0.9815 |
| 1995 | Glycogen synthase kinase-3 inhibitor | 1215 | 0.9817 |
| 1996 | Glycogen synthase stimulant | 9 | 0.8707 |
| 1997 | Glycogenin glucosyltransferase inhibitor | 8 | 0.9974 |
| 1998 | Glycolaldehyde dehydrogenase inhibitor | 6 | 0.9940 |
| 1999 | Glycolate dehydrogenase inhibitor | 3 | 0.9747 |
| 2000 | Glycolipid 2-alpha-mannosyltransferase inhibitor | 9 | 0.9978 |
| 2001 | Glycolipid 3-alpha-mannosyltransferase inhibitor | 12 | 0.9973 |
| 2002 | Glycopeptide alpha-N-acetylgalactosaminidase inhibitor | 8 | 0.9863 |
| 2003 | Glycoprotein 3-alpha-L-fucosyltransferase inhibitor | 10 | 0.9770 |
| 2004 | Glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase inhibitor | 9 | 0.9565 |
| 2005 | Glycosylceramidase inhibitor | 14 | 0.9928 |
| 2006 | Glycosylphosphatidylinositol diacylglycerol-lyase inhibitor | 17 | 0.9730 |
| 2007 | Glycosylphosphatidylinositol phospholipase D inhibitor | 4 | 0.8797 |
| 2008 | Glyoxylate oxidase inhibitor | 3 | 0.9771 |
| 2009 | Glyoxylate reductase (NADP+) inhibitor | 12 | 0.9294 |
| 2010 | Glyoxylate reductase inhibitor | 4 | 0.9231 |
| 2011 | Gly-X carboxypeptidase inhibitor | 6 | 0.9863 |
| 2012 | GMP reductase inhibitor | 17 | 0.9968 |
| 2013 | GMP synthase inhibitor | 57 | 0.9848 |
| 2014 | Gonadotropin antagonist | 24 | 0.8662 |
| 2015 | Gout treatment | 117 | 0.9402 |
| 2016 | GP IIb/IIIa receptor antagonist | 2068 | 0.9911 |
| 2017 | G-protein-coupled bile acid receptor 1 agonist | 9 | 0.9605 |
| 2018 | G-protein-coupled receptor 120 agonist | 10 | 0.9999 |
| 2019 | G-protein-coupled receptor kinase inhibitor | 22 | 0.8262 |
| 2020 | Granulocyte macrophage colony stimulating factor agonist | 12 | 0.9743 |
| 2021 | Granulocyte stimulating factor agonist | 30 | 1.0000 |
| 2022 | Granzyme A inhibitor | 9 | 0.9766 |
| 2023 | Granzyme B inhibitor | 23 | 0.9691 |
| 2024 | Growth factor agonist | 244 | 0.9172 |
| 2025 | Growth factor antagonist | 3528 | 0.9682 |
| 2026 | Growth factor receptor-bound protein 2 antagonist | 72 | 0.9999 |
| 2027 | Growth hormone agonist | 10 | 0.9527 |
| 2028 | Growth hormone release inhibitor | 69 | 0.9828 |
| 2029 | Growth hormone release promoting | 58 | 0.9829 |
| 2030 | Growth hormone releasing factor agonist | 445 | 0.9959 |
| 2031 | Growth hormone releasing factor antagonist | 38 | 0.9997 |
| 2032 | Growth stimulant | 61 | 0.9387 |
| 2033 | GRP78 expression inhibitor | 5 | 0.9999 |
| 2034 | GST A substrate | 12 | 0.9043 |
| 2035 | GST M substrate | 13 | 0.9248 |
| 2036 | GST M1-1 substrate | 8 | 0.9101 |
| 2037 | GST P substrate | 15 | 0.9555 |
| 2038 | GST P1-1 substrate | 14 | 0.9580 |
| 2039 | GST T substrate | 8 | 0.9507 |
| 2040 | GST T1-1 substrate | 8 | 0.9507 |
| 2041 | GTP cyclohydrolase I inhibitor | 15 | 0.9939 |
| 2042 | GTP cyclohydrolase IIa inhibitor | 6 | 0.9999 |
| 2043 | Guanidinoacetase inhibitor | 6 | 0.9805 |
| 2044 | Guanidinoacetate kinase inhibitor | 12 | 0.9093 |
| 2045 | Guanidinoacetate N-methyltransferase inhibitor | 6 | 0.9809 |
| 2046 | Guanidinobutyrase inhibitor | 13 | 0.9925 |
| 2047 | Guanidinodeoxy-scyllo-inositol-4-phosphatase inhibitor | 3 | 0.9938 |
| 2048 | Guanidinopropionase inhibitor | 5 | 0.9950 |
| 2049 | Guanine deaminase inhibitor | 13 | 0.9830 |
| 2050 | Guanosine-3',5'-bis(diphosphate) 3'-diphosphatase inhibitor | 4 | 0.9204 |
| 2051 | Guanylate cyclase 1 inhibitor | 8 | 1.0000 |
| 2052 | Guanylate cyclase 1 stimulant | 10 | 0.9309 |
| 2053 | Guanylate cyclase inhibitor | 96 | 0.9622 |
| 2054 | Guanylate cyclase stimulant | 74 | 0.9571 |
| 2055 | Guanylate kinase inhibitor | 15 | 0.9913 |
| 2056 | Gynecological disorders treatment | 679 | 0.9743 |
| 2057 | H+/K+-transporting ATPase inhibitor | 601 | 0.9795 |
| 2058 | H+-exporting ATPase inhibitor | 12 | 0.9271 |
| 2059 | H+-transporting two-sector ATPase inhibitor | 6 | 0.9083 |
| 2060 | Hair growth stimulant | 508 | 0.9671 |
| 2061 | Haloacetate dehalogenase inhibitor | 3 | 0.9948 |
| 2062 | Haloalkane dehalogenase inhibitor | 4 | 0.9979 |
| 2063 | HCV IRES inhibitor | 9 | 0.8681 |
| 2064 | HCV NS3/NS4A protease inhibitor | 617 | 0.9842 |
| 2065 | HCV NS3-helicase inhibitor | 86 | 0.9688 |
| 2066 | HCV NS5A inhibitor | 20 | 0.9999 |
| 2067 | HCV NS5B polymerase inhibitor | 524 | 0.9948 |
| 2068 | HDL-cholesterol increasing | 175 | 0.9532 |
| 2069 | Headache | 838 | 0.8131 |
| 2070 | Heart failure treatment | 1565 | 0.9462 |
| 2071 | Heat shock protein 27 antagonist | 9 | 0.8160 |
| 2072 | Heat shock protein 70 agonist | 24 | 0.9444 |
| 2073 | Heat shock protein 70 antagonist | 23 | 0.9637 |
| 2074 | Heat shock protein 90 antagonist | 332 | 0.9756 |
| 2075 | Heat shock protein agonist | 25 | 0.9204 |
| 2076 | Heat shock protein antagonist | 364 | 0.9702 |
| 2077 | Hedgehog signaling activator | 4 | 1.0000 |
| 2078 | Hedgehog signaling inhibitor | 83 | 0.9708 |
| 2079 | Helicase E1 (Human papillomavirus) inhibitor | 28 | 0.9998 |
| 2080 | Hematemesis | 7 | 0.8318 |
| 2081 | Hematinic | 13 | 0.9337 |
| 2082 | Hematopoietic | 68 | 0.8997 |
| 2083 | Hematopoietic inhibitor | 18 | 0.9108 |
| 2084 | Hematotoxic | 1142 | 0.8266 |
| 2085 | Hematuria | 43 | 0.8519 |
| 2086 | Heme oxygenase inhibitor | 7 | 0.8033 |
| 2087 | Heme oxygenase stimulant | 10 | 0.9861 |
| 2088 | Hemostatic | 101 | 0.8983 |
| 2089 | Heparan-alpha-glucosaminide N-acetyltransferase inhibitor | 12 | 0.9861 |
| 2090 | Heparanase inhibitor | 60 | 0.9845 |
| 2091 | Heparin epidermal growth factor antagonist | 114 | 0.9996 |
| 2092 | Hepatic disorders treatment | 706 | 0.8964 |
| 2093 | Hepatitis | 397 | 0.7976 |
| 2094 | Hepatocyte growth factor agonist | 7 | 0.8722 |
| 2095 | Hepatocyte growth factor antagonist | 526 | 0.9773 |
| 2096 | Hepatocyte nuclear factor 4 alpha agonist | 6 | 0.9996 |
| 2097 | Hepatocyte nuclear factor 4 alpha antagonist | 6 | 0.9208 |
| 2098 | Hepatocyte nuclear factor agonist | 6 | 0.9996 |
| 2099 | Hepatocyte nuclear factor antagonist | 6 | 0.9208 |
| 2100 | Hepatoprotectant | 291 | 0.9033 |
| 2101 | Hepatotoxic | 1033 | 0.8370 |
| 2102 | HERG 1 channel blocker | 38 | 0.9411 |
| 2103 | HERG channel blocker | 1207 | 0.9520 |
| 2104 | Hexokinase inhibitor | 193 | 0.9557 |
| 2105 | Hexokinase stimulant | 119 | 0.9911 |
| 2106 | HIF1A expression inhibitor | 23 | 0.8290 |
| 2107 | High-mannose-oligosaccharide beta-1,4-N-acetylglucosaminyltransferase inhibitor | 3 | 0.9983 |
| 2108 | Hippurate hydrolase inhibitor | 4 | 0.9922 |
| 2109 | Hirsutism treatment | 82 | 0.9846 |
| 2110 | Histamine agonist | 118 | 0.9367 |
| 2111 | Histamine antagonist | 2720 | 0.9636 |
| 2112 | Histamine H1 receptor agonist | 5 | 0.9848 |
| 2113 | Histamine H1 receptor antagonist | 858 | 0.9771 |
| 2114 | Histamine H2 receptor agonist | 36 | 0.9789 |
| 2115 | Histamine H2 receptor antagonist | 375 | 0.9819 |
| 2116 | Histamine H3 receptor agonist | 55 | 0.9994 |
| 2117 | Histamine H3 receptor antagonist | 1447 | 0.9944 |
| 2118 | Histamine H4 receptor antagonist | 131 | 0.9955 |
| 2119 | Histamine N-methyltransferase inhibitor | 69 | 0.9807 |
| 2120 | Histamine release inhibitor | 118 | 0.8600 |
| 2121 | Histamine release stimulant | 21 | 0.8929 |
| 2122 | Histidine ammonia-lyase inhibitor | 34 | 0.9844 |
| 2123 | Histidine decarboxylase inhibitor | 33 | 0.9802 |
| 2124 | Histidine kinase inhibitor | 4 | 0.9246 |
| 2125 | Histidine N-acetyltransferase inhibitor | 6 | 0.8181 |
| 2126 | Histidine-tRNA ligase inhibitor | 19 | 0.9940 |
| 2127 | Histidinol dehydrogenase inhibitor | 21 | 0.9347 |
| 2128 | Histidinol-phosphatase inhibitor | 6 | 0.9731 |
| 2129 | Histone acetylation inducer | 9 | 1.0000 |
| 2130 | Histone acetyltransferase inhibitor | 43 | 0.9182 |
| 2131 | Histone deacetylase 1 inhibitor | 887 | 0.9954 |
| 2132 | Histone deacetylase 1A inhibitor | 8 | 0.9996 |
| 2133 | Histone deacetylase 1B inhibitor | 36 | 0.9999 |
| 2134 | Histone deacetylase 2 inhibitor | 523 | 0.9946 |
| 2135 | Histone deacetylase 3 inhibitor | 533 | 0.9931 |
| 2136 | Histone deacetylase 4 inhibitor | 487 | 0.9939 |
| 2137 | Histone deacetylase 6 inhibitor | 719 | 0.9969 |
| 2138 | Histone deacetylase 8 inhibitor | 312 | 0.9915 |
| 2139 | Histone deacetylase class I inhibitor | 1133 | 0.9951 |
| 2140 | Histone deacetylase class II inhibitor | 811 | 0.9957 |
| 2141 | Histone deacetylase class IIa inhibitor | 497 | 0.9940 |
| 2142 | Histone deacetylase class IIb inhibitor | 726 | 0.9969 |
| 2143 | Histone deacetylase class III inhibitor | 56 | 0.9653 |
| 2144 | Histone deacetylase inhibitor | 1924 | 0.9887 |
| 2145 | Histone deacetylase SIRT1 inhibitor | 38 | 0.9562 |
| 2146 | Histone deacetylase SIRT1 stimulant | 63 | 0.9942 |
| 2147 | Histone deacetylase SIRT2 inhibitor | 42 | 0.9706 |
| 2148 | Histone deacetylase SIRT2 stimulant | 5 | 0.9989 |
| 2149 | Histone deacetylase stimulant | 63 | 0.9942 |
| 2150 | Histone-arginine N-methyltransferase inhibitor | 9 | 0.9941 |
| 2151 | Histone-lysine N-methyltransferase inhibitor | 17 | 0.9992 |
| 2152 | HIV attachment inhibitor | 13 | 0.8900 |
| 2153 | HIV fusion inhibitor | 4 | 1.0000 |
| 2154 | HIV-1 integrase (3'-Processing) inhibitor | 358 | 0.9845 |
| 2155 | HIV-1 integrase (Overall Integration) inhibitor | 55 | 0.9774 |
| 2156 | HIV-1 integrase (Strand Transfer) inhibitor | 355 | 0.9860 |
| 2157 | HIV-1 integrase inhibitor | 884 | 0.9793 |
| 2158 | HIV-1 protease inhibitor | 2615 | 0.9913 |
| 2159 | HIV-1 reverse transcriptase inhibitor | 2106 | 0.9879 |
| 2160 | HIV-2 retropepsin inhibitor | 16 | 0.9990 |
| 2161 | HIV-2 reverse transcriptase inhibitor | 3 | 0.9851 |
| 2162 | HLA-A2 antigen antagonist | 188 | 0.9992 |
| 2163 | HMG CoA reductase inhibitor | 484 | 0.9918 |
| 2164 | HMG CoA synthase inhibitor | 5 | 0.9801 |
| 2165 | HMGCS2 expression enhancer | 5 | 0.9198 |
| 2166 | HMOX1 expression enhancer | 69 | 0.9033 |
| 2167 | Homoaconitate hydratase inhibitor | 3 | 0.9894 |
| 2168 | Homocitrate synthase inhibitor | 18 | 0.9821 |
| 2169 | Homocysteine desulfhydrase inhibitor | 8 | 0.9901 |
| 2170 | Homocysteine S-methyltransferase inhibitor | 4 | 0.9948 |
| 2171 | Homogentisate 1,2-dioxygenase inhibitor | 12 | 0.9552 |
| 2172 | Homoisocitrate dehydrogenase inhibitor | 3 | 0.9999 |
| 2173 | Homoserine dehydrogenase inhibitor | 14 | 0.8914 |
| 2174 | Homoserine kinase inhibitor | 24 | 0.9844 |
| 2175 | Homoserine O-acetyltransferase inhibitor | 11 | 0.9977 |
| 2176 | Homoserine O-succinyltransferase inhibitor | 3 | 0.9977 |
| 2177 | Homospermidine synthase inhibitor | 4 | 0.9949 |
| 2178 | Horrilysin inhibitor | 3 | 0.9846 |
| 2179 | Hot flush treatment | 91 | 0.9840 |
| 2180 | Huntington's disease treatment | 143 | 0.9511 |
| 2181 | Hyaluronic acid agonist | 3 | 0.9246 |
| 2182 | Hydrogen dehydrogenase inhibitor | 3 | 0.8996 |
| 2183 | Hydroperoxide dehydratase inhibitor | 12 | 0.9904 |
| 2184 | Hydroxyacylglutathione hydrolase inhibitor | 55 | 0.9754 |
| 2185 | Hydroxylamine oxidase inhibitor | 6 | 0.9056 |
| 2186 | Hydroxylamine reductase (NADH) inhibitor | 18 | 0.8748 |
| 2187 | Hydroxylamine reductase inhibitor | 6 | 0.8633 |
| 2188 | Hydroxylysine kinase inhibitor | 9 | 0.9973 |
| 2189 | Hydroxymethylbilane synthase inhibitor | 11 | 0.9606 |
| 2190 | Hydroxymethylglutaryl-CoA lyase inhibitor | 7 | 0.9534 |
| 2191 | Hydroxymethylglutaryl-CoA reductase inhibitor | 5 | 0.9953 |
| 2192 | Hydroxypyruvate reductase inhibitor | 17 | 0.9964 |
| 2193 | Hydroxyquinol 1,2-dioxygenase inhibitor | 9 | 0.9970 |
| 2194 | Hydroxysteroid dehydrogenase inhibitor | 4 | 0.9365 |
| 2195 | Hypercalcaemic | 19 | 0.8470 |
| 2196 | Hypercalcemia treatment | 43 | 0.9584 |
| 2197 | Hypercholesterolemic | 10 | 0.8511 |
| 2198 | Hyperglycemic | 71 | 0.8011 |
| 2199 | Hyperparathyroidism treatment | 68 | 0.9845 |
| 2200 | Hyperprolactinemia treatment | 9 | 0.9760 |
| 2201 | Hypertensive | 736 | 0.8149 |
| 2202 | Hypertensive, ophthalmic | 10 | 0.9578 |
| 2203 | Hyperthermic | 263 | 0.8439 |
| 2204 | Hyperuricemia | 4 | 0.9471 |
| 2205 | Hypnotic | 715 | 0.9230 |
| 2206 | Hypocalcaemic | 29 | 0.8539 |
| 2207 | Hypoglycemic | 413 | 0.9188 |
| 2208 | Hypogonadism treatment | 125 | 0.9988 |
| 2209 | Hypolipemic | 2014 | 0.8916 |
| 2210 | Hypomagnesemia | 3 | 0.9376 |
| 2211 | Hypomania | 22 | 0.9436 |
| 2212 | Hyponitrite reductase inhibitor | 3 | 0.9781 |
| 2213 | Hypotension | 1053 | 0.8323 |
| 2214 | Hypothermic | 295 | 0.8441 |
| 2215 | Hypotonia | 98 | 0.8001 |
| 2216 | Hypoxanthine phosphoribosyltransferase inhibitor | 37 | 0.9896 |
| 2217 | Hypoxia inducible factor 1 alpha inhibitor | 60 | 0.9438 |
| 2218 | I kappa B kinase 2 inhibitor | 310 | 0.9732 |
| 2219 | I kappa B kinase inhibitor | 387 | 0.9653 |
| 2220 | I(Ks) voltage-gated potassium channel blocker | 38 | 0.9996 |
| 2221 | ICAM 1 antagonist | 389 | 0.9955 |
| 2222 | ICAM1 expression inhibitor | 58 | 0.8807 |
| 2223 | Iduronate-2-sulfatase inhibitor | 3 | 0.9951 |
| 2224 | IgA-specific metalloendopeptidase inhibitor | 9 | 0.9751 |
| 2225 | IgA-specific serine endopeptidase inhibitor | 5 | 0.9531 |
| 2226 | Ileal bile acid transport inhibitor | 144 | 0.9983 |
| 2227 | Imidazoleacetate 4-monooxygenase inhibitor | 13 | 0.9896 |
| 2228 | Imidazoleglycerol-phosphate dehydratase inhibitor | 5 | 0.9981 |
| 2229 | Imidazoline I1 receptor agonist | 3 | 0.9786 |
| 2230 | Imidazoline I1 receptor antagonist | 52 | 0.9996 |
| 2231 | Imidazoline I2 receptor antagonist | 140 | 0.9997 |
| 2232 | Imidazoline receptor agonist | 6 | 0.9715 |
| 2233 | Imidazoline receptor antagonist | 158 | 0.9994 |
| 2234 | Immunoglobulin E antagonist | 39 | 0.9417 |
| 2235 | Immunoglobulin Fc receptor antagonist | 36 | 0.9467 |
| 2236 | Immunomodulator | 1484 | 0.8917 |
| 2237 | Immunostimulant | 675 | 0.9063 |
| 2238 | Immunosuppressant | 2090 | 0.8710 |
| 2239 | IMP cyclohydrolase inhibitor | 10 | 0.9998 |
| 2240 | Indanol dehydrogenase inhibitor | 13 | 0.9249 |
| 2241 | Indole-3-acetaldehyde reductase (NADPH) inhibitor | 11 | 0.9927 |
| 2242 | Indoleacetaldoxime dehydratase inhibitor | 12 | 0.9226 |
| 2243 | Indoleamine-pyrrole 2,3-dioxygenase inhibitor | 131 | 0.9825 |
| 2244 | Indolepyruvate C-methyltransferase inhibitor | 4 | 0.9738 |
| 2245 | Inducible nitric-oxide synthase inhibitor | 441 | 0.9769 |
| 2246 | Inflammation | 442 | 0.8062 |
| 2247 | Inflammatory Bowel disease treatment | 1272 | 0.8906 |
| 2248 | Inorganic diphosphatase inhibitor | 28 | 0.9560 |
| 2249 | Inosine kinase inhibitor | 4 | 0.9999 |
| 2250 | Inosine monophosphate dehydrogenase 1 inhibitor | 69 | 0.9992 |
| 2251 | Inosine monophosphate dehydrogenase 2 inhibitor | 346 | 0.9997 |
| 2252 | Inosine monophosphate dehydrogenase inhibitor | 452 | 0.9977 |
| 2253 | Inosine nucleosidase inhibitor | 4 | 0.9908 |
| 2254 | Inosine-adenosine-guanosine-nucleoside hydrolase inhibitor | 4 | 1.0000 |
| 2255 | Inositol 1,4,5-triphosphate receptor 1 antagonist | 10 | 1.0000 |
| 2256 | Inositol 1,4,5-triphosphate receptor antagonist | 12 | 0.9628 |
| 2257 | Inositol 1,4,5-trisphosphate 3-kinase B inhibitor | 11 | 0.9865 |
| 2258 | Inositol 1,4,5-trisphosphate 3-kinase inhibitor | 15 | 0.9489 |
| 2259 | Inositol oxygenase inhibitor | 34 | 0.9533 |
| 2260 | Inositol polyphosphate-5-phosphatase D stimulant | 7 | 0.9998 |
| 2261 | Inositol-3-phosphate synthase inhibitor | 20 | 0.9923 |
| 2262 | Inositol-polyphosphate 5-phosphatase inhibitor | 19 | 0.9851 |
| 2263 | Inotropic | 36 | 0.8742 |
| 2264 | Insecticide | 193 | 0.9607 |
| 2265 | Insulin antagonist | 339 | 0.9672 |
| 2266 | Insulin growth factor antagonist | 532 | 0.9838 |
| 2267 | Insulin like growth factor 1 antagonist | 488 | 0.9810 |
| 2268 | Insulin like growth factor 3 antagonist | 44 | 1.0000 |
| 2269 | Insulin promoter | 43 | 0.8291 |
| 2270 | Insulin secretagoues | 249 | 0.9593 |
| 2271 | Insulin sensitizer | 224 | 0.9684 |
| 2272 | Insulysin inhibitor | 49 | 0.8563 |
| 2273 | Integrin alpha1beta1 antagonist | 42 | 0.9940 |
| 2274 | Integrin alpha2 antagonist | 35 | 0.9825 |
| 2275 | Integrin alpha2beta1 antagonist | 25 | 0.9788 |
| 2276 | Integrin alpha4 antagonist | 2146 | 0.9979 |
| 2277 | Integrin alpha4beta1 antagonist | 941 | 0.9968 |
| 2278 | Integrin alpha4beta7 antagonist | 602 | 0.9978 |
| 2279 | Integrin alpha5beta1 antagonist | 163 | 0.9910 |
| 2280 | Integrin alpha5beta6 antagonist | 14 | 0.9999 |
| 2281 | Integrin alphaLbeta2 antagonist | 38 | 0.9996 |
| 2282 | Integrin alphaVbeta1 antagonist | 17 | 0.9555 |
| 2283 | Integrin alphaVbeta3 antagonist | 14 | 0.9885 |
| 2284 | Integrin alphaVbeta5 antagonist | 307 | 0.9984 |
| 2285 | Integrin alphaVbeta6 antagonist | 79 | 0.9985 |
| 2286 | Integrin antagonist | 4042 | 0.9917 |
| 2287 | Integrin-linked kinase inhibitor | 13 | 1.0000 |
| 2288 | Interferon agonist | 134 | 0.9651 |
| 2289 | Interferon alpha agonist | 4 | 0.9562 |
| 2290 | Interferon antagonist | 85 | 0.9555 |
| 2291 | Interferon gamma antagonist | 84 | 0.9595 |
| 2292 | Interferon inducer | 112 | 0.9839 |
| 2293 | Interleukin 1 antagonist | 919 | 0.9527 |
| 2294 | Interleukin 1 beta converting enzyme inhibitor | 289 | 0.9895 |
| 2295 | Interleukin 10 agonist | 37 | 0.9074 |
| 2296 | Interleukin 10 antagonist | 6 | 0.9666 |
| 2297 | Interleukin 12 agonist | 130 | 0.9624 |
| 2298 | Interleukin 1a antagonist | 17 | 0.9378 |
| 2299 | Interleukin 1b antagonist | 499 | 0.9681 |
| 2300 | Interleukin 2 agonist | 15 | 0.8700 |
| 2301 | Interleukin 2 antagonist | 228 | 0.9545 |
| 2302 | Interleukin 4 antagonist | 146 | 0.9512 |
| 2303 | Interleukin 5 antagonist | 131 | 0.9621 |
| 2304 | Interleukin 6 antagonist | 214 | 0.9260 |
| 2305 | Interleukin 8 antagonist | 209 | 0.9507 |
| 2306 | Interleukin agonist | 177 | 0.9374 |
| 2307 | Interleukin antagonist | 1566 | 0.9291 |
| 2308 | Intermittent claudication treatment | 17 | 0.8350 |
| 2309 | Interstitial nephritis | 97 | 0.8195 |
| 2310 | Inulinase inhibitor | 4 | 0.9877 |
| 2311 | Iodide peroxidase inhibitor | 21 | 0.9707 |
| 2312 | Iron antagonist | 8 | 0.9962 |
| 2313 | Iron-cytochrome-c reductase inhibitor | 3 | 0.9875 |
| 2314 | Irritable Bowel syndrome treatment | 1423 | 0.9453 |
| 2315 | Irritation | 65 | 0.9154 |
| 2316 | Isoamylase inhibitor | 15 | 0.9906 |
| 2317 | Isocitrate dehydrogenase (NAD+) inhibitor | 28 | 0.9759 |
| 2318 | Isocitrate dehydrogenase (NADP+) inhibitor | 24 | 0.9914 |
| 2319 | Isocitrate lyase inhibitor | 26 | 0.9848 |
| 2320 | Isoleucine-tRNA ligase inhibitor | 25 | 0.9873 |
| 2321 | Isomaltulose synthase inhibitor | 6 | 0.9937 |
| 2322 | Isopenicillin-N epimerase inhibitor | 9 | 0.8660 |
| 2323 | Isopenicillin-N synthase inhibitor | 8 | 0.9728 |
| 2324 | Isopentenyl-diphosphate DELTA-isomerase inhibitor | 22 | 0.9985 |
| 2325 | Isoquinoline 1-oxidoreductase inhibitor | 4 | 0.9842 |
| 2326 | Isovaleryl-CoA dehydrogenase inhibitor | 6 | 0.9868 |
| 2327 | JAK2 expression inhibitor | 4 | 0.9197 |
| 2328 | Janus tyrosine kinase 1 inhibitor | 59 | 0.9725 |
| 2329 | Janus tyrosine kinase 2 inhibitor | 381 | 0.9456 |
| 2330 | Janus tyrosine kinase 3 inhibitor | 406 | 0.9861 |
| 2331 | Janus tyrosine kinase inhibitor | 768 | 0.9604 |
| 2332 | JNK mitogen-activated protein kinase inhibitor | 43 | 0.9518 |
| 2333 | Juvenile-hormone esterase inhibitor | 86 | 0.9993 |
| 2334 | K(Ca) 3.1 channel activator | 4 | 0.9869 |
| 2335 | K(Ca) 3.1 channel blocker | 41 | 0.9838 |
| 2336 | K(ir) 6.2 channel activator | 13 | 0.9506 |
| 2337 | Kainate receptor 1 agonist | 5 | 0.9984 |
| 2338 | Kainate receptor 1 antagonist | 296 | 0.9977 |
| 2339 | Kainate receptor 2 antagonist | 135 | 0.9949 |
| 2340 | Kainate receptor 3 antagonist | 140 | 0.9978 |
| 2341 | Kainate receptor 4 antagonist | 134 | 0.9972 |
| 2342 | Kainate receptor 5 antagonist | 152 | 0.9972 |
| 2343 | Kainate receptor agonist | 26 | 0.9920 |
| 2344 | Kainate receptor antagonist | 461 | 0.9942 |
| 2345 | Kallikrein 13 inhibitor | 10 | 0.9988 |
| 2346 | Kallikrein 3 inhibitor | 29 | 0.9912 |
| 2347 | Kallikrein inhibitor | 94 | 0.9569 |
| 2348 | Kanamycin kinase inhibitor | 3 | 0.9999 |
| 2349 | Keratan sulfotransferase inhibitor | 7 | 0.9990 |
| 2350 | Keratolytic | 34 | 0.9450 |
| 2351 | Keratopathy | 92 | 0.8375 |
| 2352 | Keratoses actinic (solar) treatment | 68 | 0.9534 |
| 2353 | Ketohexokinase inhibitor | 15 | 0.9422 |
| 2354 | Ketol-acid reductoisomerase inhibitor | 10 | 0.9218 |
| 2355 | Ketosteroid monooxygenase inhibitor | 5 | 0.9998 |
| 2356 | Kexin inhibitor | 16 | 0.9835 |
| 2357 | Kidney function stimulant | 7 | 0.8506 |
| 2358 | Kinase inhibitor | 11 | 0.8667 |
| 2359 | Kinesin antagonist | 374 | 0.9920 |
| 2360 | Kinesin-like protein 1 inhibitor | 374 | 0.9920 |
| 2361 | KiSS-1 receptor agonist | 3 | 1.0000 |
| 2362 | Kynureninase inhibitor | 42 | 0.9879 |
| 2363 | Kynurenine 3 monooxygenase inhibitor | 70 | 0.9991 |
| 2364 | L lactate dehydrogenase A inhibitor | 16 | 1.0000 |
| 2365 | L lactate dehydrogenase A4 inhibitor | 15 | 1.0000 |
| 2366 | L lactate dehydrogenase B inhibitor | 6 | 1.0000 |
| 2367 | L lactate dehydrogenase B4 inhibitor | 6 | 1.0000 |
| 2368 | L lactate dehydrogenase C inhibitor | 16 | 1.0000 |
| 2369 | L lactate dehydrogenase C4 inhibitor | 16 | 1.0000 |
| 2370 | L lactate dehydrogenase inhibitor | 32 | 0.9620 |
| 2371 | L(+)-Tartrate dehydratase inhibitor | 7 | 0.9996 |
| 2372 | L-3-cyanoalanine synthase inhibitor | 10 | 0.9958 |
| 2373 | Laccase inhibitor | 18 | 0.9544 |
| 2374 | Lacrimal secretion stimulant | 72 | 0.9086 |
| 2375 | Lactaldehyde dehydrogenase inhibitor | 6 | 0.9982 |
| 2376 | Lactaldehyde reductase (NADPH) inhibitor | 4 | 0.9914 |
| 2377 | Lactaldehyde reductase inhibitor | 4 | 0.9872 |
| 2378 | Lactamase A inhibitor | 7 | 0.9950 |
| 2379 | Lactamase C inhibitor | 8 | 0.9825 |
| 2380 | Lactase inhibitor | 3 | 0.8672 |
| 2381 | Lactate 2-monooxygenase inhibitor | 13 | 0.9296 |
| 2382 | Lactate-malate transhydrogenase inhibitor | 5 | 0.9954 |
| 2383 | Lactose synthase inhibitor | 14 | 0.8878 |
| 2384 | Lactosylceramide alpha-2,3-sialyltransferase inhibitor | 20 | 0.9807 |
| 2385 | Lactoylglutathione lyase inhibitor | 90 | 0.9822 |
| 2386 | Laminaribiose phosphorylase inhibitor | 9 | 0.9756 |
| 2387 | L-amino-acid oxidase inhibitor | 20 | 0.9680 |
| 2388 | L-aminoadipate-semialdehyde dehydrogenase inhibitor | 9 | 0.9950 |
| 2389 | Lanosterol 14 alpha demethylase inhibitor | 76 | 0.9487 |
| 2390 | Laryngospasm | 75 | 0.8467 |
| 2391 | L-ascorbate peroxidase inhibitor | 16 | 0.9861 |
| 2392 | Lassitude treatment | 18 | 0.9422 |
| 2393 | Laxative | 50 | 0.9352 |
| 2394 | Lck kinase inhibitor | 966 | 0.9683 |
| 2395 | LDLR expression enhancer | 118 | 0.9225 |
| 2396 | LECT1 expression enhancer | 9 | 1.0000 |
| 2397 | Leishmanolysin inhibitor | 6 | 0.8611 |
| 2398 | Leucine dehydrogenase inhibitor | 5 | 0.9172 |
| 2399 | Leucine transaminase inhibitor | 5 | 0.9933 |
| 2400 | Leucine-tRNA ligase inhibitor | 30 | 0.9359 |
| 2401 | Leucolysin inhibitor | 6 | 0.9826 |
| 2402 | Leucyltransferase inhibitor | 14 | 0.9876 |
| 2403 | Leukocyte elastase inhibitor | 184 | 0.9687 |
| 2404 | Leukopenia | 542 | 0.8200 |
| 2405 | Leukopoiesis inhibitor | 23 | 0.8407 |
| 2406 | Leukopoiesis stimulant | 9 | 0.8304 |
| 2407 | Leukotriene A4 hydrolase inhibitor | 322 | 0.9973 |
| 2408 | Leukotriene agonist | 5 | 0.9909 |
| 2409 | Leukotriene antagonist | 1324 | 0.9780 |
| 2410 | Leukotriene B4 antagonist | 588 | 0.9823 |
| 2411 | Leukotriene B4 receptor 1 antagonist | 466 | 0.9965 |
| 2412 | Leukotriene B4 receptor 2 antagonist | 197 | 0.9994 |
| 2413 | Leukotriene C antagonist | 206 | 0.9768 |
| 2414 | Leukotriene C4 antagonist | 195 | 0.9870 |
| 2415 | Leukotriene D4 antagonist | 532 | 0.9917 |
| 2416 | Leukotriene E4 antagonist | 40 | 0.9661 |
| 2417 | Leukotriene synthesis inhibitor | 192 | 0.9649 |
| 2418 | Leukotriene-B4 20-monooxygenase inhibitor | 5 | 0.9559 |
| 2419 | Leukotriene-C4 synthase inhibitor | 9 | 0.8771 |
| 2420 | Levanase inhibitor | 9 | 0.9645 |
| 2421 | Levansucrase inhibitor | 5 | 0.9519 |
| 2422 | LFA antagonist | 261 | 0.9971 |
| 2423 | LFA-1 antagonist | 261 | 0.9971 |
| 2424 | L-fuconate dehydratase inhibitor | 7 | 0.9965 |
| 2425 | L-galactonolactone oxidase inhibitor | 8 | 0.9907 |
| 2426 | L-glucuronate reductase inhibitor | 17 | 0.9560 |
| 2427 | L-glutamate oxidase inhibitor | 3 | 0.9580 |
| 2428 | Licheninase inhibitor | 6 | 0.9789 |
| 2429 | L-iditol 2-dehydrogenase inhibitor | 100 | 0.9757 |
| 2430 | L-iduronidase inhibitor | 5 | 0.9900 |
| 2431 | Ligase inhibitor | 5 | 0.9859 |
| 2432 | Limulus clotting factor B inhibitor | 4 | 0.8393 |
| 2433 | Limulus clotting factor C inhibitor | 4 | 0.9590 |
| 2434 | Linoleate diol synthase inhibitor | 15 | 0.8892 |
| 2435 | Linoleate isomerase inhibitor | 22 | 0.9954 |
| 2436 | Linoleoyl-CoA desaturase inhibitor | 6 | 0.9579 |
| 2437 | Lipase inhibitor | 185 | 0.9869 |
| 2438 | Lipid metabolism regulator | 131 | 0.8771 |
| 2439 | Lipid peroxidase inhibitor | 282 | 0.9104 |
| 2440 | Lipocortins synthesis agonist | 75 | 0.9640 |
| 2441 | Lipocortins synthesis antagonist | 10 | 0.9546 |
| 2442 | Lipoprotein disorders treatment | 4601 | 0.9534 |
| 2443 | Lipoprotein lipase inhibitor | 18 | 0.8910 |
| 2444 | Lipoprotein lipase stimulant | 23 | 0.8833 |
| 2445 | Lipotropic | 11 | 0.9770 |
| 2446 | Lipoxin receptor agonist | 12 | 0.9999 |
| 2447 | Lipoxygenase inhibitor | 2749 | 0.9711 |
| 2448 | Lipoxygenase substrate | 25 | 0.9430 |
| 2449 | Liver cirrhosis treatment | 53 | 0.9186 |
| 2450 | Liver fibrosis treatment | 266 | 0.9295 |
| 2451 | Liver X receptor agonist | 623 | 0.9932 |
| 2452 | Liver X receptor alpha agonist | 227 | 0.9891 |
| 2453 | Liver X receptor antagonist | 7 | 0.9557 |
| 2454 | Liver X receptor beta agonist | 335 | 0.9936 |
| 2455 | L-lactate dehydrogenase (cytochrome) inhibitor | 6 | 0.9981 |
| 2456 | L-lysine 6-transaminase inhibitor | 6 | 0.9910 |
| 2457 | L-lysine oxidase inhibitor | 4 | 0.9929 |
| 2458 | Lombricine kinase inhibitor | 6 | 0.9838 |
| 2459 | Long-chain-acyl-CoA dehydrogenase inhibitor | 6 | 0.9947 |
| 2460 | Long-chain-aldehyde dehydrogenase inhibitor | 4 | 0.9699 |
| 2461 | Long-chain-fatty-acid-CoA ligase inhibitor | 23 | 0.9929 |
| 2462 | Loop diuretic | 8 | 0.8686 |
| 2463 | L-Serine ammonia-lyase inhibitor | 14 | 0.9948 |
| 2464 | L-threonine 3-dehydrogenase inhibitor | 10 | 0.8788 |
| 2465 | Luteinizing hormone-releasing hormone agonist | 19 | 0.9508 |
| 2466 | Luteinizing hormone-releasing hormone antagonist | 969 | 0.9882 |
| 2467 | Luteolytic | 4 | 0.9997 |
| 2468 | Lymphocytopoiesis inhibitor | 10 | 0.9617 |
| 2469 | Lysase inhibitor | 10 | 0.8343 |
| 2470 | Lysine 2,3-aminomutase inhibitor | 5 | 0.8888 |
| 2471 | Lysine 2-monooxygenase inhibitor | 19 | 0.9720 |
| 2472 | Lysine 6-dehydrogenase inhibitor | 3 | 0.9896 |
| 2473 | Lysine carboxypeptidase inhibitor | 35 | 0.9975 |
| 2474 | Lysine decarboxylase inhibitor | 10 | 0.9901 |
| 2475 | Lysine-tRNA ligase inhibitor | 44 | 0.9844 |
| 2476 | Lysophosphatidic acid receptor agonist | 9 | 0.9975 |
| 2477 | Lysophosphatidic acid receptor antagonist | 78 | 0.9929 |
| 2478 | Lysosomal Pro-X carboxypeptidase inhibitor | 45 | 0.9830 |
| 2479 | Lysostaphin inhibitor | 3 | 0.9701 |
| 2480 | Lysozyme inhibitor | 13 | 0.9856 |
| 2481 | Lysyl endopeptidase inhibitor | 16 | 0.9831 |
| 2482 | Lysyl oxidase inhibitor | 10 | 0.8398 |
| 2483 | M7G(5')pppN diphosphatase inhibitor | 4 | 0.9998 |
| 2484 | Macrocin O-methyltransferase inhibitor | 9 | 0.9998 |
| 2485 | Macrophage colony stimulating factor agonist | 4 | 0.8201 |
| 2486 | Macrophage colony stimulating factor antagonist | 161 | 0.9935 |
| 2487 | Macrophage elastase inhibitor | 182 | 0.9791 |
| 2488 | Macrophage migration inhibitory factor inhibitor | 83 | 0.9794 |
| 2489 | Macrophage scavenger receptor antagonist | 7 | 0.9998 |
| 2490 | Macrophage stimulant | 3 | 0.9588 |
| 2491 | Macular degeneration treatment | 256 | 0.9359 |
| 2492 | Magnesium-protoporphyrin IX methyltransferase inhibitor | 11 | 0.9795 |
| 2493 | Magnesium-protoporphyrin IX monomethyl ester (oxidative) cyclase inhibitor | 10 | 0.9654 |
| 2494 | Magnolysin inhibitor | 6 | 0.9991 |
| 2495 | Maillard reaction inhibitor | 35 | 0.8939 |
| 2496 | Malate dehydrogenase (acceptor) inhibitor | 12 | 0.8640 |
| 2497 | Malate dehydrogenase (decarboxylating) inhibitor | 20 | 0.9953 |
| 2498 | Malate dehydrogenase (NADP+) inhibitor | 9 | 0.9937 |
| 2499 | Malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) inhibitor | 21 | 0.9952 |
| 2500 | Malate dehydrogenase (oxaloacetate-decarboxylating) inhibitor | 16 | 0.9859 |
| 2501 | Malate dehydrogenase inhibitor | 66 | 0.9351 |
| 2502 | Malate oxidase inhibitor | 5 | 0.8952 |
| 2503 | Malate synthase inhibitor | 18 | 0.9922 |
| 2504 | Malate-CoA ligase inhibitor | 5 | 0.9877 |
| 2505 | Male reproductive disfunction treatment | 565 | 0.9379 |
| 2506 | Maleate hydratase inhibitor | 11 | 0.9955 |
| 2507 | Maleate isomerase inhibitor | 6 | 0.9540 |
| 2508 | Maleylacetate reductase inhibitor | 4 | 0.9999 |
| 2509 | Maleylacetoacetate isomerase inhibitor | 6 | 0.9962 |
| 2510 | Malonate-semialdehyde dehydrogenase inhibitor | 3 | 0.9951 |
| 2511 | Malonyl-CoA decarboxylase inhibitor | 93 | 0.9962 |
| 2512 | Maltose-transporting ATPase inhibitor | 4 | 0.9801 |
| 2513 | Malyl-CoA lyase inhibitor | 6 | 0.9847 |
| 2514 | Mandelate 4-monooxygenase inhibitor | 11 | 0.9598 |
| 2515 | Mandelate racemase inhibitor | 27 | 0.9957 |
| 2516 | Manganese peroxidase inhibitor | 6 | 0.9183 |
| 2517 | Mannan endo-1,4-beta-mannosidase inhibitor | 3 | 0.9455 |
| 2518 | Mannan endo-1,6-alpha-mannosidase inhibitor | 4 | 0.9913 |
| 2519 | Mannitol 2-dehydrogenase inhibitor | 5 | 0.9998 |
| 2520 | Mannitol-1-phosphatase inhibitor | 3 | 0.9862 |
| 2521 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 18 | 0.9910 |
| 2522 | Mannokinase inhibitor | 9 | 0.9994 |
| 2523 | Mannonate dehydratase inhibitor | 9 | 0.9916 |
| 2524 | Mannose isomerase inhibitor | 5 | 0.9188 |
| 2525 | Mannose-1-phosphate guanylyltransferase inhibitor | 4 | 0.9999 |
| 2526 | Mannose-6-phosphate isomerase inhibitor | 109 | 0.9664 |
| 2527 | Mannosidase inhibitor | 72 | 0.9872 |
| 2528 | Mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase inhibitor | 8 | 0.9797 |
| 2529 | Mannosyl-oligosaccharide 1,2-alpha-mannosidase inhibitor | 22 | 0.9975 |
| 2530 | Mannosyl-oligosaccharide glucosidase inhibitor | 18 | 0.9970 |
| 2531 | Mannotetraose 2-alpha-N-acetylglucosaminyltransferase inhibitor | 4 | 0.9028 |
| 2532 | MAO A inhibitor | 463 | 0.9815 |
| 2533 | MAO A substrate | 25 | 0.9744 |
| 2534 | MAO B inhibitor | 672 | 0.9880 |
| 2535 | MAO B substrate | 17 | 0.9918 |
| 2536 | MAO inhibitor | 1124 | 0.9707 |
| 2537 | MAP kinase 1 inhibitor | 109 | 0.9306 |
| 2538 | MAP kinase 10 inhibitor | 293 | 0.9798 |
| 2539 | MAP kinase 14 inhibitor | 1528 | 0.9887 |
| 2540 | MAP kinase 8 inhibitor | 256 | 0.9745 |
| 2541 | MAP kinase 9 inhibitor | 320 | 0.9830 |
| 2542 | MAP kinase inhibitor | 2698 | 0.9754 |
| 2543 | MAP kinase kinase 1 inhibitor | 201 | 0.9735 |
| 2544 | MAP kinase kinase 4 inhibitor | 18 | 0.8885 |
| 2545 | MAP kinase kinase 7 inhibitor | 11 | 0.9600 |
| 2546 | MAP kinase kinase inhibitor | 180 | 0.9900 |
| 2547 | MAP kinase kinase kinase inhibitor | 143 | 0.9874 |
| 2548 | MAP kinase stimulant | 7 | 0.8717 |
| 2549 | MAP3K11 inhibitor | 37 | 0.9999 |
| 2550 | MAP3K5 inhibitor | 8 | 0.9004 |
| 2551 | MAP3K8 inhibitor | 56 | 0.9717 |
| 2552 | MAP3K9 inhibitor | 26 | 0.9987 |
| 2553 | MAP-kinase-activated kinase 1 inhibitor | 16 | 0.9664 |
| 2554 | MAP-kinase-activated kinase 2 inhibitor | 155 | 0.9629 |
| 2555 | MAP-kinase-activated kinase inhibitor | 180 | 0.9541 |
| 2556 | MarA inhibitor | 12 | 1.0000 |
| 2557 | MARK1 protein inhibitor | 7 | 1.0000 |
| 2558 | Matrilysin inhibitor | 331 | 0.9931 |
| 2559 | Matriptase inhibitor | 8 | 0.9995 |
| 2560 | Matrix metalloproteinase (membrane-type) inhibitor | 1124 | 0.9909 |
| 2561 | Matrix metalloproteinase 1 (membrane-type) inhibitor | 354 | 0.9913 |
| 2562 | Matrix metalloproteinase 1 inhibitor | 1586 | 0.9923 |
| 2563 | Matrix metalloproteinase 2 (membrane-type) inhibitor | 18 | 0.9967 |
| 2564 | Matrix metalloproteinase 3 (membrane-type) inhibitor | 878 | 0.9925 |
| 2565 | Matrix metalloproteinase inhibitor | 2580 | 0.9886 |
| 2566 | Mcl-1 antagonist | 989 | 0.9589 |
| 2567 | MDM2 inhibitor | 180 | 0.9377 |
| 2568 | Mediator release inhibitor | 146 | 0.8975 |
| 2569 | Melanin inhibitor | 32 | 0.9342 |
| 2570 | Melanin-concentrating hormone receptor 1 antagonist | 1035 | 0.9906 |
| 2571 | Melanin-concentrating hormone receptor antagonist | 1039 | 0.9906 |
| 2572 | Melanocortin 4 antagonist | 377 | 0.9970 |
| 2573 | Melanocortin agonist | 16 | 0.9600 |
| 2574 | Melanocortin antagonist | 510 | 0.9919 |
| 2575 | Melanocortin MC-4 agonist | 10 | 0.9830 |
| 2576 | Melatonin 1 agonist | 27 | 0.9959 |
| 2577 | Melatonin 1 antagonist | 560 | 0.9969 |
| 2578 | Melatonin 1a antagonist | 404 | 0.9974 |
| 2579 | Melatonin 1b antagonist | 127 | 0.9941 |
| 2580 | Melatonin 2 agonist | 15 | 0.9996 |
| 2581 | Melatonin 2 antagonist | 233 | 0.9991 |
| 2582 | Melatonin 3 antagonist | 100 | 0.9988 |
| 2583 | Melatonin 5 antagonist | 68 | 0.9995 |
| 2584 | Melatonin agonist | 98 | 0.9975 |
| 2585 | Melatonin antagonist | 789 | 0.9964 |
| 2586 | Membrane dipeptidase inhibitor | 43 | 0.9554 |
| 2587 | Membrane integrity agonist | 15 | 0.8324 |
| 2588 | Membrane integrity antagonist | 56 | 0.8667 |
| 2589 | Membrane permeability enhancer | 44 | 0.8802 |
| 2590 | Membrane permeability inhibitor | 40 | 0.8262 |
| 2591 | Membrane-oligosaccharide glycerophosphotransferase inhibitor | 6 | 0.9989 |
| 2592 | Menopausal disorders treatment | 53 | 0.8664 |
| 2593 | Menstruation disorders treatment | 235 | 0.9274 |
| 2594 | Mental retardation treatment | 7 | 0.9912 |
| 2595 | Meprin A inhibitor | 13 | 0.9747 |
| 2596 | Meprin B inhibitor | 3 | 0.9810 |
| 2597 | Metabolic disease treatment | 164 | 0.9214 |
| 2598 | Metallocarboxypeptidase D inhibitor | 7 | 0.9578 |
| 2599 | Metalloproteinase inhibitor | 2981 | 0.9865 |
| 2600 | Metalloproteinase-11 inhibitor | 31 | 0.9818 |
| 2601 | Metalloproteinase-2 inhibitor | 1812 | 0.9872 |
| 2602 | Metalloproteinase-3 inhibitor | 951 | 0.9924 |
| 2603 | Metalloproteinase-9 inhibitor | 1837 | 0.9895 |
| 2604 | Methane monooxygenase inhibitor | 13 | 0.9012 |
| 2605 | Methanol dehydrogenase inhibitor | 3 | 0.9840 |
| 2606 | Methemoglobinemia | 16 | 0.9551 |
| 2607 | Methenyltetrahydrofolate cyclohydrolase inhibitor | 7 | 0.9926 |
| 2608 | Methionine adenosyltransferase inhibitor | 27 | 0.9927 |
| 2609 | Methionine decarboxylase inhibitor | 6 | 0.9907 |
| 2610 | Methionine-tRNA ligase inhibitor | 139 | 0.9928 |
| 2611 | Methionyl aminopeptidase 1 inhibitor | 186 | 0.9978 |
| 2612 | Methionyl aminopeptidase 2 inhibitor | 230 | 0.9947 |
| 2613 | Methionyl aminopeptidase inhibitor | 455 | 0.9956 |
| 2614 | Methionyl-tRNA formyltransferase inhibitor | 7 | 0.9997 |
| 2615 | Methylamine-glutamate N-methyltransferase inhibitor | 3 | 0.9601 |
| 2616 | Methylaspartate ammonia-lyase inhibitor | 8 | 0.9838 |
| 2617 | Methylaspartate mutase inhibitor | 8 | 0.9991 |
| 2618 | Methylcrotonoyl-CoA carboxylase inhibitor | 11 | 0.9878 |
| 2619 | Methylenetetrahydrofolate dehydrogenase (NADP+) inhibitor | 10 | 0.9890 |
| 2620 | Methylenetetrahydrofolate reductase (NADPH) inhibitor | 10 | 0.9238 |
| 2621 | Methylglutamate dehydrogenase inhibitor | 7 | 0.9880 |
| 2622 | Methylglyoxal synthase inhibitor | 15 | 0.9982 |
| 2623 | Methylmalonyl-CoA carboxytransferase inhibitor | 7 | 0.9997 |
| 2624 | Methylmalonyl-CoA decarboxylase inhibitor | 7 | 0.9903 |
| 2625 | Methylmalonyl-CoA epimerase inhibitor | 9 | 0.9990 |
| 2626 | Methylmalonyl-CoA mutase inhibitor | 11 | 0.9912 |
| 2627 | Methylthioadenosine nucleosidase inhibitor | 16 | 0.9942 |
| 2628 | Methyltransferase inhibitor | 5 | 0.9997 |
| 2629 | Methyltransferase substrate | 4 | 0.9873 |
| 2630 | Methylumbelliferyl-acetate deacetylase inhibitor | 7 | 0.8731 |
| 2631 | Mevalonate kinase inhibitor | 11 | 0.9828 |
| 2632 | MexAB-OprM inhibitor | 3 | 1.0000 |
| 2633 | Microbial collagenase inhibitor | 514 | 0.9946 |
| 2634 | Microsomal triglyceride transfer protein inhibitor | 423 | 0.9992 |
| 2635 | Microtubule formation inhibitor | 320 | 0.9397 |
| 2636 | Microtubule stabilization | 142 | 0.9921 |
| 2637 | Mineralocorticoid | 16 | 0.9998 |
| 2638 | Mineralocorticoid antagonist | 441 | 0.9900 |
| 2639 | Miotic | 122 | 0.8950 |
| 2640 | Mitochondrial intermediate peptidase inhibitor | 6 | 0.9787 |
| 2641 | Mitochondrial processing peptidase inhibitor | 6 | 0.8265 |
| 2642 | MMP9 expression inhibitor | 16 | 0.8764 |
| 2643 | MO15-related protein kinase Pfmrk inhibitor | 18 | 0.9230 |
| 2644 | Monoamine oxidase substrate | 45 | 0.9832 |
| 2645 | Monoamine uptake inhibitor | 41 | 0.9159 |
| 2646 | Monocarboxylic acid transporter 1 inhibitor | 6 | 0.9733 |
| 2647 | Monocarboxylic acid transporter inhibitor | 6 | 0.9733 |
| 2648 | Monodehydroascorbate reductase (NADH) inhibitor | 17 | 0.9197 |
| 2649 | Monophenol monooxygenase inhibitor | 113 | 0.9637 |
| 2650 | Mood disorders treatment | 8303 | 0.9181 |
| 2651 | Morphine 6-dehydrogenase inhibitor | 13 | 0.9582 |
| 2652 | Motilin receptor agonist | 101 | 0.9920 |
| 2653 | Motilin receptor antagonist | 78 | 0.9999 |
| 2654 | Movement disorders treatment | 43 | 0.9388 |
| 2655 | mRNA (guanine-N7-)-methyltransferase inhibitor | 18 | 0.9655 |
| 2656 | mRNA (nucleoside-2'-O-)-methyltransferase inhibitor | 16 | 1.0000 |
| 2657 | mTOR inhibitor | 643 | 0.9941 |
| 2658 | Mucinaminylserine mucinaminidase inhibitor | 5 | 0.8302 |
| 2659 | Mucolytic | 104 | 0.9210 |
| 2660 | Mucomembranous protector | 33 | 0.8045 |
| 2661 | Muconate cycloisomerase inhibitor | 4 | 0.9976 |
| 2662 | Mucorpepsin inhibitor | 5 | 0.9649 |
| 2663 | Mucositis treatment | 14 | 0.8398 |
| 2664 | Multidrug resistance-associated protein 1 inhibitor | 223 | 0.9667 |
| 2665 | Multidrug resistance-associated protein inhibitor | 224 | 0.9623 |
| 2666 | Multiple inositol-polyphosphate phosphatase inhibitor | 5 | 0.9998 |
| 2667 | Multiple organ failure | 3 | 0.8848 |
| 2668 | Multiple sclerosis treatment | 959 | 0.8914 |
| 2669 | Muramoyltetrapeptide carboxypeptidase inhibitor | 5 | 0.9334 |
| 2670 | Muscle relaxant | 395 | 0.9217 |
| 2671 | Muscle weakness | 191 | 0.8482 |
| 2672 | Muscular dystrophy treatment | 62 | 0.8660 |
| 2673 | Mutagenic | 3542 | 0.9713 |
| 2674 | Mutagenic, Salmonella | 3302 | 0.9740 |
| 2675 | Myc inhibitor | 9 | 0.8699 |
| 2676 | Mycodextranase inhibitor | 6 | 0.9945 |
| 2677 | Mycolysin inhibitor | 3 | 0.9974 |
| 2678 | Mycothiol-S-conjugate amidase inhibitor | 3 | 0.8929 |
| 2679 | Mydriatic | 211 | 0.9042 |
| 2680 | Myelin associated glycoprotein antagonist | 4 | 1.0000 |
| 2681 | Myeloblastin inhibitor | 4 | 0.9831 |
| 2682 | Myocardial infarction treatment | 600 | 0.9504 |
| 2683 | Myocardial ischemia treatment | 1664 | 0.9511 |
| 2684 | Myocarditis | 25 | 0.8236 |
| 2685 | Myoclonus | 79 | 0.8420 |
| 2686 | Myosin ATPase inhibitor | 11 | 0.8730 |
| 2687 | Myosin-light-chain-phosphatase inhibitor | 6 | 0.9757 |
| 2688 | Myristoyl transferase 1 inhibitor | 73 | 0.9972 |
| 2689 | Myristoyl transferase inhibitor | 93 | 0.9975 |
| 2690 | Myt1 kinase inhibitor | 7 | 1.0000 |
| 2691 | N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase inhibitor | 8 | 0.9837 |
| 2692 | N-(long-chain-acyl)ethanolamine deacylase inhibitor | 7 | 0.9738 |
| 2693 | N4-(beta-N-acetylglucosaminyl)-L-asparaginase inhibitor | 10 | 0.9844 |
| 2694 | N6-methyl-lysine oxidase inhibitor | 4 | 0.9843 |
| 2695 | Na+ K+ transporting ATPase inhibitor | 165 | 0.9854 |
| 2696 | Na+-transporting two-sector ATPase inhibitor | 7 | 0.8289 |
| 2697 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 158 | 0.9986 |
| 2698 | N-acetylgalactosamine-4-sulfatase inhibitor | 3 | 0.9999 |
| 2699 | N-acetyl-gamma-glutamyl-phosphate reductase inhibitor | 3 | 0.9893 |
| 2700 | N-acetylglucosamine kinase inhibitor | 15 | 0.9929 |
| 2701 | N-acetylglucosamine-6-phosphate deacetylase inhibitor | 10 | 0.9938 |
| 2702 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase inhibitor | 6 | 0.9978 |
| 2703 | N-acetylglucosaminyldiphosphoundecaprenol N-acetyl-beta-D-mannosaminyltransferase inhibitor | 3 | 0.9403 |
| 2704 | N-acetyllactosamine synthase inhibitor | 6 | 0.9669 |
| 2705 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase inhibitor | 5 | 0.9707 |
| 2706 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase inhibitor | 7 | 0.9970 |
| 2707 | N-acetylmuramoyl-L-alanine amidase inhibitor | 11 | 0.9970 |
| 2708 | N-acetylneuraminate 4-O-acetyltransferase inhibitor | 3 | 0.9785 |
| 2709 | N-acetylneuraminate 7-O(or 9-O)-acetyltransferase inhibitor | 6 | 0.8127 |
| 2710 | N-acetylneuraminate lyase inhibitor | 14 | 0.9926 |
| 2711 | N-acetylneuraminate synthase inhibitor | 4 | 0.9911 |
| 2712 | N-Acyl-D-amino-acid deacylase inhibitor | 4 | 0.9890 |
| 2713 | N-Acyl-D-aspartate deacylase inhibitor | 3 | 0.9850 |
| 2714 | N-acylmannosamine kinase inhibitor | 5 | 0.8834 |
| 2715 | N-acylneuraminate cytidylyltransferase inhibitor | 15 | 0.9930 |
| 2716 | NAD(P)+ transhydrogenase (AB-specific) inhibitor | 31 | 0.9784 |
| 2717 | NAD(P)+ transhydrogenase (B-specific) inhibitor | 11 | 0.9630 |
| 2718 | NAD(P)+-arginine ADP-ribosyltransferase inhibitor | 11 | 0.8620 |
| 2719 | NAD(P)H dehydrogenase (quinone) 1 inhibitor | 50 | 0.9986 |
| 2720 | NAD(P)H dehydrogenase (quinone) inhibitor | 147 | 0.9804 |
| 2721 | NAD+ diphosphatase inhibitor | 11 | 0.9920 |
| 2722 | NAD+ kinase inhibitor | 17 | 0.9634 |
| 2723 | NAD+ nucleosidase inhibitor | 19 | 0.9937 |
| 2724 | NAD+ synthase (glutamine-hydrolysing) inhibitor | 4 | 0.9832 |
| 2725 | NAD+-dinitrogen-reductase ADP-D-ribosyltransferase inhibitor | 3 | 0.9934 |
| 2726 | NADH dehydrogenase inhibitor | 17 | 0.9554 |
| 2727 | NADH kinase inhibitor | 3 | 0.9754 |
| 2728 | NADH oxidase inhibitor | 18 | 0.9999 |
| 2729 | NADPH oxidase inhibitor | 76 | 0.9679 |
| 2730 | NADPH oxidoreductase inhibitor | 20 | 0.9894 |
| 2731 | NADPH peroxidase inhibitor | 4 | 0.9089 |
| 2732 | NADPH-cytochrome-c2 reductase inhibitor | 3 | 0.8785 |
| 2733 | NADPH-ferrihemoprotein reductase inhibitor | 10 | 0.8683 |
| 2734 | Nail discoloration | 4 | 0.8386 |
| 2735 | Naphthalene 1,2-dioxygenase inhibitor | 3 | 0.9674 |
| 2736 | Narcolepsy treatment | 12 | 0.9626 |
| 2737 | Narcotic antagonist | 71 | 0.9676 |
| 2738 | Nardilysin inhibitor | 8 | 0.9337 |
| 2739 | NAT1 substrate | 20 | 0.9948 |
| 2740 | NAT2 substrate | 35 | 0.9874 |
| 2741 | Nausea | 1042 | 0.8186 |
| 2742 | Nav1.1 sodium channel blocker | 164 | 0.9608 |
| 2743 | Nav1.2 sodium channel blocker | 222 | 0.9594 |
| 2744 | Nav1.3 sodium channel blocker | 160 | 0.9603 |
| 2745 | Nav1.4 sodium channel blocker | 23 | 0.9885 |
| 2746 | Nav1.5 sodium channel blocker | 91 | 0.9313 |
| 2747 | Nav1.7 sodium channel blocker | 97 | 0.9655 |
| 2748 | Nav1.8 sodium channel blocker | 190 | 0.9597 |
| 2749 | N-benzyloxycarbonylglycine hydrolase inhibitor | 6 | 0.8806 |
| 2750 | N-Carbamoyl-D-amino acid hydrolase inhibitor | 5 | 0.9863 |
| 2751 | N-carbamoyl-L-amino-acid hydrolase inhibitor | 10 | 0.9833 |
| 2752 | Necroptosis inhibitor | 6 | 0.9424 |
| 2753 | Necrosis | 183 | 0.8038 |
| 2754 | Necrosis treatment | 6 | 1.0000 |
| 2755 | Neolactotetraosylceramide alpha-2,3-sialyltransferase inhibitor | 6 | 0.9933 |
| 2756 | Nephritis | 124 | 0.8164 |
| 2757 | Nephrotic syndrome | 56 | 0.8089 |
| 2758 | Nephrotoxic | 787 | 0.8402 |
| 2759 | Nerve growth factor antagonist | 40 | 0.9928 |
| 2760 | Neuraminidase (Influenza A) inhibitor | 166 | 0.9999 |
| 2761 | Neuraminidase (Influenza B) inhibitor | 65 | 0.9998 |
| 2762 | Neuraminidase (influenza) inhibitor | 195 | 0.9977 |
| 2763 | Neuraminidase inhibitor | 309 | 0.9875 |
| 2764 | Neurodegenerative diseases treatment | 5571 | 0.8598 |
| 2765 | Neurokinin 1 antagonist | 1433 | 0.9957 |
| 2766 | Neurokinin 2 antagonist | 708 | 0.9903 |
| 2767 | Neurokinin 3 antagonist | 344 | 0.9918 |
| 2768 | Neurokinin antagonist | 2057 | 0.9926 |
| 2769 | Neuroleptic malignant syndrome | 51 | 0.9007 |
| 2770 | Neurolysin inhibitor | 25 | 0.9859 |
| 2771 | Neuronal nicotinic receptor antagonist | 739 | 0.9941 |
| 2772 | Neuronal nitric-oxide synthase inhibitor | 437 | 0.9966 |
| 2773 | Neuropathy treatment | 21 | 0.9992 |
| 2774 | Neuropeptide agonist | 16 | 0.9100 |
| 2775 | Neuropeptide antagonist | 1444 | 0.9687 |
| 2776 | Neuropeptide FF agonist | 8 | 0.8792 |
| 2777 | Neuropeptide FF antagonist | 66 | 0.9979 |
| 2778 | Neuropeptide FF1 antagonist | 30 | 0.9972 |
| 2779 | Neuropeptide FF2 agonist | 8 | 0.8792 |
| 2780 | Neuropeptide S antagonist | 4 | 0.8927 |
| 2781 | Neuropeptide Y agonist | 7 | 0.9577 |
| 2782 | Neuropeptide Y antagonist | 1374 | 0.9679 |
| 2783 | Neuropeptide Y1 agonist | 6 | 1.0000 |
| 2784 | Neuropeptide Y1 antagonist | 389 | 0.9539 |
| 2785 | Neuropeptide Y2 antagonist | 117 | 0.8752 |
| 2786 | Neuropeptide Y4 antagonist | 6 | 0.8028 |
| 2787 | Neuropeptide Y5 antagonist | 837 | 0.9923 |
| 2788 | Neuropsin inhibitor | 5 | 0.9891 |
| 2789 | Neurotensin 1 receptor agonist | 3 | 0.9981 |
| 2790 | Neurotensin 1 receptor antagonist | 53 | 0.9740 |
| 2791 | Neurotensin 2 receptor antagonist | 27 | 1.0000 |
| 2792 | Neurotensin 3 receptor antagonist | 25 | 1.0000 |
| 2793 | Neurotensin receptor agonist | 16 | 0.9984 |
| 2794 | Neurotensin receptor antagonist | 113 | 0.9936 |
| 2795 | Neurotoxic | 638 | 0.8575 |
| 2796 | Neurotransmitter antagonist | 9 | 0.8311 |
| 2797 | Neurotransmitter uptake inhibitor | 3 | 0.8987 |
| 2798 | Neurotrophic factor | 468 | 0.9612 |
| 2799 | Neurotrophic factor enhancer | 74 | 0.9296 |
| 2800 | Neutral endopeptidase inhibitor | 698 | 0.9953 |
| 2801 | Neutropenia treatment | 54 | 0.9997 |
| 2802 | Neutrophil collagenase inhibitor | 746 | 0.9882 |
| 2803 | Neutrophil fMLF receptor antagonist | 23 | 1.0000 |
| 2804 | Neutrophilic dermatosis (Sweet's syndrome) | 4 | 0.8396 |
| 2805 | NF-E2-related factor 2 stimulant | 10 | 0.9493 |
| 2806 | N-formylglutamate deformylase inhibitor | 16 | 0.9946 |
| 2807 | N-formylmethionyl-peptidase inhibitor | 3 | 0.9691 |
| 2808 | N-hydroxy-2-acetamidofluorene reductase inhibitor | 3 | 0.9809 |
| 2809 | N-hydroxyarylamine O-acetyltransferase inhibitor | 11 | 0.8409 |
| 2810 | Nicotinamidase inhibitor | 24 | 0.9839 |
| 2811 | Nicotinamide phosphoribosyltransferase inhibitor | 13 | 0.9667 |
| 2812 | Nicotinamide-nucleotide adenylyltransferase inhibitor | 7 | 0.9916 |
| 2813 | Nicotinamide-nucleotide amidase inhibitor | 6 | 1.0000 |
| 2814 | Nicotinate dehydrogenase inhibitor | 6 | 0.8542 |
| 2815 | Nicotinate phosphoribosyltransferase inhibitor | 17 | 0.9952 |
| 2816 | Nicotinate-nucleotide diphosphorylase (carboxylating) inhibitor | 32 | 0.9941 |
| 2817 | Nicotine dehydrogenase inhibitor | 5 | 0.8152 |
| 2818 | Nicotinic acid receptor 1 agonist | 102 | 0.9872 |
| 2819 | Nicotinic acid receptor 2 agonist | 26 | 0.9962 |
| 2820 | Nicotinic acid receptor agonist | 201 | 0.9929 |
| 2821 | Nicotinic alpha2beta2 receptor antagonist | 4 | 0.8885 |
| 2822 | Nicotinic alpha2beta4 receptor agonist | 4 | 0.8620 |
| 2823 | Nicotinic alpha3beta4 receptor agonist | 12 | 0.9911 |
| 2824 | Nicotinic alpha4 receptor agonist | 16 | 0.9998 |
| 2825 | Nicotinic alpha4beta2 receptor agonist | 34 | 0.9986 |
| 2826 | Nicotinic alpha4beta2 receptor antagonist | 18 | 0.9430 |
| 2827 | Nicotinic alpha4beta4 receptor agonist | 3 | 0.9002 |
| 2828 | Nicotinic alpha6 receptor agonist | 3 | 0.9964 |
| 2829 | Nicotinic alpha6beta3beta4alpha5 receptor antagonist | 3 | 0.8470 |
| 2830 | Nicotinic alpha7 receptor agonist | 535 | 0.9938 |
| 2831 | Nicotinic neuronal receptor agonist | 611 | 0.9908 |
| 2832 | Nicotinic receptor alpha7 subunit antagonist | 59 | 0.9913 |
| 2833 | Niemann-Pick C1-like 1 protein antagonist | 23 | 0.9197 |
| 2834 | Nitrate reductase (cytochrome) inhibitor | 11 | 0.8698 |
| 2835 | Nitrate reductase inhibitor | 30 | 0.9388 |
| 2836 | Nitric oxide antagonist | 146 | 0.9455 |
| 2837 | Nitric oxide donor | 197 | 0.9939 |
| 2838 | Nitric oxide scavenger | 4 | 0.9437 |
| 2839 | Nitric-oxide synthase inhibitor | 1075 | 0.9776 |
| 2840 | Nitric-oxide synthase stimulant | 19 | 0.9072 |
| 2841 | Nitrilase inhibitor | 18 | 0.9832 |
| 2842 | Nitrile hydratase inhibitor | 22 | 0.9874 |
| 2843 | Nitrite reductase (NO-forming) inhibitor | 3 | 0.9543 |
| 2844 | Nitrite reductase [NAD(P)H] inhibitor | 18 | 0.8771 |
| 2845 | NMDA 2 receptor antagonist | 941 | 0.9898 |
| 2846 | NMDA 2A receptor antagonist | 568 | 0.9947 |
| 2847 | NMDA 2B receptor antagonist | 396 | 0.9899 |
| 2848 | NMDA receptor agonist | 164 | 0.9811 |
| 2849 | NMDA receptor antagonist | 4021 | 0.9799 |
| 2850 | NMDA receptor glutamate site antagonist | 41 | 0.9986 |
| 2851 | NMDA receptor glycine site agonist | 127 | 0.9885 |
| 2852 | NMDA receptor glycine site antagonist | 586 | 0.9975 |
| 2853 | NMDA receptor glycine site B antagonist | 5 | 0.9992 |
| 2854 | NMDA receptor phencyclidine site antagonist | 152 | 0.9986 |
| 2855 | NMDA receptor polyamine site agonist | 3 | 0.9994 |
| 2856 | NMDA receptor polyamine site antagonist | 5 | 0.9416 |
| 2857 | N-methyl-2-oxoglutaramate hydrolase inhibitor | 9 | 0.9714 |
| 2858 | N-methylhydantoinase (ATP-hydrolysing) inhibitor | 5 | 0.9685 |
| 2859 | NMN nucleosidase inhibitor | 16 | 0.9928 |
| 2860 | Nociceptin (N/OFQ) receptor agonist | 8 | 0.9999 |
| 2861 | Nociceptin (N/OFQ) receptor antagonist | 320 | 0.9961 |
| 2862 | Non mutagenic, Salmonella | 450 | 0.9209 |
| 2863 | Non-steroidal antiinflammatory agent | 1075 | 0.9162 |
| 2864 | Nootropic | 1128 | 0.7596 |
| 2865 | NOS2 expression inhibitor | 43 | 0.9349 |
| 2866 | NOS3 expression enhancer | 73 | 0.9570 |
| 2867 | NTPase/helicase (JEV) inhibitor | 3 | 0.9998 |
| 2868 | NTPase/helicase (WNF) inhibitor | 9 | 0.9999 |
| 2869 | Nuclear receptor subfamily 4, group A, member 2 agonist | 24 | 0.9977 |
| 2870 | Nuclease inhibitor | 14 | 0.9615 |
| 2871 | Nucleoside deoxyribosyltransferase inhibitor | 8 | 0.9979 |
| 2872 | Nucleoside oxidase (H2O2-forming) inhibitor | 6 | 0.9676 |
| 2873 | Nucleoside phosphoacylhydrolase inhibitor | 4 | 0.9878 |
| 2874 | Nucleoside transporters inhibitor | 18 | 0.9988 |
| 2875 | Nucleoside-diphosphatase inhibitor | 10 | 0.9702 |
| 2876 | Nucleoside-triphosphate diphosphatase inhibitor | 7 | 0.9999 |
| 2877 | Nucleoside-triphosphate-adenylate kinase inhibitor | 7 | 0.9856 |
| 2878 | Nucleotidase inhibitor | 6 | 0.9447 |
| 2879 | Nucleotide diphosphatase inhibitor | 37 | 0.9794 |
| 2880 | Nucleotide metabolism regulator | 138 | 0.8675 |
| 2881 | Nucleotidyltransferase (FIV) inhibitor | 15 | 0.9961 |
| 2882 | Nucleotidyltransferase inhibitor | 18 | 0.9981 |
| 2883 | O6-alkylguanine-DNA alkyltransferase inhibitor | 130 | 0.9946 |
| 2884 | O-acetylhomoserine aminocarboxypropyltransferase inhibitor | 15 | 0.9789 |
| 2885 | O-aminophenol oxidase inhibitor | 12 | 0.9137 |
| 2886 | Obsessive-compulsive disorder treatment | 68 | 0.9473 |
| 2887 | Occult bleeding | 3 | 0.8960 |
| 2888 | Octadecanal decarbonylase inhibitor | 6 | 0.9942 |
| 2889 | Octopamine agonist | 67 | 0.9994 |
| 2890 | Octopamine antagonist | 5 | 0.8008 |
| 2891 | Ocular toxicity | 639 | 0.8211 |
| 2892 | Oleamide hydrolase inhibitor | 308 | 0.9909 |
| 2893 | Oligo-1,6-glucosidase inhibitor | 24 | 0.9900 |
| 2894 | Oligonucleotidase inhibitor | 10 | 0.9941 |
| 2895 | Oligopeptidase B inhibitor | 7 | 0.9716 |
| 2896 | Omega-amidase inhibitor | 8 | 0.9904 |
| 2897 | Omptin inhibitor | 4 | 0.8813 |
| 2898 | Opheline kinase inhibitor | 3 | 0.9794 |
| 2899 | Ophthalmic drug | 1892 | 0.8946 |
| 2900 | Opine dehydrogenase inhibitor | 4 | 0.9784 |
| 2901 | Opioid delta 1 receptor antagonist | 11 | 0.9549 |
| 2902 | Opioid delta 2 receptor antagonist | 12 | 0.9995 |
| 2903 | Opioid dependency treatment | 36 | 0.8757 |
| 2904 | Opioid kappa 1 receptor antagonist | 90 | 0.9915 |
| 2905 | Opioid kappa 2 receptor antagonist | 14 | 1.0000 |
| 2906 | Opioid kappa 2b receptor antagonist | 14 | 1.0000 |
| 2907 | Opioid kappa 3 receptor antagonist | 10 | 0.8496 |
| 2908 | Opioid mu 1 receptor antagonist | 21 | 0.9793 |
| 2909 | Opioid mu 2 receptor antagonist | 24 | 0.9853 |
| 2910 | Optic neuritis | 60 | 0.7812 |
| 2911 | Optic neuropathy | 68 | 0.7759 |
| 2912 | Orcinol 2-monooxygenase inhibitor | 7 | 0.9991 |
| 2913 | Orexin receptor 1 antagonist | 475 | 0.9601 |
| 2914 | Orexin receptor 2 antagonist | 244 | 0.9988 |
| 2915 | Orexin receptor antagonist | 742 | 0.9670 |
| 2916 | Ornithine carbamoyltransferase inhibitor | 40 | 0.9901 |
| 2917 | Ornithine cyclodeaminase inhibitor | 3 | 0.9881 |
| 2918 | Ornithine decarboxylase inhibitor | 102 | 0.9804 |
| 2919 | Ornithine-oxo-acid transaminase inhibitor | 39 | 0.9602 |
| 2920 | Orotate phosphoribosyltransferase inhibitor | 36 | 0.9947 |
| 2921 | Orotate reductase (NADH) inhibitor | 8 | 0.9867 |
| 2922 | Orotate reductase (NADPH) inhibitor | 5 | 0.9974 |
| 2923 | Orotidylate decarboxylase inhibitor | 4 | 0.9991 |
| 2924 | Orsellinate decarboxylase inhibitor | 5 | 1.0000 |
| 2925 | Oryzin inhibitor | 10 | 0.9179 |
| 2926 | Osmotic diuretic | 6 | 0.9985 |
| 2927 | Osteoarthritis treatment | 279 | 0.9500 |
| 2928 | Osteoclast antagonist | 81 | 0.9822 |
| 2929 | Ototoxicity | 43 | 0.8737 |
| 2930 | Ovulation inhibitor | 15 | 0.8575 |
| 2931 | Oxalate oxidase inhibitor | 13 | 0.9477 |
| 2932 | Oxaloacetate decarboxylase inhibitor | 15 | 0.9927 |
| 2933 | Oxaloacetate tautomerase inhibitor | 15 | 0.9960 |
| 2934 | Oxidizing agent | 16 | 0.9542 |
| 2935 | Oxidoreductase inhibitor | 82 | 0.8443 |
| 2936 | Oxoglutarate dehydrogenase (lipoamide) inhibitor | 17 | 0.9886 |
| 2937 | Oxygen scavenger | 9 | 0.8446 |
| 2938 | Oxytocic | 20 | 0.9050 |
| 2939 | Oxytocin agonist | 16 | 0.9563 |
| 2940 | Oxytocin antagonist | 793 | 0.9907 |
| 2941 | P2 nucleoside transporter inhibitor | 11 | 1.0000 |
| 2942 | p21-activated kinase 1 inhibitor | 9 | 0.8763 |
| 2943 | p21-activated kinase 4 inhibitor | 20 | 0.9510 |
| 2944 | p21-activated kinase inhibitor | 22 | 0.9248 |
| 2945 | P3 purinoceptor-like protein antagonist | 35 | 0.9999 |
| 2946 | p38 MAP kinase inhibitor | 423 | 0.9769 |
| 2947 | p53 inhibitor | 27 | 0.9643 |
| 2948 | Paget's disease treatment | 43 | 0.9791 |
| 2949 | Pain | 970 | 0.8176 |
| 2950 | Palmitoyl-CoA hydrolase inhibitor | 44 | 0.9787 |
| 2951 | Palpitation | 31 | 0.8475 |
| 2952 | Pancreatic disorders treatment | 148 | 0.9072 |
| 2953 | Pancreatic elastase inhibitor | 10 | 0.8008 |
| 2954 | Pancreatic endopeptidase E inhibitor | 6 | 0.9896 |
| 2955 | Pancreatic ribonuclease inhibitor | 10 | 0.9144 |
| 2956 | Panic | 13 | 0.9091 |
| 2957 | Pantetheine-phosphate adenylyltransferase inhibitor | 16 | 0.9666 |
| 2958 | Pantoate 4-dehydrogenase inhibitor | 3 | 0.9938 |
| 2959 | Pantoate-beta-alanine ligase inhibitor | 39 | 0.9736 |
| 2960 | Pantothenase inhibitor | 10 | 0.9887 |
| 2961 | Pantothenate kinase inhibitor | 18 | 0.9987 |
| 2962 | Papillary necrosis | 4 | 0.9968 |
| 2963 | Pappalysin-1 inhibitor | 4 | 0.9702 |
| 2964 | Para amino benzoic acid antagonist | 8 | 0.8823 |
| 2965 | Paralysis | 134 | 0.8005 |
| 2966 | Paraoxonase substrate | 5 | 0.9870 |
| 2967 | Parathyroid hormone antagonist | 19 | 0.9854 |
| 2968 | Parathyroid hormone secretion stimulant | 71 | 0.9981 |
| 2969 | Parkinsonism | 27 | 0.8627 |
| 2970 | P-benzoquinone reductase (NADPH) inhibitor | 8 | 0.8491 |
| 2971 | Pectate lyase inhibitor | 11 | 0.9810 |
| 2972 | Pectin lyase inhibitor | 11 | 0.9870 |
| 2973 | Pediculicide | 10 | 0.9647 |
| 2974 | Penicillin amidase inhibitor | 10 | 0.9579 |
| 2975 | Penicillopepsin inhibitor | 14 | 0.9713 |
| 2976 | Pepsin inhibitor | 80 | 0.9947 |
| 2977 | Peptide agonist | 3 | 0.9471 |
| 2978 | Peptide alpha-N-acetyltransferase inhibitor | 6 | 0.9354 |
| 2979 | Peptide deformylase inhibitor | 181 | 0.9908 |
| 2980 | Peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase inhibitor | 6 | 0.9053 |
| 2981 | Peptide-tryptophan 2,3-dioxygenase inhibitor | 9 | 0.9828 |
| 2982 | Peptidoglycan beta-N-acetylmuramidase inhibitor | 3 | 0.9939 |
| 2983 | Peptidoglycan glycosyltransferase inhibitor | 4 | 0.9178 |
| 2984 | Peptidylamidoglycolate lyase inhibitor | 5 | 0.9887 |
| 2985 | Peptidyl-dipeptidase B inhibitor | 7 | 0.8547 |
| 2986 | Peptidyl-dipeptidase Dcp inhibitor | 6 | 0.9418 |
| 2987 | Peptidyl-glycinamidase inhibitor | 11 | 0.9756 |
| 2988 | Peptidylglycine monooxygenase inhibitor | 38 | 0.9864 |
| 2989 | Peptidyl-Lys metalloendopeptidase inhibitor | 22 | 0.9503 |
| 2990 | Peptidyl-prolyl cis-trans isomerase inhibitor | 388 | 0.9928 |
| 2991 | Peptidyltransferase inhibitor | 20 | 0.8964 |
| 2992 | Periodontitis treatment | 20 | 0.9723 |
| 2993 | Peristaltic stimulant | 174 | 0.9472 |
| 2994 | Peroxidase inhibitor | 16 | 0.9313 |
| 2995 | Peroxidase substrate | 33 | 0.9183 |
| 2996 | Peroxisome proliferator-activated receptor agonist | 1958 | 0.9883 |
| 2997 | Peroxisome proliferator-activated receptor alpha agonist | 1005 | 0.9919 |
| 2998 | Peroxisome proliferator-activated receptor alpha antagonist | 383 | 0.9956 |
| 2999 | Peroxisome proliferator-activated receptor antagonist | 966 | 0.9782 |
| 3000 | Peroxisome proliferator-activated receptor delta agonist | 409 | 0.9963 |
| 3001 | Peroxisome proliferator-activated receptor delta antagonist | 260 | 0.9964 |
| 3002 | Peroxisome proliferator-activated receptor gamma agonist | 935 | 0.9861 |
| 3003 | Peroxisome proliferator-activated receptor gamma antagonist | 810 | 0.9757 |
| 3004 | PfA-M1 aminopeptidase inhibitor | 55 | 0.9231 |
| 3005 | pFOX inhibitor | 5 | 0.9996 |
| 3006 | P-glycoprotein 1 inhibitor | 450 | 0.9359 |
| 3007 | P-glycoprotein inhibitor | 644 | 0.9340 |
| 3008 | P-glycoprotein substrate | 59 | 0.8506 |
| 3009 | Phenol 2-monooxygenase inhibitor | 25 | 0.9598 |
| 3010 | Phenol O-methyltransferase inhibitor | 3 | 0.9537 |
| 3011 | Phenylacetaldehyde dehydrogenase inhibitor | 5 | 0.9887 |
| 3012 | Phenylacetate-CoA ligase inhibitor | 8 | 0.9782 |
| 3013 | Phenylalanine 2-monooxygenase inhibitor | 6 | 0.9992 |
| 3014 | Phenylalanine 4-hydroxylase inhibitor | 30 | 0.9788 |
| 3015 | Phenylalanine decarboxylase inhibitor | 8 | 0.9827 |
| 3016 | Phenylalanine dehydrogenase inhibitor | 19 | 0.9872 |
| 3017 | Phenylalanine racemase (ATP-hydrolysing) inhibitor | 10 | 0.9787 |
| 3018 | Phenylalanine(histidine) transaminase inhibitor | 4 | 0.9823 |
| 3019 | Phenylalanine-tRNA ligase inhibitor | 22 | 0.9896 |
| 3020 | Phenylethanolamine N methyltransferase inhibitor | 88 | 0.9979 |
| 3021 | Phenylpyruvate decarboxylase inhibitor | 3 | 0.9938 |
| 3022 | Phenylpyruvate tautomerase inhibitor | 5 | 1.0000 |
| 3023 | Phloroglucinol reductase inhibitor | 13 | 0.9168 |
| 3024 | Phobic disorders treatment | 4 | 0.8161 |
| 3025 | Phosphatase inhibitor | 9 | 0.8017 |
| 3026 | Phosphate acetyltransferase inhibitor | 14 | 0.9845 |
| 3027 | Phosphate butyryltransferase inhibitor | 4 | 1.0000 |
| 3028 | Phosphate transporter inhibitor | 26 | 0.9813 |
| 3029 | Phosphatidate cytidylyltransferase inhibitor | 17 | 0.9831 |
| 3030 | Phosphatidate phosphatase inhibitor | 24 | 0.9469 |
| 3031 | Phosphatidylcholine-retinol O-acyltransferase inhibitor | 4 | 0.8246 |
| 3032 | Phosphatidylcholine-sterol O-acyltransferase inhibitor | 16 | 0.8973 |
| 3033 | Phosphatidylglycerol-membrane-oligosaccharide glycerophosphotransferase inhibitor | 3 | 0.9961 |
| 3034 | Phosphatidylglycerophosphatase inhibitor | 8 | 0.9716 |
| 3035 | Phosphatidylinositol 3-kinase alpha inhibitor | 622 | 0.9889 |
| 3036 | Phosphatidylinositol 3-kinase beta inhibitor | 303 | 0.9901 |
| 3037 | Phosphatidylinositol 3-kinase delta inhibitor | 290 | 0.9889 |
| 3038 | Phosphatidylinositol 3-kinase gamma inhibitor | 520 | 0.9938 |
| 3039 | Phosphatidylinositol 3-kinase inhibitor | 1201 | 0.9863 |
| 3040 | Phosphatidylinositol 3-kinase stimulant | 6 | 0.8208 |
| 3041 | Phosphatidylinositol diacylglycerol-lyase inhibitor | 12 | 0.9256 |
| 3042 | Phosphatidylinositol kinase inhibitor | 1235 | 0.9859 |
| 3043 | Phosphatidylserine decarboxylase inhibitor | 10 | 0.9343 |
| 3044 | Phosphoadenylylsulfatase inhibitor | 5 | 0.9979 |
| 3045 | Phosphodiesterase 10A inhibitor | 106 | 0.9912 |
| 3046 | Phosphodiesterase 11A inhibitor | 68 | 0.9943 |
| 3047 | Phosphodiesterase 1B inhibitor | 223 | 0.9776 |
| 3048 | Phosphodiesterase 3A inhibitor | 257 | 0.9835 |
| 3049 | Phosphodiesterase 4A inhibitor | 744 | 0.9861 |
| 3050 | Phosphodiesterase 4B inhibitor | 1050 | 0.9875 |
| 3051 | Phosphodiesterase 4C inhibitor | 925 | 0.9889 |
| 3052 | Phosphodiesterase 4D inhibitor | 1053 | 0.9882 |
| 3053 | Phosphodiesterase 5A inhibitor | 469 | 0.9829 |
| 3054 | Phosphodiesterase 6A inhibitor | 176 | 0.9987 |
| 3055 | Phosphodiesterase 6B inhibitor | 106 | 0.9979 |
| 3056 | Phosphodiesterase 7A inhibitor | 55 | 0.9865 |
| 3057 | Phosphodiesterase 9A inhibitor | 32 | 0.9995 |
| 3058 | Phosphodiesterase I inhibitor | 403 | 0.9656 |
| 3059 | Phosphodiesterase II inhibitor | 120 | 0.9740 |
| 3060 | Phosphodiesterase III inhibitor | 1127 | 0.9863 |
| 3061 | Phosphodiesterase inhibitor | 5905 | 0.9709 |
| 3062 | Phosphodiesterase IV inhibitor | 3418 | 0.9868 |
| 3063 | Phosphodiesterase IX inhibitor | 35 | 0.9998 |
| 3064 | Phosphodiesterase V inhibitor | 1029 | 0.9844 |
| 3065 | Phosphodiesterase VI inhibitor | 260 | 0.9971 |
| 3066 | Phosphodiesterase VII inhibitor | 167 | 0.9837 |
| 3067 | Phosphodiesterase X inhibitor | 106 | 0.9912 |
| 3068 | Phosphodiesterase XI inhibitor | 68 | 0.9943 |
| 3069 | Phosphoenolpyruvate carboxykinase (ATP) inhibitor | 34 | 0.9456 |
| 3070 | Phosphoenolpyruvate carboxykinase (diphosphate) inhibitor | 8 | 0.9947 |
| 3071 | Phosphoenolpyruvate carboxykinase (GTP) inhibitor | 25 | 0.9970 |
| 3072 | Phosphoenolpyruvate carboxylase inhibitor | 73 | 0.9892 |
| 3073 | Phosphoenolpyruvate mutase inhibitor | 3 | 0.9865 |
| 3074 | Phosphoenolpyruvate-protein phosphotransferase inhibitor | 4 | 0.9901 |
| 3075 | Phosphofructokinase-1 inhibitor | 33 | 0.9847 |
| 3076 | Phosphoglucomutase inhibitor | 16 | 0.9947 |
| 3077 | Phosphogluconate 2-dehydrogenase inhibitor | 14 | 0.9989 |
| 3078 | Phosphogluconate dehydrogenase (decarboxylating) inhibitor | 56 | 0.9901 |
| 3079 | Phosphoglycerate dehydrogenase inhibitor | 16 | 0.9960 |
| 3080 | Phosphoglycerate kinase inhibitor | 189 | 0.9956 |
| 3081 | Phosphoglycerate mutase inhibitor | 10 | 0.9910 |
| 3082 | Phosphoglycerate phosphatase inhibitor | 6 | 0.9995 |
| 3083 | Phosphoglycolate phosphatase inhibitor | 12 | 0.9928 |
| 3084 | Phosphoinositide 5-phosphatase inhibitor | 11 | 0.9058 |
| 3085 | Phosphoinositide dependent kinase 1 inhibitor | 39 | 0.9814 |
| 3086 | Phosphoinositide phospholipase C inhibitor | 9 | 0.9386 |
| 3087 | Phosphoketolase inhibitor | 10 | 0.9974 |
| 3088 | Phospholipase A1 inhibitor | 16 | 0.9449 |
| 3089 | Phospholipase A2 IIa inhibitor | 127 | 0.9905 |
| 3090 | Phospholipase A2 inhibitor | 541 | 0.9648 |
| 3091 | Phospholipase C inhibitor | 51 | 0.9282 |
| 3092 | Phospholipase D inhibitor | 107 | 0.9686 |
| 3093 | Phospholipase D1 inhibitor | 41 | 0.9606 |
| 3094 | Phospholipase D2 inhibitor | 86 | 0.9872 |
| 3095 | Phospholipase inhibitor | 687 | 0.9604 |
| 3096 | Phospholipid-translocating ATPase inhibitor | 4 | 0.8761 |
| 3097 | Phosphomannomutase inhibitor | 17 | 0.9979 |
| 3098 | Phosphomevalonate kinase inhibitor | 14 | 0.9924 |
| 3099 | Phospho-N-acetylmuramoyl-pentapeptide-transferase inhibitor | 127 | 0.9967 |
| 3100 | Phosphonoacetate hydrolase inhibitor | 6 | 0.9919 |
| 3101 | Phosphopantothenoylcysteine decarboxylase inhibitor | 7 | 0.9411 |
| 3102 | Phosphopyruvate hydratase inhibitor | 7 | 0.9997 |
| 3103 | Phosphoribosylformylglycinamidine cyclo-ligase inhibitor | 3 | 0.9999 |
| 3104 | Phosphoribosylformylglycinamidine synthase inhibitor | 7 | 0.9980 |
| 3105 | Phosphoribosylglycinamide formyltransferase inhibitor | 121 | 0.9998 |
| 3106 | Phosphoribulokinase inhibitor | 10 | 0.9931 |
| 3107 | Phosphorylase a inhibitor | 26 | 0.9908 |
| 3108 | Phosphorylase b inhibitor | 5 | 0.9637 |
| 3109 | Phosphorylase inhibitor | 279 | 0.9853 |
| 3110 | Phosphorylase kinase inhibitor | 57 | 0.9721 |
| 3111 | Phosphoserine phosphatase inhibitor | 10 | 0.9887 |
| 3112 | Phosphoserine transaminase inhibitor | 5 | 0.9991 |
| 3113 | Photinus-luciferin 4-monooxygenase (ATP-hydrolysing) inhibitor | 43 | 0.9523 |
| 3114 | Photoallergy dermatitis | 58 | 0.8445 |
| 3115 | Photosensitizer | 29 | 0.9440 |
| 3116 | Phthalate 4,5-dioxygenase inhibitor | 3 | 0.8714 |
| 3117 | Phytanoyl-CoA dioxygenase inhibitor | 3 | 0.9786 |
| 3118 | Picornain 2A inhibitor | 10 | 0.9809 |
| 3119 | Picornain 3C inhibitor | 8 | 0.9779 |
| 3120 | Piloerection | 13 | 0.8744 |
| 3121 | Pim kinase inhibitor | 150 | 0.9643 |
| 3122 | Pim-1 kinase inhibitor | 91 | 0.9473 |
| 3123 | Pim-2 kinase inhibitor | 60 | 0.9538 |
| 3124 | Pim-3 kinase inhibitor | 19 | 0.9493 |
| 3125 | Pin1 inhibitor | 5 | 0.8888 |
| 3126 | Pitrilysin inhibitor | 10 | 0.9409 |
| 3127 | Plasmanylethanolamine desaturase inhibitor | 8 | 0.9804 |
| 3128 | Plasmepsin I inhibitor | 63 | 0.9997 |
| 3129 | Plasmepsin II inhibitor | 99 | 0.9741 |
| 3130 | Plasmepsin inhibitor | 108 | 0.9755 |
| 3131 | Plasmin inhibitor | 323 | 0.9876 |
| 3132 | Plasminogen activator inhibitor | 134 | 0.9857 |
| 3133 | Plasminogen activator inhibitor antagonist | 165 | 0.9843 |
| 3134 | Plasminogen activator stimulant | 14 | 0.9719 |
| 3135 | Plastoquinol-plastocyanin reductase inhibitor | 7 | 0.9391 |
| 3136 | Platelet activating factor alpha antagonist | 605 | 0.9833 |
| 3137 | Platelet activating factor antagonist | 2431 | 0.9715 |
| 3138 | Platelet activating factor beta antagonist | 921 | 0.9814 |
| 3139 | Platelet adhesion inhibitor | 17 | 0.8238 |
| 3140 | Platelet aggregation inhibitor | 3826 | 0.9100 |
| 3141 | Platelet aggregation stimulant | 7 | 0.8475 |
| 3142 | Platelet antagonist | 1928 | 0.9517 |
| 3143 | Platelet derived growth factor receptor kinase inhibitor | 13 | 0.8643 |
| 3144 | Platelet growth factor antagonist | 756 | 0.9866 |
| 3145 | Platelet growth factor beta antagonist | 186 | 0.9928 |
| 3146 | Plus-end-directed kinesin ATPase inhibitor | 3 | 0.9867 |
| 3147 | Pneumotoxic | 17 | 0.9551 |
| 3148 | Polar-amino-acid-transporting ATPase inhibitor | 4 | 0.9662 |
| 3149 | Polarisation inhibitor | 41 | 0.9362 |
| 3150 | Polarisation stimulant | 9 | 0.9084 |
| 3151 | Polo-like kinase inhibitor | 295 | 0.9758 |
| 3152 | Polo-like kinase-1 inhibitor | 214 | 0.9772 |
| 3153 | Poly(3-hydroxybutyrate) depolymerase inhibitor | 13 | 0.9877 |
| 3154 | Poly(ADP-ribose) glycohydrolase inhibitor | 19 | 0.9748 |
| 3155 | Poly(ADP-ribose) polymerase 1 inhibitor | 622 | 0.9950 |
| 3156 | Poly(ADP-ribose) polymerase 2 inhibitor | 53 | 0.9887 |
| 3157 | Poly(ADP-ribose) polymerase inhibitor | 1241 | 0.9894 |
| 3158 | Poly(alpha-L-guluronate) lyase inhibitor | 5 | 0.9793 |
| 3159 | Poly(beta-D-mannuronate) lyase inhibitor | 4 | 0.9679 |
| 3160 | Polyamine biosynthesis inhibitor | 18 | 0.9913 |
| 3161 | Polyamine oxidase inhibitor | 14 | 0.9568 |
| 3162 | Polyamine-transporting ATPase inhibitor | 3 | 0.9530 |
| 3163 | Polygalacturonase inhibitor | 6 | 0.9672 |
| 3164 | Polyneuridine-aldehyde esterase inhibitor | 3 | 0.9876 |
| 3165 | Polynucleotide 5'-hydroxy-kinase inhibitor | 15 | 0.9194 |
| 3166 | Polynucleotide adenylyltransferase inhibitor | 27 | 0.9472 |
| 3167 | Polypeptide N-acetylgalactosaminyltransferase inhibitor | 16 | 0.9884 |
| 3168 | Polyphosphate kinase inhibitor | 4 | 0.9953 |
| 3169 | Polyphosphate-glucose phosphotransferase inhibitor | 5 | 0.9996 |
| 3170 | Polyporopepsin inhibitor | 6 | 0.8342 |
| 3171 | Polyribonucleotide nucleotidyltransferase inhibitor | 9 | 0.9054 |
| 3172 | Porphobilinogen synthase inhibitor | 22 | 0.9855 |
| 3173 | Porphyria | 28 | 0.8727 |
| 3174 | Postcoital contraceptive | 42 | 0.9905 |
| 3175 | Postmenopausal disorders treatment | 242 | 0.9815 |
| 3176 | Postsynaptic density protein 95 inhibitor | 3 | 1.0000 |
| 3177 | Posttraumatic stress disorder treatment | 30 | 0.9443 |
| 3178 | Postural (orthostatic) hypotension | 27 | 0.8790 |
| 3179 | Potassium channel (ATP-sensitive) activator | 172 | 0.9797 |
| 3180 | Potassium channel (ATP-sensitive) blocker | 239 | 0.9884 |
| 3181 | Potassium channel (Ca-activated) activator | 186 | 0.9716 |
| 3182 | Potassium channel (Ca-activated) blocker | 261 | 0.9835 |
| 3183 | Potassium channel (Inward rectifier) 1 blocker | 80 | 0.9983 |
| 3184 | Potassium channel (Inward rectifier) 11 blocker | 86 | 0.9937 |
| 3185 | Potassium channel (Inward rectifier) activator | 172 | 0.9797 |
| 3186 | Potassium channel (Inward rectifier) blocker | 394 | 0.9897 |
| 3187 | Potassium channel (Voltage-sensitive) activator | 162 | 0.9916 |
| 3188 | Potassium channel (Voltage-sensitive) blocker | 2102 | 0.9549 |
| 3189 | Potassium channel activator | 1430 | 0.9809 |
| 3190 | Potassium channel blocker | 3131 | 0.9498 |
| 3191 | Potassium channel intermediate-conductance Ca-activated 4 blocker | 34 | 1.0000 |
| 3192 | Potassium channel intermediate-conductance Ca-activated activator | 4 | 0.9869 |
| 3193 | Potassium channel intermediate-conductance Ca-activated blocker | 66 | 0.9891 |
| 3194 | Potassium channel KCNQ activator | 162 | 0.9916 |
| 3195 | Potassium channel KCNQ blocker | 8 | 0.9973 |
| 3196 | Potassium channel KCNQ2 activator | 45 | 0.9998 |
| 3197 | Potassium channel KCNQ3 activator | 6 | 0.9829 |
| 3198 | Potassium channel Kv1.1 blocker | 135 | 0.9826 |
| 3199 | Potassium channel Kv1.3 blocker | 245 | 0.9894 |
| 3200 | Potassium channel Kv1.5 blocker | 444 | 0.9829 |
| 3201 | Potassium channel Kv4.3 blocker | 82 | 0.9785 |
| 3202 | Potassium channel large-conductance Ca-activated activator | 161 | 0.9808 |
| 3203 | Potassium channel small-conductance Ca-activated 3 activator | 6 | 0.9900 |
| 3204 | Potassium channel small-conductance Ca-activated 3 blocker | 42 | 0.9997 |
| 3205 | Potassium channel small-conductance Ca-activated activator | 9 | 0.9990 |
| 3206 | Potassium channel small-conductance Ca-activated blocker | 125 | 0.9966 |
| 3207 | Pregnane X receptor agonist | 13 | 0.9471 |
| 3208 | Pregnane X receptor antagonist | 35 | 0.9873 |
| 3209 | Premature ejaculation treatment | 112 | 0.9794 |
| 3210 | Premenstrual syndrome treatment | 26 | 0.9567 |
| 3211 | Preneoplastic conditions treatment | 8 | 0.8643 |
| 3212 | Prenyl-diphosphatase inhibitor | 5 | 0.9747 |
| 3213 | Prephenate dehydratase inhibitor | 23 | 0.9938 |
| 3214 | Prephenate dehydrogenase inhibitor | 20 | 0.9501 |
| 3215 | Prepilin peptidase inhibitor | 3 | 0.9948 |
| 3216 | Preterm labor treatment | 87 | 0.9747 |
| 3217 | Prion diseases treatment | 31 | 0.8309 |
| 3218 | PRL phosphatase inhibitor | 28 | 0.9609 |
| 3219 | Procollagen C-endopeptidase inhibitor | 17 | 0.9658 |
| 3220 | Procollagen galactosyltransferase inhibitor | 13 | 0.9974 |
| 3221 | Procollagen glucosyltransferase inhibitor | 13 | 0.9942 |
| 3222 | Procollagen N-endopeptidase inhibitor | 7 | 0.9729 |
| 3223 | Procollagen-lysine 5-dioxygenase inhibitor | 21 | 0.9629 |
| 3224 | Procollagen-proline 3-dioxygenase inhibitor | 14 | 0.9999 |
| 3225 | Progesterone agonist | 173 | 0.9925 |
| 3226 | Progesterone antagonist | 1088 | 0.9961 |
| 3227 | Progesterone receptor A antagonist | 98 | 0.9997 |
| 3228 | Progesterone receptor B antagonist | 66 | 0.9990 |
| 3229 | Progesterone receptor B1 antagonist | 24 | 0.9999 |
| 3230 | Prokinetic | 512 | 0.9798 |
| 3231 | Prokineticin receptor 1 antagonist | 3 | 1.0000 |
| 3232 | Prolactin inhibitor | 43 | 0.9680 |
| 3233 | Prolactin release inhibitor | 63 | 0.9878 |
| 3234 | Proliferative diseases treatment | 207 | 0.9141 |
| 3235 | Proline dehydrogenase inhibitor | 4 | 0.9981 |
| 3236 | Proline racemase inhibitor | 17 | 0.9942 |
| 3237 | Proline transporter inhibitor | 23 | 1.0000 |
| 3238 | Prolyl aminopeptidase inhibitor | 13 | 0.9376 |
| 3239 | Prolyl endopeptidase inhibitor | 354 | 0.9865 |
| 3240 | Pro-opiomelanocortin converting enzyme inhibitor | 5 | 0.9402 |
| 3241 | Propanediol dehydratase inhibitor | 17 | 0.9940 |
| 3242 | Propionate CoA-transferase inhibitor | 4 | 0.9992 |
| 3243 | Propionate-CoA ligase inhibitor | 7 | 0.9940 |
| 3244 | Prostacyclin agonist | 62 | 0.9844 |
| 3245 | Prostacyclin antagonist | 138 | 0.9948 |
| 3246 | Prostaglandin A1 agonist | 3 | 1.0000 |
| 3247 | Prostaglandin agonist | 324 | 0.9900 |
| 3248 | Prostaglandin antagonist | 1739 | 0.9870 |
| 3249 | Prostaglandin D2 agonist | 9 | 0.9769 |
| 3250 | Prostaglandin D2 antagonist | 564 | 0.9978 |
| 3251 | Prostaglandin E1 agonist | 20 | 0.9995 |
| 3252 | Prostaglandin E1 antagonist | 4 | 0.9555 |
| 3253 | Prostaglandin E2 agonist | 120 | 0.9963 |
| 3254 | Prostaglandin E2 antagonist | 717 | 0.9869 |
| 3255 | Prostaglandin EP1 antagonist | 127 | 0.9978 |
| 3256 | Prostaglandin EP12 antagonist | 50 | 0.9996 |
| 3257 | Prostaglandin EP2 agonist | 38 | 0.9996 |
| 3258 | Prostaglandin EP2 antagonist | 173 | 0.9984 |
| 3259 | Prostaglandin EP3 antagonist | 471 | 0.9976 |
| 3260 | Prostaglandin EP4 agonist | 70 | 1.0000 |
| 3261 | Prostaglandin EP4 antagonist | 290 | 0.9983 |
| 3262 | Prostaglandin F2 alpha agonist | 26 | 0.9997 |
| 3263 | Prostaglandin F2 alpha antagonist | 48 | 0.9811 |
| 3264 | Prostaglandin H2 antagonist | 379 | 0.9981 |
| 3265 | Prostaglandin-A1 DELTA-isomerase inhibitor | 4 | 0.9251 |
| 3266 | Prostaglandin-E synthase inhibitor | 158 | 0.9971 |
| 3267 | Prostaglandin-E2 9-reductase inhibitor | 15 | 0.8922 |
| 3268 | Prostaglandin-E2 synthase 1 inhibitor | 32 | 0.9957 |
| 3269 | Prostaglandin-I synthase inhibitor | 42 | 0.9886 |
| 3270 | Prostate cancer treatment | 2865 | 0.9315 |
| 3271 | Prostate disorders treatment | 394 | 0.8980 |
| 3272 | Prostatic (benign) hyperplasia treatment | 1874 | 0.9665 |
| 3273 | Protease (Human cytomegalovirus) inhibitor | 149 | 0.9994 |
| 3274 | Protease 3C (Human rhinovirus) inhibitor | 177 | 0.9933 |
| 3275 | Protease activated receptor 1 antagonist | 145 | 0.9902 |
| 3276 | Protease activated receptor antagonist | 161 | 0.9792 |
| 3277 | Protease inhibitor | 513 | 0.9506 |
| 3278 | Proteasome ATPase inhibitor | 3 | 0.9027 |
| 3279 | Proteasome endopeptidase complex inhibitor | 32 | 0.9662 |
| 3280 | Proteasome inhibitor | 133 | 0.9635 |
| 3281 | Protein 30S ribosomal subunit inhibitor | 63 | 0.9738 |
| 3282 | Protein 50S ribosomal subunit inhibitor | 108 | 0.9878 |
| 3283 | Protein C (activated) inhibitor | 14 | 0.9913 |
| 3284 | Protein glycation inhibitor | 4 | 1.0000 |
| 3285 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 567 | 0.9893 |
| 3286 | Protein kinase (CK1) delta inhibitor | 45 | 0.9643 |
| 3287 | Protein kinase (CK1) epsilon inhibitor | 21 | 0.9533 |
| 3288 | Protein kinase (CK1) inhibitor | 60 | 0.9366 |
| 3289 | Protein kinase (CK2) inhibitor | 97 | 0.9616 |
| 3290 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 690 | 0.9837 |
| 3291 | Protein kinase (PKA, PKC, AKT, GRK, AGC-related, RSK, DBF2, SGK) inhibitor | 92 | 0.9667 |
| 3292 | Protein kinase A inhibitor | 438 | 0.9859 |
| 3293 | Protein kinase B alpha inhibitor | 42 | 0.9486 |
| 3294 | Protein kinase B beta inhibitor | 258 | 0.9846 |
| 3295 | Protein kinase B gamma inhibitor | 120 | 0.9685 |
| 3296 | Protein kinase B inhibitor | 721 | 0.9748 |
| 3297 | Protein kinase B stimulant | 27 | 0.9510 |
| 3298 | Protein kinase C alpha inhibitor | 602 | 0.9879 |
| 3299 | Protein kinase C beta I inhibitor | 68 | 0.9993 |
| 3300 | Protein kinase C beta II inhibitor | 85 | 0.9997 |
| 3301 | Protein kinase C beta inhibitor | 463 | 0.9824 |
| 3302 | Protein kinase C delta inhibitor | 560 | 0.9885 |
| 3303 | Protein kinase C epsilon inhibitor | 397 | 0.9841 |
| 3304 | Protein kinase C eta inhibitor | 346 | 0.9820 |
| 3305 | Protein kinase C gamma inhibitor | 372 | 0.9894 |
| 3306 | Protein kinase C inhibitor | 1355 | 0.9726 |
| 3307 | Protein kinase C mu inhibitor | 144 | 0.9856 |
| 3308 | Protein kinase C nu inhibitor | 135 | 0.9836 |
| 3309 | Protein kinase C stimulant | 61 | 0.9882 |
| 3310 | Protein kinase C theta inhibitor | 379 | 0.9875 |
| 3311 | Protein kinase C zeta inhibitor | 177 | 0.9935 |
| 3312 | Protein kinase inhibitor | 14972 | 0.9373 |
| 3313 | Protein kinase stimulant | 101 | 0.9450 |
| 3314 | Protein N-acetylglucosaminyltransferase inhibitor | 8 | 0.9952 |
| 3315 | Protein phosphatase 2A inhibitor | 50 | 0.9987 |
| 3316 | Protein phosphatase inhibitor | 1971 | 0.9642 |
| 3317 | Protein synthesis inhibitor | 356 | 0.9422 |
| 3318 | Protein synthesis stimulant | 9 | 0.9627 |
| 3319 | Protein-arginine deiminase inhibitor | 7 | 0.9277 |
| 3320 | Protein-arginine N-methyltransferase inhibitor | 6 | 1.0000 |
| 3321 | Protein-disulfide reductase (glutathione) inhibitor | 11 | 0.8021 |
| 3322 | Protein-glucosylgalactosylhydroxylysine glucosidase inhibitor | 3 | 0.9918 |
| 3323 | Protein-glutamate methylesterase inhibitor | 13 | 0.9618 |
| 3324 | Protein-glutamate O-methyltransferase inhibitor | 4 | 0.9888 |
| 3325 | Protein-L-isoaspartate (D-aspartate) O-methyltransferase inhibitor | 3 | 0.9998 |
| 3326 | Protein-Npi-phosphohistidine-sugar phosphotransferase inhibitor | 12 | 0.9600 |
| 3327 | Protein-serine-threonine kinase inhibitor | 2400 | 0.9610 |
| 3328 | Protein-S-isoprenylcysteine O-methyltransferase inhibitor | 26 | 0.9706 |
| 3329 | Protein-synthesizing GTPase inhibitor | 15 | 0.9005 |
| 3330 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 607 | 0.9695 |
| 3331 | Protein-tyrosine kinase Lyn inhibitor | 204 | 0.9598 |
| 3332 | Protein-tyrosine kinase p55(blk) inhibitor | 33 | 0.9245 |
| 3333 | Protein-tyrosine phosphatase 1B inhibitor | 1185 | 0.9823 |
| 3334 | Protein-tyrosine phosphatase 2C inhibitor | 59 | 0.9701 |
| 3335 | Protein-tyrosine phosphatase beta inhibitor | 11 | 0.9983 |
| 3336 | Protein-tyrosine phosphatase C inhibitor | 4 | 1.0000 |
| 3337 | Protein-tyrosine phosphatase epsilon inhibitor | 5 | 1.0000 |
| 3338 | Protein-tyrosine phosphatase inhibitor | 1813 | 0.9687 |
| 3339 | Protein-tyrosine phosphatase mu inhibitor | 4 | 0.9998 |
| 3340 | Protein-tyrosine phosphatase yopH inhibitor | 9 | 0.9908 |
| 3341 | Protein-tyrosine sulfotransferase inhibitor | 10 | 0.9789 |
| 3342 | Protocatechuate 3,4-dioxygenase inhibitor | 28 | 0.9933 |
| 3343 | Protocatechuate 4,5-dioxygenase inhibitor | 11 | 0.9995 |
| 3344 | Protocollagen prolyl hydroxylase inhibitor | 105 | 0.9837 |
| 3345 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 257 | 0.9945 |
| 3346 | Proto-oncogene tyrosine-protein kinase Fgr inhibitor | 14 | 0.9047 |
| 3347 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 84 | 0.9384 |
| 3348 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 386 | 0.9782 |
| 3349 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 42 | 0.9291 |
| 3350 | Prunasin beta-glucosidase inhibitor | 6 | 0.9729 |
| 3351 | Pseudolysin inhibitor | 4 | 0.8089 |
| 3352 | Pseudoporphyria | 7 | 0.8393 |
| 3353 | Pseudouridylate synthase inhibitor | 4 | 0.9763 |
| 3354 | Psychomotor impairment | 34 | 0.8232 |
| 3355 | Psychoses | 62 | 0.8137 |
| 3356 | Psychosexual dysfunction treatment | 61 | 0.9444 |
| 3357 | Pteridine reductase inhibitor | 9 | 0.9787 |
| 3358 | Pterin deaminase inhibitor | 4 | 0.9314 |
| 3359 | Pullulanase inhibitor | 7 | 0.9503 |
| 3360 | Pulmonary edema | 94 | 0.8605 |
| 3361 | Pulmonary hypertension treatment | 133 | 0.8936 |
| 3362 | Pure red cell aplasia | 9 | 0.8919 |
| 3363 | Purine antagonist | 21 | 0.9987 |
| 3364 | Purine biosynthesis inhibitor | 14 | 0.9935 |
| 3365 | Purine nucleosidase inhibitor | 26 | 0.9967 |
| 3366 | Purine nucleoside phosphorylase inhibitor | 232 | 0.9969 |
| 3367 | Purinergic P2 agonist | 17 | 0.9768 |
| 3368 | Purinergic P2 antagonist | 864 | 0.9803 |
| 3369 | Purinergic P2T antagonist | 74 | 0.9809 |
| 3370 | Purinergic P2X agonist | 6 | 0.9994 |
| 3371 | Purinergic P2X antagonist | 525 | 0.9867 |
| 3372 | Purinergic P2X1 antagonist | 15 | 0.9391 |
| 3373 | Purinergic P2X2 antagonist | 41 | 0.9891 |
| 3374 | Purinergic P2X3 antagonist | 53 | 0.9762 |
| 3375 | Purinergic P2X4 antagonist | 14 | 0.9980 |
| 3376 | Purinergic P2X7 antagonist | 452 | 0.9945 |
| 3377 | Purinergic P2Y agonist | 7 | 0.9516 |
| 3378 | Purinergic P2Y antagonist | 274 | 0.9820 |
| 3379 | Purinergic P2Y1 antagonist | 75 | 0.9731 |
| 3380 | Purinergic P2Y12 antagonist | 178 | 0.9855 |
| 3381 | Purinergic receptor agonist | 17 | 0.9768 |
| 3382 | Purinergic receptor antagonist | 906 | 0.9772 |
| 3383 | Puromycin-sensitive aminopeptidase inhibitor | 4 | 1.0000 |
| 3384 | Putrescine carbamoyltransferase inhibitor | 6 | 0.9988 |
| 3385 | Putrescine oxidase inhibitor | 14 | 0.9853 |
| 3386 | Pyridoxal 4-dehydrogenase inhibitor | 9 | 0.9998 |
| 3387 | Pyridoxal kinase inhibitor | 45 | 0.9637 |
| 3388 | Pyridoxamine-oxaloacetate transaminase inhibitor | 13 | 0.9984 |
| 3389 | Pyridoxamine-phosphate oxidase inhibitor | 9 | 0.9968 |
| 3390 | Pyridoxamine-pyruvate transaminase inhibitor | 4 | 0.9997 |
| 3391 | Pyridoxine 4-oxidase inhibitor | 3 | 0.9790 |
| 3392 | Pyridoxine 5-dehydrogenase inhibitor | 6 | 0.9921 |
| 3393 | Pyrimidine antagonist | 41 | 0.9827 |
| 3394 | Pyrimidine-deoxynucleoside 2'-dioxygenase inhibitor | 6 | 0.9911 |
| 3395 | Pyroglutamyl-peptidase I inhibitor | 40 | 0.9537 |
| 3396 | Pyroglutamyl-peptidase II inhibitor | 14 | 0.8603 |
| 3397 | Pyrroline-5-carboxylate reductase inhibitor | 17 | 0.9902 |
| 3398 | Pyruvate carboxylase inhibitor | 27 | 0.9358 |
| 3399 | Pyruvate decarboxylase inhibitor | 7 | 0.9325 |
| 3400 | Pyruvate dehydrogenase (cytochrome) inhibitor | 4 | 0.9885 |
| 3401 | Pyruvate dehydrogenase (lipoamide) inhibitor | 22 | 0.9776 |
| 3402 | Pyruvate dehydrogenase inhibitor | 25 | 0.9529 |
| 3403 | Pyruvate dehydrogenase kinase inhibitor | 192 | 0.9722 |
| 3404 | Pyruvate dehydrogenase stimulant | 48 | 0.9986 |
| 3405 | Pyruvate kinase inhibitor | 38 | 0.9725 |
| 3406 | Pyruvate synthase inhibitor | 5 | 0.9994 |
| 3407 | Pyruvate, phosphate dikinase inhibitor | 21 | 0.9922 |
| 3408 | Pyruvate, water dikinase inhibitor | 10 | 0.9946 |
| 3409 | QT interval prolongation | 117 | 0.8617 |
| 3410 | Quercetin 2,3-dioxygenase inhibitor | 11 | 0.9829 |
| 3411 | Queuine tRNA-ribosyltransferase inhibitor | 37 | 0.9961 |
| 3412 | Quinate 5-dehydrogenase inhibitor | 4 | 0.9994 |
| 3413 | Quinoline-4-carboxylate 2-oxidoreductase inhibitor | 4 | 0.9785 |
| 3414 | Quinoprotein glucose dehydrogenase inhibitor | 4 | 0.9726 |
| 3415 | Quisqualate antagonist | 4 | 0.9557 |
| 3416 | Radical formation agonist | 28 | 0.9597 |
| 3417 | Radioprotector | 246 | 0.8950 |
| 3418 | Radiosensitizer | 183 | 0.8517 |
| 3419 | Raf kinase B inhibitor | 280 | 0.9891 |
| 3420 | Raf kinase C inhibitor | 93 | 0.9770 |
| 3421 | Raf kinase inhibitor | 665 | 0.9839 |
| 3422 | RAS guanyl releasing protein antagonist | 4 | 1.0000 |
| 3423 | Raynaud's phenomenon treatment | 11 | 0.8713 |
| 3424 | Reductant | 62 | 0.9113 |
| 3425 | Reductase inhibitor | 4 | 0.9057 |
| 3426 | RELA expression inhibitor | 14 | 0.8559 |
| 3427 | Releasing hormone agonist | 23 | 0.9442 |
| 3428 | Renal disease treatment | 1001 | 0.9383 |
| 3429 | Renal failure treatment | 489 | 0.9468 |
| 3430 | Renal tissue kallikrein inhibitor | 14 | 0.9141 |
| 3431 | Renilla-luciferin 2-monooxygenase inhibitor | 12 | 0.9891 |
| 3432 | Renin inhibitor | 1609 | 0.9931 |
| 3433 | Replication protein E1 (HPV) antagonist | 3 | 1.0000 |
| 3434 | Reproductive dysfunction | 219 | 0.7925 |
| 3435 | Respiratory analeptic | 175 | 0.8796 |
| 3436 | Respiratory distress syndrome treatment | 321 | 0.9097 |
| 3437 | Respiratory failure | 323 | 0.8336 |
| 3438 | Respiratory impairment | 35 | 0.8073 |
| 3439 | Restenosis treatment | 784 | 0.9404 |
| 3440 | Restless leg syndrome treatment | 21 | 0.9452 |
| 3441 | RET inhibitor | 81 | 0.9335 |
| 3442 | Retinal dehydrogenase inhibitor | 7 | 0.9047 |
| 3443 | Retinoic acid alpha receptor agonist | 27 | 0.9973 |
| 3444 | Retinoic acid alpha receptor antagonist | 243 | 0.9988 |
| 3445 | Retinoic acid beta receptor agonist | 15 | 0.9925 |
| 3446 | Retinoic acid beta receptor antagonist | 249 | 0.9995 |
| 3447 | Retinoic acid metabolism inhibitor | 8 | 0.9139 |
| 3448 | Retinoic acid receptor agonist | 147 | 0.9944 |
| 3449 | Retinoic acid receptor antagonist | 383 | 0.9975 |
| 3450 | Retinoic acid receptor gamma antagonist | 278 | 0.9966 |
| 3451 | Retinoid X alpha receptor agonist | 23 | 0.9952 |
| 3452 | Retinoid X alpha receptor antagonist | 212 | 0.9998 |
| 3453 | Retinoid X beta receptor antagonist | 58 | 0.9996 |
| 3454 | Retinoid X gamma receptor antagonist | 63 | 0.9997 |
| 3455 | Retinoid X receptor agonist | 110 | 0.9980 |
| 3456 | Retinoid X receptor antagonist | 221 | 0.9998 |
| 3457 | Retinol dehydrogenase inhibitor | 6 | 0.9662 |
| 3458 | Retinol O-fatty-acyltransferase inhibitor | 7 | 0.9944 |
| 3459 | Retinopathy treatment | 22 | 0.9208 |
| 3460 | Retinoprotector | 21 | 0.8230 |
| 3461 | Retinyl-palmitate esterase inhibitor | 18 | 0.9816 |
| 3462 | Retroperitoneal fibrosis | 9 | 0.8101 |
| 3463 | Reverse transcriptase (Hepatitis B) inhibitor | 36 | 1.0000 |
| 3464 | Rhamnulose-1-phosphate aldolase inhibitor | 7 | 0.9757 |
| 3465 | Rheumatoid arthritis treatment | 1677 | 0.9074 |
| 3466 | Rhinitis treatment | 284 | 0.8633 |
| 3467 | Rhizopuspepsin inhibitor | 4 | 0.9403 |
| 3468 | Rho-associated kinase I inhibitor | 76 | 0.9780 |
| 3469 | Rho-associated kinase II inhibitor | 230 | 0.9897 |
| 3470 | Rho-associated kinase inhibitor | 341 | 0.9897 |
| 3471 | Rhodesain inhibitor | 78 | 0.9967 |
| 3472 | Rhodopsin kinase inhibitor | 34 | 0.9410 |
| 3473 | Rhodotorulapepsin inhibitor | 9 | 0.9677 |
| 3474 | Ribitol 2-dehydrogenase inhibitor | 6 | 0.9953 |
| 3475 | Riboflavin kinase inhibitor | 24 | 0.9974 |
| 3476 | Riboflavin phosphotransferase inhibitor | 4 | 0.9893 |
| 3477 | Riboflavin synthase inhibitor | 12 | 0.9988 |
| 3478 | Ribonuclease inhibitor | 48 | 0.9494 |
| 3479 | Ribonuclease L inhibitor | 9 | 1.0000 |
| 3480 | Ribonuclease T2 inhibitor | 26 | 0.9989 |
| 3481 | Ribonuclease U2 inhibitor | 5 | 0.9894 |
| 3482 | Ribonucleoside diphosphate reductase inhibitor | 93 | 0.9814 |
| 3483 | Ribonucleoside triphosphate reductase inhibitor | 17 | 0.8985 |
| 3484 | Ribonucleotide reductase inhibitor | 199 | 0.9860 |
| 3485 | Ribose-5-phosphate adenylyltransferase inhibitor | 7 | 0.9912 |
| 3486 | Ribose-5-phosphate isomerase inhibitor | 21 | 0.9919 |
| 3487 | Ribose-5-phosphate-ammonia ligase inhibitor | 7 | 0.9871 |
| 3488 | Ribose-phosphate diphosphokinase inhibitor | 38 | 0.9933 |
| 3489 | Ribosomal protein S6 kinase 1, 70-kDa inhibitor | 64 | 0.9633 |
| 3490 | Ribosomal protein S6 kinase inhibitor | 121 | 0.9707 |
| 3491 | Ribosomal protein S6 kinase, 70-kDa inhibitor | 98 | 0.9568 |
| 3492 | Ribosomal protein S6 kinase, 90kD, polypeptide 5 inhibitor | 4 | 1.0000 |
| 3493 | Ribosomal protein S6 kinase, 90-kDa inhibitor | 42 | 0.9624 |
| 3494 | Ribosylpyrimidine nucleosidase inhibitor | 9 | 0.9981 |
| 3495 | Ribulose-bisphosphate carboxylase inhibitor | 15 | 0.9869 |
| 3496 | Ribulose-phosphate 3-epimerase inhibitor | 3 | 0.8606 |
| 3497 | RNA agonist | 3 | 0.9993 |
| 3498 | RNA directed DNA polymerase inhibitor | 129 | 0.9089 |
| 3499 | RNA ligase (ATP) inhibitor | 15 | 0.9999 |
| 3500 | RNA synthesis inhibitor | 106 | 0.8979 |
| 3501 | RNA-directed RNA polymerase (Influenza A) inhibitor | 13 | 0.9998 |
| 3502 | RNA-directed RNA polymerase inhibitor | 26 | 0.8614 |
| 3503 | RNA-directed RNA polymerase stimulant | 7 | 0.9984 |
| 3504 | Rotamase (FKBP) inhibitor | 6 | 0.9968 |
| 3505 | Rotamase (FKBP12) inhibitor | 77 | 0.9932 |
| 3506 | rRNA (adenosine-2'-O-)-methyltransferase inhibitor | 12 | 0.9985 |
| 3507 | Rubefacient | 7 | 0.9703 |
| 3508 | Rubredoxin-NAD+ reductase inhibitor | 14 | 0.8197 |
| 3509 | Ryanodine receptor 1 antagonist | 7 | 0.9934 |
| 3510 | Ryanodine receptor antagonist | 7 | 0.9934 |
| 3511 | Saccharolysin inhibitor | 4 | 0.9865 |
| 3512 | Saccharopepsin inhibitor | 3 | 0.8770 |
| 3513 | Saccharopine dehydrogenase (NAD+, L-glutamate-forming) inhibitor | 4 | 0.9930 |
| 3514 | Saccharopine dehydrogenase (NAD+, L-lysine-forming) inhibitor | 19 | 0.9790 |
| 3515 | Saccharopine dehydrogenase (NADP+, L-glutamate-forming) inhibitor | 5 | 0.9905 |
| 3516 | Saccharopine dehydrogenase (NADP+, L-lysine-forming) inhibitor | 12 | 0.9948 |
| 3517 | S-adenosyl-L-homocysteine hydrolase inhibitor | 69 | 0.9997 |
| 3518 | S-adenosyl-L-methionine decarboxylase inhibitor | 58 | 0.9985 |
| 3519 | Salicylate 1-monooxygenase inhibitor | 6 | 0.9660 |
| 3520 | S-alkylcysteine lyase inhibitor | 3 | 0.9744 |
| 3521 | Saluretic | 95 | 0.9280 |
| 3522 | Saponin-like | 8 | 1.0000 |
| 3523 | Sarcopenia treatment | 25 | 0.9786 |
| 3524 | Sarcosine oxidase inhibitor | 14 | 0.9850 |
| 3525 | Sclerosant | 4 | 0.9424 |
| 3526 | Scyllo-inosamine-4-phosphate amidinotransferase inhibitor | 4 | 0.9939 |
| 3527 | Scytalone dehydratase inhibitor | 21 | 0.9915 |
| 3528 | Secretase alpha stimulant | 11 | 0.8479 |
| 3529 | Secretase beta 1 inhibitor | 754 | 0.9906 |
| 3530 | Secretase beta 2 inhibitor | 296 | 0.9965 |
| 3531 | Secretase beta inhibitor | 956 | 0.9898 |
| 3532 | Secretase gamma inhibitor | 415 | 0.9981 |
| 3533 | Secretase inhibitor | 1367 | 0.9875 |
| 3534 | Secretase stimulant | 11 | 0.8479 |
| 3535 | Secretory phospholipase A2 inhibitor | 151 | 0.9888 |
| 3536 | Sedative | 1223 | 0.9176 |
| 3537 | Sedoheptulose-bisphosphatase inhibitor | 7 | 0.9545 |
| 3538 | Selectin antagonist | 219 | 0.9854 |
| 3539 | Selectin E antagonist | 147 | 0.9817 |
| 3540 | Selectin L antagonist | 30 | 0.9993 |
| 3541 | Selectin P antagonist | 65 | 0.9984 |
| 3542 | Selenide, water dikinase inhibitor | 4 | 0.9998 |
| 3543 | Selenocysteine lyase inhibitor | 3 | 0.9895 |
| 3544 | Sensitization | 161 | 0.9250 |
| 3545 | Sensory disturbance | 800 | 0.8177 |
| 3546 | Sepiapterin deaminase inhibitor | 12 | 0.9969 |
| 3547 | Sepiapterin reductase inhibitor | 46 | 0.9573 |
| 3548 | Sepsis treatment | 154 | 0.9339 |
| 3549 | Septic shock treatment | 922 | 0.9211 |
| 3550 | Serine 3-dehydrogenase inhibitor | 6 | 0.9891 |
| 3551 | Serine carboxypeptidase inhibitor | 38 | 0.9800 |
| 3552 | Serine O-acetyltransferase inhibitor | 15 | 0.9593 |
| 3553 | Serine protease unspecified inhibitor | 22 | 0.9419 |
| 3554 | Serine-glyoxylate transaminase inhibitor | 12 | 0.9938 |
| 3555 | Serine-phosphoethanolamine synthase inhibitor | 10 | 0.9869 |
| 3556 | Serine-pyruvate transaminase inhibitor | 4 | 0.9833 |
| 3557 | Serine-sulfate ammonia-lyase inhibitor | 30 | 0.9955 |
| 3558 | Serine-tRNA ligase inhibitor | 6 | 0.9905 |
| 3559 | Serine-type D-Ala-D-Ala carboxypeptidase inhibitor | 36 | 0.9954 |
| 3560 | Serralysin inhibitor | 22 | 0.9629 |
| 3561 | Serratia marcescens nuclease inhibitor | 7 | 0.9708 |
| 3562 | Serum-glucocorticoid regulated kinase 1 inhibitor | 24 | 0.8755 |
| 3563 | Serum-glucocorticoid regulated kinase inhibitor | 52 | 0.9333 |
| 3564 | Severe acute respiratory syndrome treatment | 29 | 0.9270 |
| 3565 | S-formylglutathione hydrolase inhibitor | 8 | 0.8870 |
| 3566 | Shab potassium channel blocker | 4 | 0.8520 |
| 3567 | Shaker potassium channel blocker | 824 | 0.9843 |
| 3568 | Shal potassium channel blocker | 82 | 0.9785 |
| 3569 | Shikimate 5-dehydrogenase inhibitor | 6 | 0.9840 |
| 3570 | Shikimate kinase inhibitor | 22 | 0.9718 |
| 3571 | Shikimate O-hydroxycinnamoyltransferase inhibitor | 4 | 0.9751 |
| 3572 | Shivering | 6 | 0.8362 |
| 3573 | Shock treatment | 55 | 0.9752 |
| 3574 | Sialorrhea | 22 | 0.8348 |
| 3575 | Sickle-cell anemia treatment | 54 | 0.9236 |
| 3576 | Sigma 1 receptor agonist | 14 | 0.9656 |
| 3577 | Sigma 1 receptor antagonist | 1058 | 0.9949 |
| 3578 | Sigma 2 receptor antagonist | 585 | 0.9958 |
| 3579 | Sigma 3 receptor antagonist | 11 | 0.9999 |
| 3580 | Sigma receptor agonist | 23 | 0.9321 |
| 3581 | Sigma receptor antagonist | 2161 | 0.9874 |
| 3582 | Signal peptidase I inhibitor | 12 | 0.9697 |
| 3583 | Signal peptidase IB inhibitor | 3 | 1.0000 |
| 3584 | Signal transduction pathways inhibitor | 3899 | 0.9214 |
| 3585 | Simian immunodeficiency virus proteinase inhibitor | 4 | 0.8632 |
| 3586 | Sirtuin 2 inhibitor | 39 | 0.9968 |
| 3587 | Sirtuin inhibitor | 47 | 0.9962 |
| 3588 | Site-specific DNA-methyltransferase (adenine-specific) inhibitor | 4 | 0.9909 |
| 3589 | Skeletal muscle relaxant | 219 | 0.9180 |
| 3590 | Skin irritation, corrasive | 15 | 0.9072 |
| 3591 | Skin irritation, high | 405 | 0.9556 |
| 3592 | Skin irritation, inactive | 188 | 0.9358 |
| 3593 | Skin irritation, moderate | 269 | 0.9756 |
| 3594 | Skin irritation, weak | 468 | 0.9683 |
| 3595 | Skin irritative effect | 1117 | 0.9594 |
| 3596 | Skin whitener | 48 | 0.9748 |
| 3597 | Sleep apnea treatment | 79 | 0.9597 |
| 3598 | Sleep disorders treatment | 1271 | 0.9611 |
| 3599 | Sleep disturbance | 1188 | 0.8204 |
| 3600 | Small monomeric GTPase inhibitor | 3 | 0.9947 |
| 3601 | S-methyl-5-thioadenosine phosphorylase inhibitor | 47 | 0.9955 |
| 3602 | S-methyl-5-thioribose kinase inhibitor | 9 | 0.9913 |
| 3603 | SMN2 expression enhancer | 22 | 0.9208 |
| 3604 | Smo receptor agonist | 3 | 1.0000 |
| 3605 | Smo receptor antagonist | 122 | 0.9935 |
| 3606 | Smooth muscle myosin light chain kinase inhibitor | 46 | 0.9002 |
| 3607 | Snapalysin inhibitor | 4 | 0.9873 |
| 3608 | Sneezing | 56 | 0.8172 |
| 3609 | Sodium channel (voltage-gated) blocker | 537 | 0.9647 |
| 3610 | Sodium channel blocker | 1004 | 0.9381 |
| 3611 | Sodium channel blocker class Ib | 6 | 0.9721 |
| 3612 | Sodium/bile acid cotransporter inhibitor | 16 | 0.9703 |
| 3613 | Sodium/calcium exchanger 1 inhibitor | 25 | 0.9727 |
| 3614 | Sodium/calcium exchanger inhibitor | 109 | 0.9874 |
| 3615 | Sodium/glucose cotransporter 1 inhibitor | 180 | 0.9920 |
| 3616 | Sodium/glucose cotransporter 2 inhibitor | 425 | 0.9980 |
| 3617 | Sodium/glucose cotransporter inhibitor | 587 | 0.9940 |
| 3618 | Sodium/hydrogen exchanger 1 inhibitor | 296 | 0.9986 |
| 3619 | Sodium/hydrogen exchanger 2 inhibitor | 157 | 0.9995 |
| 3620 | Sodium/hydrogen exchanger 3 inhibitor | 220 | 0.9987 |
| 3621 | Sodium/hydrogen exchanger 5 inhibitor | 6 | 0.9956 |
| 3622 | Sodium/hydrogen exchanger inhibitor | 665 | 0.9982 |
| 3623 | Sodium-dependent vitamin C transporter 2 inhibitor | 3 | 1.0000 |
| 3624 | Somatostatin 1 antagonist | 219 | 0.9939 |
| 3625 | Somatostatin 2 agonist | 7 | 0.9875 |
| 3626 | Somatostatin 2 antagonist | 319 | 0.9936 |
| 3627 | Somatostatin 3 antagonist | 276 | 0.9943 |
| 3628 | Somatostatin 4 antagonist | 311 | 0.9941 |
| 3629 | Somatostatin 5 agonist | 15 | 0.9991 |
| 3630 | Somatostatin 5 antagonist | 279 | 0.9929 |
| 3631 | Somatostatin agonist | 34 | 0.9632 |
| 3632 | Somatostatin antagonist | 397 | 0.9922 |
| 3633 | Sorbitol-6-phosphate 2-dehydrogenase inhibitor | 3 | 0.9766 |
| 3634 | Sorbose dehydrogenase inhibitor | 3 | 0.9948 |
| 3635 | Spasmolytic | 1457 | 0.9068 |
| 3636 | Spasmolytic, Papaverin-like | 188 | 0.9330 |
| 3637 | Spasmolytic, urinary | 24 | 0.8539 |
| 3638 | Spermicide | 54 | 0.8635 |
| 3639 | Spermidine dehydrogenase inhibitor | 5 | 0.8197 |
| 3640 | Spermidine synthase inhibitor | 36 | 0.9952 |
| 3641 | Spermine antagonist | 3 | 0.9997 |
| 3642 | Spermine synthase inhibitor | 23 | 0.9953 |
| 3643 | Sphinganine kinase inhibitor | 6 | 0.8230 |
| 3644 | Sphinganine-1-phosphate aldolase inhibitor | 6 | 0.9794 |
| 3645 | Sphingomyelinase inhibitor | 15 | 0.9853 |
| 3646 | Sphingosine 1-phosphate receptor 1 agonist | 107 | 0.9996 |
| 3647 | Sphingosine 1-phosphate receptor 1 antagonist | 122 | 0.9299 |
| 3648 | Sphingosine 1-phosphate receptor 3 agonist | 12 | 1.0000 |
| 3649 | Sphingosine 1-phosphate receptor 3 antagonist | 157 | 0.9844 |
| 3650 | Sphingosine 1-phosphate receptor 4 agonist | 5 | 0.9999 |
| 3651 | Sphingosine 1-phosphate receptor 4 antagonist | 208 | 0.9473 |
| 3652 | Sphingosine 1-phosphate receptor 5 agonist | 5 | 0.8629 |
| 3653 | Sphingosine 1-phosphate receptor 5 antagonist | 91 | 0.9877 |
| 3654 | Sphingosine 1-phosphate receptor agonist | 108 | 0.9996 |
| 3655 | Sphingosine 1-phosphate receptor antagonist | 344 | 0.9481 |
| 3656 | Sphingosine kinase 1 inhibitor | 23 | 0.9988 |
| 3657 | Sphingosine kinase inhibitor | 32 | 0.9907 |
| 3658 | Sphingosine kinase stimulant | 3 | 1.0000 |
| 3659 | Splenomegaly | 27 | 0.8291 |
| 3660 | Sporulation kinase A inhibitor | 11 | 0.9942 |
| 3661 | Squalene epoxidase inhibitor | 71 | 0.9604 |
| 3662 | Squalene synthetase inhibitor | 504 | 0.9936 |
| 3663 | Squalene-hopene cyclase inhibitor | 35 | 0.9692 |
| 3664 | Src kinase inhibitor | 2629 | 0.9691 |
| 3665 | Stearoyl-CoA desaturase inhibitor | 299 | 0.9817 |
| 3666 | Stem cell growth factor agonist | 190 | 0.9716 |
| 3667 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 365 | 0.9949 |
| 3668 | Steroid 9alpha-monooxygenase inhibitor | 3 | 0.9979 |
| 3669 | Steroid DELTA-isomerase inhibitor | 28 | 0.9730 |
| 3670 | Steroid N-acetylglucosaminyltransferase inhibitor | 4 | 0.9570 |
| 3671 | Steroid sulfotransferase inhibitor | 11 | 0.9268 |
| 3672 | Steroid synthesis inhibitor | 10 | 0.8688 |
| 3673 | Steroid-like | 18 | 0.9974 |
| 3674 | Sterol 24-C-methyltransferase inhibitor | 27 | 0.9851 |
| 3675 | Sterol 3-beta-glucosyltransferase inhibitor | 12 | 0.9573 |
| 3676 | Stipitatonate decarboxylase inhibitor | 5 | 0.9983 |
| 3677 | Stomatitis | 255 | 0.7835 |
| 3678 | Streptogrisin A inhibitor | 3 | 0.9996 |
| 3679 | Streptomycin 6-kinase inhibitor | 6 | 0.9968 |
| 3680 | Streptopain inhibitor | 13 | 0.9869 |
| 3681 | Stroke treatment | 4811 | 0.9224 |
| 3682 | Strombine dehydrogenase inhibitor | 5 | 0.9996 |
| 3683 | Stromelysin 2 inhibitor | 11 | 0.9019 |
| 3684 | Styrene-oxide isomerase inhibitor | 3 | 0.9865 |
| 3685 | Substance P antagonist | 307 | 0.9803 |
| 3686 | Subtilisin inhibitor | 27 | 0.9605 |
| 3687 | Succinate dehydrogenase inhibitor | 14 | 0.9573 |
| 3688 | Succinate-CoA ligase (ADP-forming) inhibitor | 16 | 0.9825 |
| 3689 | Succinate-hydroxymethylglutarate CoA-transferase inhibitor | 8 | 0.9924 |
| 3690 | Succinate-semialdehyde dehydrogenase [NAD(P)+] inhibitor | 7 | 0.8456 |
| 3691 | Succinate-semialdehyde dehydrogenase inhibitor | 20 | 0.9926 |
| 3692 | Succinic dehydrogenase inhibitor | 8 | 0.9681 |
| 3693 | Sucrose alpha-glucosidase inhibitor | 19 | 0.9960 |
| 3694 | Sucrose phosphorylase inhibitor | 5 | 0.9996 |
| 3695 | Sucrose synthase inhibitor | 16 | 0.9923 |
| 3696 | Sucrose-phosphate phosphatase inhibitor | 7 | 0.9980 |
| 3697 | Sucrose-phosphate synthase inhibitor | 19 | 0.9730 |
| 3698 | Sugar-phosphatase inhibitor | 3 | 0.9015 |
| 3699 | Sulfate adenylyltransferase (ADP) inhibitor | 8 | 0.9858 |
| 3700 | Sulfate adenylyltransferase inhibitor | 14 | 0.9831 |
| 3701 | Sulfinoalanine decarboxylase inhibitor | 18 | 0.9935 |
| 3702 | Sulfite dehydrogenase inhibitor | 9 | 0.8467 |
| 3703 | Sulfite oxidase inhibitor | 9 | 0.9377 |
| 3704 | Sulfite reductase inhibitor | 6 | 0.9703 |
| 3705 | Sulfonylureas | 3 | 0.9993 |
| 3706 | Sulfotransferase substrate | 183 | 0.9624 |
| 3707 | Sulfur dioxygenase inhibitor | 6 | 0.9869 |
| 3708 | Sulfur reductase inhibitor | 8 | 0.8660 |
| 3709 | SULT1A1 substrate | 42 | 0.9783 |
| 3710 | SULT1A2 substrate | 24 | 0.9936 |
| 3711 | SULT1A3 substrate | 17 | 0.9777 |
| 3712 | SULT1E1 substrate | 4 | 0.9859 |
| 3713 | SULT2A1 substrate | 9 | 0.9415 |
| 3714 | Superoxide dismutase inhibitor | 15 | 0.8843 |
| 3715 | Sweating | 107 | 0.8098 |
| 3716 | Sweetener | 24 | 0.9559 |
| 3717 | Syk tyrosine kinase inhibitor | 268 | 0.9754 |
| 3718 | Synaptic vesicle protein SV2, levetiracetam binding site antagonist | 32 | 1.0000 |
| 3719 | Systemic lupus erythematosus treatment | 124 | 0.8686 |
| 3720 | T cell inhibitor | 247 | 0.9533 |
| 3721 | T cell receptor antagonist | 17 | 1.0000 |
| 3722 | T cell receptor gamma-delta antagonist | 17 | 1.0000 |
| 3723 | T2-induced deoxynucleotide kinase inhibitor | 3 | 0.9999 |
| 3724 | Tachycardiac | 437 | 0.8110 |
| 3725 | Tagaturonate reductase inhibitor | 3 | 0.9946 |
| 3726 | Tankyrase 2 inhibitor | 5 | 1.0000 |
| 3727 | Tankyrase inhibitor | 10 | 0.8892 |
| 3728 | Tannase inhibitor | 14 | 0.9957 |
| 3729 | Tardive dyskinesia treatment | 40 | 0.9347 |
| 3730 | Tartrate decarboxylase inhibitor | 5 | 0.9998 |
| 3731 | Tartrate dehydrogenase inhibitor | 5 | 1.0000 |
| 3732 | Taurine dehydrogenase inhibitor | 7 | 0.8612 |
| 3733 | Taurine-2-oxoglutarate transaminase inhibitor | 3 | 0.9758 |
| 3734 | Taurocyamine kinase inhibitor | 3 | 0.9794 |
| 3735 | Tauropine dehydrogenase inhibitor | 8 | 0.9594 |
| 3736 | T-cell protein-tyrosine phosphatase inhibitor | 243 | 0.9915 |
| 3737 | TEC kinase inhibitor | 25 | 0.9745 |
| 3738 | Telangiectasia | 18 | 0.8955 |
| 3739 | Telomerase inhibitor | 206 | 0.9613 |
| 3740 | Telomerase stimulant | 6 | 1.0000 |
| 3741 | Tentoxilysin inhibitor | 4 | 0.9454 |
| 3742 | Teratogen | 1552 | 0.9052 |
| 3743 | Testosterone 17beta-dehydrogenase (NADP+) inhibitor | 3 | 0.8648 |
| 3744 | Testosterone 17beta-dehydrogenase inhibitor | 11 | 0.9698 |
| 3745 | Testosterone agonist | 5 | 0.9964 |
| 3746 | Tetanus neurotoxin inhibitor | 3 | 1.0000 |
| 3747 | Tetracycline antiport transporter antagonist | 36 | 1.0000 |
| 3748 | Tetrahydroxynaphthalene reductase inhibitor | 7 | 0.9819 |
| 3749 | TGF beta receptor type I kinase inhibitor | 197 | 0.9965 |
| 3750 | TGF beta receptor type II kinase inhibitor | 14 | 1.0000 |
| 3751 | TH expression enhancer | 11 | 0.8851 |
| 3752 | Theanine hydrolase inhibitor | 13 | 0.9991 |
| 3753 | Thermitase inhibitor | 12 | 0.9022 |
| 3754 | Thermolysin inhibitor | 23 | 0.9966 |
| 3755 | Thermomycolin inhibitor | 3 | 0.9956 |
| 3756 | Thiamine pyridinylase inhibitor | 5 | 0.8594 |
| 3757 | Thiamine-phosphate diphosphorylase inhibitor | 7 | 0.9880 |
| 3758 | Thiamine-phosphate kinase inhibitor | 5 | 0.9862 |
| 3759 | Thiamine-triphosphatase inhibitor | 9 | 0.8771 |
| 3760 | Thiazolidinedione | 18 | 0.9995 |
| 3761 | Thimet oligopeptidase inhibitor | 20 | 0.9374 |
| 3762 | Thioether S-methyltransferase inhibitor | 3 | 0.9947 |
| 3763 | Thiol oxidase inhibitor | 13 | 0.9485 |
| 3764 | Thiol protease inhibitor | 232 | 0.9279 |
| 3765 | Thiol S-methyltransferase inhibitor | 8 | 0.9809 |
| 3766 | Thiol sulfotransferase inhibitor | 4 | 0.9999 |
| 3767 | Thiopurine S-methyltransferase inhibitor | 17 | 0.9438 |
| 3768 | Thioredoxin inhibitor | 3 | 0.9190 |
| 3769 | Thioredoxin reductase inhibitor | 53 | 0.9299 |
| 3770 | Thiosulfate dehydrogenase inhibitor | 10 | 0.8789 |
| 3771 | Thiosulfate sulfurtransferase inhibitor | 21 | 0.9878 |
| 3772 | Threonine aldolase inhibitor | 5 | 0.9759 |
| 3773 | Threonine ammonia-lyase inhibitor | 27 | 0.9848 |
| 3774 | Threonine synthase inhibitor | 11 | 0.9984 |
| 3775 | Threonine-tRNA ligase inhibitor | 5 | 0.9319 |
| 3776 | Thrombin inhibitor | 2482 | 0.9799 |
| 3777 | Thrombocytopenia | 494 | 0.8163 |
| 3778 | Thrombocytopoiesis inhibitor | 11 | 0.8399 |
| 3779 | Thrombolytic | 143 | 0.9304 |
| 3780 | Thrombophlebitis | 146 | 0.8016 |
| 3781 | Thrombopoietin agonist | 113 | 0.9997 |
| 3782 | Thromboxane A2 antagonist | 280 | 0.9826 |
| 3783 | Thromboxane agonist | 3 | 0.9995 |
| 3784 | Thromboxane antagonist | 491 | 0.9752 |
| 3785 | Thromboxane B2 antagonist | 18 | 0.8416 |
| 3786 | Thromboxane synthase inhibitor | 900 | 0.9864 |
| 3787 | Thromboxane synthase stimulant | 3 | 0.9890 |
| 3788 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 38 | 0.9999 |
| 3789 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 15 | 1.0000 |
| 3790 | Thymidine kinase 1 inhibitor | 28 | 0.9802 |
| 3791 | Thymidine kinase 2 inhibitor | 25 | 0.9999 |
| 3792 | Thymidine kinase inhibitor | 192 | 0.9827 |
| 3793 | Thymidine phosphorylase inhibitor | 65 | 0.9939 |
| 3794 | Thymidine-triphosphatase inhibitor | 6 | 0.9989 |
| 3795 | Thymidylate 5'-phosphatase inhibitor | 5 | 0.8077 |
| 3796 | Thymidylate synthase inhibitor | 839 | 0.9932 |
| 3797 | Thymine dioxygenase inhibitor | 14 | 0.9998 |
| 3798 | Thyroid hormone agonist | 104 | 0.9862 |
| 3799 | Thyroid hormone alpha 1 agonist | 5 | 1.0000 |
| 3800 | Thyroid hormone alpha 1 antagonist | 12 | 1.0000 |
| 3801 | Thyroid hormone alpha agonist | 5 | 1.0000 |
| 3802 | Thyroid hormone alpha antagonist | 93 | 0.9998 |
| 3803 | Thyroid hormone antagonist | 261 | 0.9930 |
| 3804 | Thyroid hormone beta 1 agonist | 5 | 1.0000 |
| 3805 | Thyroid hormone beta 1 antagonist | 156 | 0.9996 |
| 3806 | Thyroid hormone beta agonist | 74 | 0.9997 |
| 3807 | Thyroid hormone beta antagonist | 178 | 0.9996 |
| 3808 | Thyrotropin releasing hormone agonist | 15 | 0.9999 |
| 3809 | Thyrotropin releasing hormone antagonist | 6 | 1.0000 |
| 3810 | Thyroxine 5-deiodinase inhibitor | 7 | 0.9462 |
| 3811 | TIE antagonist | 749 | 0.9842 |
| 3812 | TIE-2 agonist | 6 | 1.0000 |
| 3813 | TIE-2 antagonist | 734 | 0.9842 |
| 3814 | TNF convertase inhibitor | 1028 | 0.9981 |
| 3815 | TNF expression inhibitor | 55 | 0.8758 |
| 3816 | Tocolytic | 141 | 0.9779 |
| 3817 | Toll-Like receptor 2 antagonist | 10 | 0.9998 |
| 3818 | Toll-Like receptor 7 agonist | 86 | 0.9979 |
| 3819 | Toll-Like receptor 8 agonist | 9 | 1.0000 |
| 3820 | Toll-Like receptor agonist | 88 | 0.9931 |
| 3821 | Toll-Like receptor antagonist | 16 | 0.8733 |
| 3822 | Topoisomerase I inhibitor | 478 | 0.9625 |
| 3823 | Topoisomerase II inhibitor | 726 | 0.9650 |
| 3824 | Torsades de pointes | 90 | 0.8224 |
| 3825 | Torticollis | 28 | 0.8350 |
| 3826 | Toxic | 5112 | 0.8644 |
| 3827 | Toxic, gastrointestinal | 1362 | 0.8187 |
| 3828 | Toxic, respiration | 80 | 0.8211 |
| 3829 | Toxic, respiratory center | 15 | 0.9270 |
| 3830 | Toxic, vascular | 194 | 0.8349 |
| 3831 | TP53 expression enhancer | 99 | 0.8227 |
| 3832 | Tpr proteinase (Porphyromonas gingivalis) inhibitor | 4 | 0.8533 |
| 3833 | Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase inhibitor | 42 | 0.9582 |
| 3834 | Trans-2-enoyl-CoA reductase (NAD+) inhibitor | 4 | 0.9885 |
| 3835 | Trans-acenaphthene-1,2-diol dehydrogenase inhibitor | 5 | 0.8085 |
| 3836 | Transactivator transcription protein inhibitor | 25 | 0.8505 |
| 3837 | Transaldolase inhibitor | 5 | 0.9998 |
| 3838 | Transcortin receptor antagonist | 29 | 0.9997 |
| 3839 | Transcription factor AP-1 inhibitor | 249 | 0.9711 |
| 3840 | Transcription factor inhibitor | 1287 | 0.9166 |
| 3841 | Transcription factor NF kappa A inhibitor | 7 | 0.8406 |
| 3842 | Transcription factor NF kappa B inhibitor | 534 | 0.9560 |
| 3843 | Transcription factor NF kappa B stimulant | 7 | 0.8530 |
| 3844 | Transcription factor rho inhibitor | 7 | 1.0000 |
| 3845 | Transcription factor STAT inhibitor | 269 | 0.8997 |
| 3846 | Transcription factor STAT3 inhibitor | 234 | 0.9104 |
| 3847 | Transcription factor STAT6 inhibitor | 20 | 0.9849 |
| 3848 | Transcription factor stimulant | 7 | 0.8530 |
| 3849 | Transforming growth factor antagonist | 241 | 0.9858 |
| 3850 | Transforming growth factor beta 1 agonist | 3 | 0.8895 |
| 3851 | Transforming growth factor beta 1 antagonist | 186 | 0.9920 |
| 3852 | Transforming growth factor beta 3 antagonist | 20 | 0.9999 |
| 3853 | Transforming growth factor beta antagonist | 227 | 0.9895 |
| 3854 | Transglutaminase 2 inhibitor | 27 | 0.9730 |
| 3855 | Transketolase inhibitor | 7 | 0.9168 |
| 3856 | Translation initiation factor IF-2 antagonist | 5 | 0.9998 |
| 3857 | Trans-octaprenyltranstransferase inhibitor | 12 | 0.9917 |
| 3858 | Trans-pentaprenyltranstransferase inhibitor | 5 | 0.9878 |
| 3859 | Transplant rejection treatment | 694 | 0.9135 |
| 3860 | Transthyretin amyloid fibril formation inhibitor | 29 | 0.9842 |
| 3861 | Trehalose-phosphatase inhibitor | 3 | 0.9956 |
| 3862 | Tremor | 537 | 0.8349 |
| 3863 | Triacetate-lactonase inhibitor | 3 | 0.9894 |
| 3864 | Trimerelysin II inhibitor | 7 | 0.9921 |
| 3865 | Trimethylamine dehydrogenase inhibitor | 9 | 0.9323 |
| 3866 | Trimethylamine-N-oxide reductase inhibitor | 11 | 0.9902 |
| 3867 | Trimethylamine-oxide aldolase inhibitor | 5 | 0.8099 |
| 3868 | Trimethyllysine dioxygenase inhibitor | 7 | 0.9819 |
| 3869 | Triose-phosphate isomerase inhibitor | 23 | 0.9855 |
| 3870 | Tripeptide aminopeptidase inhibitor | 23 | 0.9404 |
| 3871 | Tripeptidyl peptidase II inhibitor | 36 | 0.9993 |
| 3872 | Tripeptidyl-peptidase I inhibitor | 22 | 0.9634 |
| 3873 | TRKA antagonist | 146 | 0.9826 |
| 3874 | TRKB antagonist | 21 | 0.9548 |
| 3875 | tRNA (adenine-N1-)-methyltransferase inhibitor | 6 | 0.9992 |
| 3876 | tRNA (cytosine-5-)-methyltransferase inhibitor | 5 | 0.9852 |
| 3877 | tRNA (guanine-N1-)-methyltransferase inhibitor | 4 | 0.9935 |
| 3878 | tRNA (guanine-N2-)-methyltransferase inhibitor | 5 | 0.9937 |
| 3879 | tRNA (guanine-N7-)-methyltransferase inhibitor | 6 | 0.9909 |
| 3880 | tRNA (uracil-5-)-methyltransferase inhibitor | 10 | 0.9994 |
| 3881 | tRNA adenylyltransferase inhibitor | 9 | 0.9863 |
| 3882 | tRNA cytidylyltransferase inhibitor | 15 | 0.9894 |
| 3883 | tRNA methyltransferase inhibitor | 22 | 0.9950 |
| 3884 | tRNA nucleotidyltransferase inhibitor | 3 | 0.9918 |
| 3885 | tRNA-pseudouridine synthase I inhibitor | 3 | 0.9684 |
| 3886 | Tropinesterase inhibitor | 3 | 0.8568 |
| 3887 | TRPA1 agonist | 10 | 0.9334 |
| 3888 | TRPA1 antagonist | 17 | 0.9778 |
| 3889 | Trypanothione-disulfide reductase inhibitor | 62 | 0.9610 |
| 3890 | Trypsin inhibitor | 1401 | 0.9889 |
| 3891 | Tryptase 1 inhibitor | 144 | 0.9995 |
| 3892 | Tryptase inhibitor | 198 | 0.9860 |
| 3893 | Tryptophan 2,3-dioxygenase inhibitor | 24 | 0.8809 |
| 3894 | Tryptophan 2-monooxygenase inhibitor | 20 | 0.9620 |
| 3895 | Tryptophan 5 hydroxylase inhibitor | 25 | 0.9483 |
| 3896 | Tryptophan alpha,beta-oxidase inhibitor | 4 | 0.9583 |
| 3897 | Tryptophan dimethylallyltransferase inhibitor | 8 | 0.9733 |
| 3898 | Tryptophan hydroxylase 1 inhibitor | 16 | 0.9999 |
| 3899 | Tryptophan synthase inhibitor | 14 | 0.9953 |
| 3900 | Tryptophan transaminase inhibitor | 4 | 0.9877 |
| 3901 | Tryptophanamidase inhibitor | 5 | 0.9851 |
| 3902 | Tryptophan-tRNA ligase inhibitor | 38 | 0.9898 |
| 3903 | Tryptophanyl aminopeptidase inhibitor | 3 | 0.9901 |
| 3904 | TTK protein kinase inhibitor | 6 | 0.9631 |
| 3905 | Tubulin agonist | 26 | 0.9999 |
| 3906 | Tubulin antagonist | 1164 | 0.9725 |
| 3907 | Tubulin GTPase inhibitor | 6 | 0.9967 |
| 3908 | Tubulin-tyrosine ligase inhibitor | 17 | 0.9871 |
| 3909 | Tubulinyl-Tyr carboxypeptidase inhibitor | 6 | 0.9983 |
| 3910 | Tumour necrosis factor alpha antagonist | 688 | 0.9470 |
| 3911 | Tumour necrosis factor alpha release inhibitor | 2422 | 0.9445 |
| 3912 | Tumour necrosis factor antagonist | 781 | 0.9372 |
| 3913 | Twitching | 7 | 0.8119 |
| 3914 | Tyrosine 2,3-aminomutase inhibitor | 6 | 0.9944 |
| 3915 | Tyrosine 3 hydroxylase inhibitor | 12 | 0.8836 |
| 3916 | Tyrosine 3 hydroxylase stimulant | 3 | 1.0000 |
| 3917 | Tyrosine kinase inhibitor | 6059 | 0.9491 |
| 3918 | Tyrosine kinase stimulant | 3 | 0.9559 |
| 3919 | Tyrosine phenol-lyase inhibitor | 20 | 0.9981 |
| 3920 | Tyrosine transaminase inhibitor | 34 | 0.9855 |
| 3921 | Tyrosine-ester sulfotransferase inhibitor | 24 | 0.9873 |
| 3922 | Tyrosine-protein kinase EMT inhibitor | 199 | 0.9894 |
| 3923 | Tyrosine-protein kinase receptor antagonist | 161 | 0.9831 |
| 3924 | Tyrosine-protein kinase receptor FLT3 inhibitor | 388 | 0.9821 |
| 3925 | Tyrosine-protein kinase TYRO 10 inhibitor | 8 | 0.9205 |
| 3926 | Ubiquinol-cytochrome-c reductase inhibitor | 10 | 0.8164 |
| 3927 | Ubiquitin thiolesterase inhibitor | 7 | 0.9596 |
| 3928 | Ubiquitin-protein ligase inhibitor | 27 | 0.9710 |
| 3929 | UDP-3-O-acyl-N-acetylglucosamine deacetylase inhibitor | 60 | 0.9990 |
| 3930 | UDP-glucose 4-epimerase inhibitor | 28 | 0.9721 |
| 3931 | UDP-glucose 6-dehydrogenase inhibitor | 8 | 0.9509 |
| 3932 | UDP-glucose-hexose-1-phosphate uridylyltransferase inhibitor | 18 | 0.9755 |
| 3933 | UDP-glucuronate 4-epimerase inhibitor | 13 | 0.9998 |
| 3934 | UDP-glucuronate 5'-epimerase inhibitor | 3 | 0.9997 |
| 3935 | UDP-glucuronate decarboxylase inhibitor | 12 | 0.9954 |
| 3936 | UDP-glucuronosyltransferase substrate | 817 | 0.9303 |
| 3937 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 20 | 0.9900 |
| 3938 | UDP-N-acetylglucosamine 2-epimerase inhibitor | 7 | 0.9915 |
| 3939 | UDP-N-acetylglucosamine 4-epimerase inhibitor | 3 | 0.9015 |
| 3940 | UDP-N-acetylglucosamine diphosphorylase inhibitor | 8 | 0.9931 |
| 3941 | UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase inhibitor | 11 | 0.9808 |
| 3942 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase inhibitor | 9 | 0.9966 |
| 3943 | UDP-N-acetylmuramate dehydrogenase inhibitor | 20 | 0.9880 |
| 3944 | UDP-N-acetylmuramate-L-alanine ligase inhibitor | 18 | 0.9760 |
| 3945 | UDP-N-acetylmuramoylalanine-D-glutamate ligase inhibitor | 18 | 0.9877 |
| 3946 | UDP-N-acetylmuramoylalanyl-D-glutamate-2,6-diaminopimelate ligase inhibitor | 8 | 0.9997 |
| 3947 | UDP-sugar diphosphatase inhibitor | 4 | 0.9956 |
| 3948 | UGT1A substrate | 313 | 0.9305 |
| 3949 | UGT1A1 substrate | 113 | 0.9443 |
| 3950 | UGT1A10 substrate | 99 | 0.9457 |
| 3951 | UGT1A3 substrate | 118 | 0.9426 |
| 3952 | UGT1A4 substrate | 128 | 0.9451 |
| 3953 | UGT1A5 substrate | 16 | 0.9413 |
| 3954 | UGT1A6 substrate | 85 | 0.9291 |
| 3955 | UGT1A7 substrate | 61 | 0.9443 |
| 3956 | UGT1A8 substrate | 99 | 0.9543 |
| 3957 | UGT1A9 substrate | 92 | 0.8929 |
| 3958 | UGT2B substrate | 259 | 0.9537 |
| 3959 | UGT2B1 substrate | 99 | 0.9609 |
| 3960 | UGT2B10 substrate | 20 | 0.9092 |
| 3961 | UGT2B11 substrate | 37 | 0.9553 |
| 3962 | UGT2B12 substrate | 4 | 0.8678 |
| 3963 | UGT2B15 substrate | 84 | 0.9549 |
| 3964 | UGT2B17 substrate | 15 | 0.9269 |
| 3965 | UGT2B18 substrate | 6 | 0.9698 |
| 3966 | UGT2B19 substrate | 5 | 0.9921 |
| 3967 | UGT2B20 substrate | 19 | 0.9958 |
| 3968 | UGT2B23 substrate | 5 | 0.9921 |
| 3969 | UGT2B28 substrate | 8 | 0.9620 |
| 3970 | UGT2B30 substrate | 5 | 0.9921 |
| 3971 | UGT2B4 substrate | 35 | 0.9100 |
| 3972 | UGT2B4D substrate | 5 | 0.9921 |
| 3973 | UGT2B4E substrate | 5 | 0.9921 |
| 3974 | UGT2B7 substrate | 138 | 0.9520 |
| 3975 | UGT2B7H substrate | 28 | 0.9793 |
| 3976 | UGT2B7Y substrate | 28 | 0.9793 |
| 3977 | UGT2B9 substrate | 39 | 0.9508 |
| 3978 | Ulcer, aphthous | 9 | 0.8311 |
| 3979 | Ulcer, gastric | 27 | 0.9072 |
| 3980 | Ulcer, peptic | 34 | 0.8848 |
| 3981 | Ulceration | 53 | 0.9074 |
| 3982 | Ulcerative colitis treatment | 3 | 0.9999 |
| 3983 | Undecaprenyl-diphosphatase inhibitor | 5 | 0.9828 |
| 3984 | Undecaprenyldiphospho-muramoylpentapeptide beta-N-acetylglucosaminyltransferase inhibitor | 3 | 0.9560 |
| 3985 | Undecaprenyl-phosphate galactose phosphotransferase inhibitor | 6 | 0.9997 |
| 3986 | Undecaprenyl-phosphate mannosyltransferase inhibitor | 3 | 0.9480 |
| 3987 | Uracil phosphoribosyltransferase inhibitor | 14 | 0.9955 |
| 3988 | Urate transporter 1 inhibitor | 29 | 0.9790 |
| 3989 | Urate-ribonucleotide phosphorylase inhibitor | 12 | 0.9232 |
| 3990 | Urease inhibitor | 18 | 0.9250 |
| 3991 | Urethanase inhibitor | 10 | 0.8744 |
| 3992 | Uric acid excretion stimulant | 122 | 0.9431 |
| 3993 | Uridine kinase inhibitor | 7 | 0.9931 |
| 3994 | Uridine nucleosidase inhibitor | 15 | 0.9913 |
| 3995 | Uridine phosphorylase inhibitor | 106 | 0.9979 |
| 3996 | Urinary incontinence treatment | 1959 | 0.9539 |
| 3997 | Urinary retention | 181 | 0.8040 |
| 3998 | Urine discoloration | 9 | 0.9539 |
| 3999 | Urocanate hydratase inhibitor | 16 | 0.9940 |
| 4000 | Urokinase inhibitor | 304 | 0.9906 |
| 4001 | Urolithiasis treatment | 6 | 0.9001 |
| 4002 | Urologic disorders treatment | 2025 | 0.9433 |
| 4003 | Uroporphyrinogen decarboxylase inhibitor | 30 | 0.9908 |
| 4004 | Uroporphyrinogen-III synthase inhibitor | 9 | 0.9397 |
| 4005 | Urotensin II agonist | 26 | 0.9999 |
| 4006 | Urotensin II antagonist | 45 | 0.9967 |
| 4007 | Urticaria treatment | 8 | 0.9538 |
| 4008 | Uterine relaxant | 43 | 0.8611 |
| 4009 | Uterine rupture | 3 | 0.9998 |
| 4010 | Uterine stimulant | 33 | 0.9474 |
| 4011 | UTP-glucose-1-phosphate uridylyltransferase inhibitor | 10 | 0.9998 |
| 4012 | Valine decarboxylase inhibitor | 4 | 0.9903 |
| 4013 | Valine dehydrogenase (NADP+) inhibitor | 6 | 0.9949 |
| 4014 | Valine-pyruvate transaminase inhibitor | 3 | 0.9999 |
| 4015 | Valine-tRNA ligase inhibitor | 10 | 0.9784 |
| 4016 | Vanilloid 1 agonist | 14 | 0.8629 |
| 4017 | Vanilloid 1 antagonist | 248 | 0.9932 |
| 4018 | Vanilloid 3 antagonist | 6 | 1.0000 |
| 4019 | Vanilloid 4 agonist | 6 | 1.0000 |
| 4020 | Vanilloid 4 antagonist | 73 | 0.9793 |
| 4021 | Vanilloid agonist | 20 | 0.9211 |
| 4022 | Vanilloid antagonist | 1066 | 0.9925 |
| 4023 | Vanillyl-alcohol oxidase inhibitor | 7 | 0.9951 |
| 4024 | Vascular (periferal) disease treatment | 799 | 0.9113 |
| 4025 | Vascular adhesion protein 1 inhibitor | 11 | 0.9012 |
| 4026 | Vascular dementia treatment | 10 | 0.8839 |
| 4027 | Vascular endothelial growth factor 1 antagonist | 593 | 0.9734 |
| 4028 | Vascular endothelial growth factor 2 antagonist | 3219 | 0.9793 |
| 4029 | Vascular endothelial growth factor 3 antagonist | 361 | 0.9760 |
| 4030 | Vascular endothelial growth factor antagonist | 3913 | 0.9709 |
| 4031 | Vasculitis treatment | 26 | 0.9529 |
| 4032 | Vasodilator | 1105 | 0.8928 |
| 4033 | Vasodilator, coronary | 220 | 0.8584 |
| 4034 | Vasodilator, peripheral | 190 | 0.8519 |
| 4035 | Vasopressin 1 agonist | 17 | 1.0000 |
| 4036 | Vasopressin 1 antagonist | 951 | 0.9955 |
| 4037 | Vasopressin 1A agonist | 9 | 1.0000 |
| 4038 | Vasopressin 1A antagonist | 847 | 0.9968 |
| 4039 | Vasopressin 1B agonist | 8 | 1.0000 |
| 4040 | Vasopressin 1B antagonist | 292 | 0.9976 |
| 4041 | Vasopressin 2 agonist | 132 | 0.9986 |
| 4042 | Vasopressin 2 antagonist | 748 | 0.9976 |
| 4043 | Vasopressor | 124 | 0.8674 |
| 4044 | Vasoprotector | 22 | 0.8107 |
| 4045 | VCAM antagonist | 414 | 0.9894 |
| 4046 | VCAM-1 antagonist | 413 | 0.9894 |
| 4047 | VCAM1 expression inhibitor | 56 | 0.9502 |
| 4048 | VEGF expression inhibitor | 38 | 0.9414 |
| 4049 | VEGFR2 expression inhibitor | 5 | 1.0000 |
| 4050 | Venom exonuclease inhibitor | 8 | 0.8720 |
| 4051 | Venombin A inhibitor | 9 | 0.9829 |
| 4052 | Venombin AB inhibitor | 5 | 0.8818 |
| 4053 | Vesicant | 6 | 0.9937 |
| 4054 | Vesicle monoamine transporter 2 inhibitor | 13 | 1.0000 |
| 4055 | Vesicle monoamine transporter inhibitor | 14 | 0.9955 |
| 4056 | Vesicular acetylcholine transporter inhibitor | 75 | 0.9984 |
| 4057 | Vesicular glutamate transport inhibitor | 4 | 1.0000 |
| 4058 | Vestibular dysfunction | 10 | 0.9202 |
| 4059 | Vibriolysin inhibitor | 12 | 0.9987 |
| 4060 | Viral entry inhibitor | 66 | 0.8665 |
| 4061 | Viral fusion inhibitor | 3 | 1.0000 |
| 4062 | Visual acuity impairment | 6 | 0.8920 |
| 4063 | Vitamin | 102 | 0.9817 |
| 4064 | Vitamin D receptor agonist | 102 | 0.9996 |
| 4065 | Vitamin D receptor antagonist | 75 | 0.9998 |
| 4066 | Vitamin D3 hydroxylase inhibitor | 15 | 0.9992 |
| 4067 | Vitamin D-like | 16 | 0.9995 |
| 4068 | Vitamin K-like | 19 | 0.9995 |
| 4069 | Vitamin-K-epoxide reductase (warfarin-insensitive) inhibitor | 7 | 0.9471 |
| 4070 | Vitronectin receptor antagonist | 1721 | 0.9968 |
| 4071 | VLA-4 antagonist | 1119 | 0.9958 |
| 4072 | Vomilenine glucosyltransferase inhibitor | 6 | 0.9833 |
| 4073 | Weakness | 250 | 0.8054 |
| 4074 | Wee-1 tyrosine kinase inhibitor | 5 | 0.9985 |
| 4075 | Weight gain | 25 | 0.8546 |
| 4076 | Weight loss | 169 | 0.8296 |
| 4077 | Withdrawal | 13 | 0.8280 |
| 4078 | Wound healing agent | 282 | 0.9068 |
| 4079 | Xaa-Pro dipeptidyl-peptidase inhibitor | 11 | 0.9837 |
| 4080 | Xanthine dehydrogenase inhibitor | 93 | 0.9798 |
| 4081 | Xanthine oxidase inhibitor | 110 | 0.9576 |
| 4082 | Xanthine oxidase substrate | 42 | 0.9765 |
| 4083 | Xanthine phosphoribosyltransferase inhibitor | 39 | 0.9971 |
| 4084 | Xanthine-like | 23 | 0.9986 |
| 4085 | Xanthommatin reductase inhibitor | 5 | 0.9853 |
| 4086 | Xenobiotic-transporting ATPase inhibitor | 13 | 0.9191 |
| 4087 | Xerostomia | 405 | 0.8001 |
| 4088 | X-His dipeptidase inhibitor | 22 | 0.9765 |
| 4089 | X-methyl-His dipeptidase inhibitor | 10 | 0.8782 |
| 4090 | X-Pro dipeptidase inhibitor | 21 | 0.9855 |
| 4091 | X-Trp aminopeptidase inhibitor | 7 | 0.9944 |
| 4092 | Xylan 1,4-beta-xylosidase inhibitor | 14 | 0.9935 |
| 4093 | Xylan endo-1,3-beta-xylosidase inhibitor | 5 | 0.9716 |
| 4094 | Xylose isomerase inhibitor | 11 | 0.9872 |
| 4095 | YAK3 inhibitor | 15 | 0.9999 |
| 4096 | Yawning | 39 | 0.8661 |
| 4097 | Yeast ribonuclease inhibitor | 3 | 0.9616 |
| 4098 | ZAP-70 protein tyrosine kinase inhibitor | 104 | 0.9823 |
| 4099 | Zinc deficiency | 4 | 0.9747 |



